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During human embryonic development the first definitive haematopoietic stem cells (HSCs) arise in 
the aorta-gonad-mesonephros (AGM) region between Carnegie stages (CS) 13 to 17. More specifically, 
these HSCs are considered to derive from the endothelial cells of the dorsal aorta which undergo an 
endothelial-to-haematopoietic transition and bud into the lumen to form intra-aortic clusters of 
haematopoietic cells. This process is localised to the ventral domain and spatial polarisation of signals 
along the dorsal-ventral axis of the dorsal aorta has been shown to be essential for HSC emergence in 
the mouse AGM. This PhD project utilised laser capture microscopy coupled with RNA-Sequencing 
(LCM-Seq) to generate a spatial transcriptome map of the human embryonic AGM region and in doing 
so revealed many polarised genes and signalling pathways. Single cell and bulk sorted population RNA-
Seq analysis of the dorsal and ventral portions of the aorta further resolved signalling in the AGM both 
elucidating a gene signature for haematopoietic progenitors and mapping niche signals to cell 
populations. Genes encoding the blood pressure regulators renin and endothelin-1 were amongst the 
most ventrally enriched factors with elements of their signalling pathways expressed across the niche 
on perivascular, endothelial, haematopoietic progenitor and mature cells. Renin, endothelin-1 and 
endothelin-2 were functionally assessed for their role in promoting HSC emergence and were shown 
to enhance HSC production in culture of E9.5 caudal tissues of the mouse embryo as validated by 
enhanced reconstitution of the haematopoietic system of irradiated mice. The “transcriptome map” 
dataset generated in this study can be utilised to identify signals that promote HSC emergence and 






Haematopoietic stem cells (HSCs), which are stem cells that produce all the cells of the adult blood 
and immune system, are first generated in the early human embryo. The aim of this project was to 
investigate the biological signals and processes that lead to embryonic HSC generation. Specifically, 
HSCs develop in the dorsal aorta, the central blood vessel which runs through the body of the embryo. 
In this project we have investigated the cells of the dorsal aorta to see what genes are switched on at 
the exact time and place of HSC generation. This analysis will help reveal the mechanisms and 
processes underlying HSC production in the embryo. By understanding these signals we can hope to 
mimic them in a cell culture system and artificially generate HSCs. When successful, these HSCs would 
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 Overview  
The first long-term self-renewing haematopoietic stem cells (HSCs) which can generate all 
haematopoietic lineages first emerge during development within the embryo proper. In mammals, 
HSCs arise from endothelial cells in the dorsal aorta within a region of the embryo called the aorta-
gonad-mesonephros (AGM) region (Medvinsky and Dzierzak, 1996; Medvinsky et al., 1993). HSCs in 
the AGM are rare, and there are not currently markers which identify them from within the larger 
haematopoietic progenitor population which has hampered their characterisation and understanding 
of the mechanisms behind their emergence (Kumaravelu et al., 2002; Medvinsky, Rybtsov and Taoudi, 
2011). However, much progress has been made in the mouse model in revealing the complex signals 
in the AGM which underlie HSC generation. Yet there is relatively little known of the human AGM. This 
PhD project has investigated signalling within the human AGM niche, and in turn identified factors 
that support HSC generation with implications for ex vivo derivation of human HSCs for clinical 
translation.  
This introduction provides the background for the current understanding of haematopoiesis in the 
embryo and the mechanisms behind HSC emergence. It first describes what an HSC is in the adult 
context and their clinical importance. It then describes the specifics of what is known about 
haematopoiesis in the embryo from studies in model organisms, including an in-depth review of 
signalling in the niche, before describing what is known in the human system. Finally, an overview of 
progress in the endeavour to artificially generate HSCs for therapeutic applications highlights the 
utility of developmental haematopoiesis to inform translational studies.  
 What is a Haematopoietic Stem Cell? 
HSCs are the long-term self-renewing cells which, in the adult, reside in a specialised 
microenvironment within the bone marrow (BM) and give rise to all the mature cells of the blood and 
immune lineages throughout life.  Studies into the effects of radiation on the body following the 
nuclear bombs of WWII led to the discovery that the haematopoietic system is particularly sensitive 
to radiation(Armstrong et al., 2012). Soon after, experiments showed that transplantation of cells from 
haematopoietic tissues into irradiated mice facilitated haematopoietic regeneration and enhanced 
survival but investigators did not yet attribute this to the haematopoietic cells themselves(Jacobson 
et al., 1951). The clonality of haematopoietic cells and thus the existence of HSCs or progenitors was 
first shown in 1963 by Becker et al., with the finding that colonies of radiation damaged donor-derived 
BM cells transplanted in the spleens of irradiated mice were made up predominantly of cells with the 
same chromosomal aberration (Becker, McCulloch and Till, 1963). Later experiments that tracked 
retrovirally marked HSCs demonstrated their capacity to give regeneration of all lineages of the 
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haematopoietic system (Lemischka, Raulet and Mulligan, 1986). The advent of fluorescence-activated 
cell sorting (FACS) technologies to sort cells based on cell surface markers has helped to refine the 
phenotype of HSCs in the BM and facilitate their characterisation (Spangrude, Heimfeld and 
Weissman, 1988).   
Under physiological conditions, HSCs largely remain quiescent or slowly cycling  and give rise to rapidly 
cycling progenitors which generate the cell turnover required for a homeostatic haematopoietic 
system (Foudi et al., 2009; Wilson et al., 2008). The classical paradigm of the haematopoietic system 
sits HSCs at the top of a hierarchy progressing through a multipotent progenitor (MPP) with less self-
renewal capacity and through successive branching progenitors with progressively restricted potency 
until the mature haematopoietic cell is generated (Fig.1a). A critical point in this hierarchy is the first 
lineage bifurcation of progenitors with myeloid and lymphoid potential into common myeloid 
progenitors and common lymphoid progenitors respectively (CMPs, CLPs) (Kondo, Weissman and 
Akashi, 1997; Akashi et al., 2000). In recent years this paradigm has been challenged. The first wave of 
evidence gave rise to a more plastic model of differentiation with several multipotent progenitors with 
lymphoid, myeloid or megakaryocytic priming but retaining multilineage potential (Adolfsson et al., 
2005; Mansson et al., 2007; Cabezas-Wallscheid et al., 2014; Sanjuan-Pla et al., 2013). Furthermore, 
there was evidence that lymphoid progenitors still retained potential for some myeloid subtypes such 
as dendritic cells (DCs) and macrophages, indicating a branching point beyond that of the CLP 
(Doulatov et al., 2010; Adolfsson et al., 2005). Most recently, single cell analyses indicate that whilst 
the foetal haematopoietic hierarchy contains oligopotent progenitors, in the BM there is a more linear 
differentiation from a primed HSC/progenitor population with less clearly defined lineage branching 
points and only rare bipotent progenitors (Fig1.b) (Notta et al., 2016; Paul et al., 2015; Olsson et al., 




Figure 1. The revised haematopoietic hierarchy taken from Notta et al., 2016. a) The classical model shows a 
tree with bifurcating fate choices and stepwise lineage restriction. b) The redefined model shows some fate 
restriction in progenitors in the foetal system but unipotent differentiation from the stem cell compartment in 
the adult BM. 
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 The dawn of haematopoietic stem cell transplantation therapy 
The demonstrated sensitivity of haematopoietic cells to radiation in the post-war era along with the 
proven regenerative potential of donor haematopoietic tissues yielded the development of the first 
stem cell therapy – haematopoietic stem cell transplants (HSCTs).  These treatments, which were 
initially led by E. Donnall Thomas in the 50s and for which he was awarded the 1990 Nobel Prize in 
Physiology, are still the most common form of stem cell treatment today. According to the 2018 report 
from the European Society for BM Transplantation in 2017 there were 41,100 HSCTs in Europe alone 
to treat, in order of frequency, lymphoid and myeloid malignancies, solid tumours and other non-
malignant disorders (European Society for Bone Marrow Transplantation - Annual Report 2018, 2018). 
The patient is given radiation or chemotherapy which eradicates or depletes the cancerous 
haematopoietic cells but also any residual healthy clones. Then, healthy HSCs derived from the BM or 
umbilical cord blood (UCB) samples are transplanted into the patient where they home to the BM and 
reconstitute the haematopoietic system.  
However, there are obstacles to be overcome. HSCTs are either autologous (patients’ own cells) or 
allogeneic (donor derived). Allogeneic transplants need to be a close human leukocyte antigen (HLA) 
match which is not always possible, particularly due to the lack of ethnically diverse donor material. A 
poor match can lead to graft-versus-host disease (GVHD) where the immune cells of the transplant 
recognise the patient’s cells as non-self and launch an immune attack which can also lead to liver 
failure (Majhail, 2017). The immunosuppressive drugs required to reduce risk of GVHD also increases 
the patients’ susceptibility to infection and disease. Acute myeloid leukaemia (AML) survival rates for 
5 years for HLA-matched and unrelated donor HSCT are ~20-60% and ~20-50% respectively, depending 
on how early the disease is treated (D'Souza A, 2018) . 
There is a clear need for an alternative source of HSCs that provide quick reconstitution of the ablated 
haematopoietic system and that are well-tolerated by the patient without eliciting or executing an 
immune response. To this end, artificial generation of these HSCs ex vivo is the goal for many 
researchers in the field. This includes directed differentiation and reprogramming protocols to 
generate HSCs from embryonic stem cells (ESCs) although these cells, if poorly matched to the patient 
may still be immunogenic (Drukker and Benvenisty, 2004). Another strategy is to take the patients’ 
own cells, screen them for the cancer-causing mutagens or gene-correct them, re-program them into 
pluripotent stem cells (PSCs) called induced PSCs (iPSCs) then direct differentiation towards HSCs. In 
this way, a need for a donor match would be negated. Furthermore, methods to expand HSCs in 
culture without losing their ‘stem-ness’, i.e. their multilineage potential and long-term self-renewal 
capacity, need to be refined. Recent reports have demonstrated great progress in the expansion of 
mouse HSCs ex vivo through fine tuning of levels of key secreted factors in culture (Wilkinson et al., 
2019). Furthermore, recent clinical trials have demonstrated safe engraftment of human umbilical 
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cord blood HSCs expanded with the cell cycle agonist UM171 (Cohen et al., 2020). Further refinement 
of these methods would not only generate a source of HSCs for transplantation, but they would also 
provide a potentially limitless supply for in vitro drugs and therapy testing, as well as provide easily 
manipulatable models of disease (Daniel et al., 2016). A deep understanding of the niche signals that 
promote HSC development in vivo facilitates optimisation of culture protocols that mimic this 
development from PSCs.  
 The embryonic origins of HSCs 
The onset of haematopoiesis in the embryo occurs in 3 sequential waves. The first two are transitory 
and generate haematopoietic progenitors to meet the immediate needs of the developing embryo 
and subsequently the third wave generates adult-type self-renewing HSCs that power the 
haematopoietic system throughout life (Fig.2).  
i: The primitive wave 
The first wave occurs around embryonic day (E) 7.5 in the mouse and is referred to as the ‘primitive 
wave’. This takes place in the yolk sac (YS) in mesoderm derived clusters of cells adhering to the yolk 
sac endoderm termed ‘blood islands’ (Ferkowicz and Yoder, 2005). These blood islands are the site of 
generation of primitive erythroid progenitors and nucleated erythrocytes which express embryonic-
specific haemoglobins (Palis et al., 1999). These enter the bloodstream at the onset of circulation at 
E8.25 and provide oxygen to the growing tissues which are now too large to receive sufficient oxygen 
by diffusion. During the primitive wave, macrophages and megakaryocytes are also generated (Palis 
et al., 1999; Tober et al., 2007).  
ii: The second or ‘pro-definitive’ wave 
The second wave beginning at E8.25 which also takes place in the yolk sac is defined by production of 
erythro-myeloid progenitors (EMPs) which generate erythroid cells expressing a unique combination 
of embryonic and adult-type haemoglobins along with myeloid cells (Bertrand et al., 2005; Palis et al., 
1999; Tober et al., 2007; McGrath et al., 2011). Furthermore, from E9 there is production of MPPs with 
granulocytic, monocytic and the first lymphoid potential but without erythroid and megakaryocytic 
potential (Yoshimoto et al., 2012; Boiers et al., 2013; Palis et al., 1999; Tober et al., 2007). The 
progenitors of these restricted MPPs derive from endothelial cells with haematopoietic potential 
termed haematogenic (Yoshimoto et al., 2012). The second wave cells are generally considered to 
serve the embryonic and foetal immune systems, but there is a growing body of evidence that some 




iii: The definitive wave 
The third wave of haematopoiesis occurs within the embryo proper and produces adult-type HSCs 
termed definitive HSCs. Evidence for an intraembryonic origin of adult haematopoiesis first emerged 
in the 70s with seminal experiments from Dieterlen-Lièvre in the avian model (Dieterlen-Lievre, 1975). 
An inter-species chimera was generated comprising a quail body and chick extra-embryonic tissue 
which demonstrated that before hatching, the haematopoietic tissues were colonised by quail, and 
therefore intra-embryonic derived, cells. Later publications by Lassila et al., confirmed this observation 
in the adult bird (Lassila et al., 1978). Prior to this, haematopoiesis was widely considered to originate 
solely from the yolk sac. An intraembryonic production of adult-type haematopoiesis was then 
confirmed in the amphibian system (Maeno, Tochinai and Katagiri, 1985; Ciau-Uitz, Walmsley and 
Patient, 2000; Turpen, Knudson and Hoefen, 1981). However, it was a while longer before it was 
demonstrated in the mammalian system. Pivotal findings came in 1993 utilising as a measure of MPP 
haematopoietic capacity the Colony-Forming Unit-Spleen (CFU-S) Assay whereby haematopoietic cells 
are injected into sub-lethally irradiated mice and macroscopic haematopoietic colonies in the spleen 
are measured. In this paper, CFU-S were not found in the YS  prior to E9.5 despite the production of 
blood there since E7.5 (Medvinsky et al., 1993). Furthermore, when the yolk sac begins producing CFU-
S from E9.5, there is a consistently higher production in the intraembryonic region of the aorta-gonad-
mesonephros (AGM) region which comprises the dorsal aorta and the urogenital ridges (UGRs). 
Subsequently, it was determined that HSCs arise in the AGM at E10 before the YS by using the gold-
standard test of an HSC, the long-term repopulation assay (Medvinsky and Dzierzak, 1996; Muller et 
al., 1994). This involves injection of donor cells into an irradiated recipient mouse and analysis of its 
capacity for reconstitution of the haematopoietic system. A definitive (adult-type) HSC is defined by 
its ability to provide long-term, multi-lineage reconstitution of the haematopoietic system in this assay 
which remains the only true read-out of an HSC. 
Although, this study indicated definitive haematopoiesis is initiated in the AGM, it could not be ruled 
out that it is not also initiated in the YS. A novel organ culture system allowed separate culturing of  
AGM and YS explants from E10 and E11 embryos and showed conclusively that although both gave 
rise to CFU-S in culture, only the AGM has cell-autonomous generation of HSCs (Medvinsky and 
Dzierzak, 1996). HSCs in the AGM specifically emerge between E10.5 and E11.5 and are rare with 
approximately 1-3 per AGM quantified by transplanting several dilutions of low AGM cell numbers into 
irradiated recipient mice (Kumaravelu et al., 2002; Medvinsky and Dzierzak, 1996). They then migrate 
to the foetal liver and undergo significant expansion (Johnson and Moore, 1975; Houssaint, 1981; Ema 
and Nakauchi, 2000; Kumaravelu et al., 2002) before they migrate to the adult haematopoietic niches; 
the BM, the spleen and the thymus.  In zebrafish, HSCs colonise the caudal haematopoietic tissues 
(CHT), which is the equivalent HSC expansion niche to the mammalian foetal liver, via the posterior 
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cardinal veins (Kissa et al., 2008) and a similar colonisation via the blood vessels is expected in the 
mammalian system.  
The degree of relatedness between the 3 waves of haematopoiesis is not yet fully understood. One 
model suggests that the 3 waves derive from the same haematogenic endothelial cell that undergoes 
3 distinct spatio-temporally controlled maturations (Dzierzak and Bigas, 2018) although primitive 
EMPs show, at least in part, separate mesodermal origins to the later waves (Zovein et al., 2010). 
Alternatively, the haematopoietic cells from each of the 3 waves may derive from distinct cell types. 
Indeed, HSCs and second wave EMPs have been shown to derive from distinct haematogenic 
endothelial cell populations (Chen et al., 2011). It was also postulated that the cells from earlier waves 
are required for the specification and/or maturation of HSCs in the definitive wave and it has been 
shown that myeloid cells from earlier waves produce inflammatory signatures that promote HSC 
emergence (Espin-Palazon et al., 2014; Mariani et al., 2019).  Fine dissection of the spatio-temporally 
controlled signalling events that lead to the differential development of the 3 waves will be of great 
importance to facilitate future in vitro HSC derivation cultures.  
 
 
Figure 2. Haematopoiesis during mouse embryonic development adapted from Yoder MC, 2014 (Yoder, 2014). 
Haematopoiesis in the mouse embryo occurs in three waves of increasing developmental complexity in different 
tissues and haematopoietic organs culminating in the production of adult-type HSCs in the AGM and extra-





 Other sites of haematopoiesis in the embryo 
 Placenta 
The placenta is also a source of HSCs in the embryo, but it remains uncertain over whether they 
emerge there or have migrated there from the AGM. They appear there within the same time window 
as HSC emergence in the AGM between E10.5 and E11.5 but soon expand to much higher numbers 
than in the AGM; 13 – 50 HSCs at E12.5 (Ottersbach and Dzierzak, 2005; Gekas et al., 2005). The strong 
association of the HSCs with the endothelial cells in position and gene expression indicates derivation 
from a haematogenic endothelium and the placentas in Ncx1(-/-) mice which lack blood circulation 
generate cells with myelo-erythroid and lymphoid potential(Gekas et al., 2005; Ottersbach and 
Dzierzak, 2005; Rhodes et al., 2008).  However placenta explant cultures have failed to maintain HSCs 
so direct evidence for autonomous production of HSCs in the placenta is lacking (Gekas et al., 2005; 
Ottersbach and Dzierzak, 2005; Robin et al., 2006).  
 Vitelline and umbilical arteries 
The extraembryonic vitelline and umbilical arteries which connect the dorsal aorta to the yolk sac and 
placenta respectively also contain haematopoietic clusters and functional HSCs as demonstrated by 
repopulation assays(de Bruijn et al., 2000; Garcia-Porrero, Godin and Dieterlen-Lievre, 1995). 
Furthermore, culture of these vessels under conditions that support HSC maturation from precursors 
(more details in section 1.6.1) expanded the numbers of HSCs indicating that the extra-embryonic 
arteries are sites of HSC generation (Gordon-Keylock et al., 2013).  
 Head 
Multilineage LT-HSCs have also been shown to emerge in the embryo head concomitantly with AGM 
HSC emergence at E10.5 – E11.5(Li et al., 2012). However, attempts to visualise an EHT in the head 
were unsuccessful (Iizuka et al., 2016; Li et al., 2016).  Therefore, HSC migration to the head from the 
AGM or other tissues cannot be ruled out. 
 HSC development in the AGM 
Within the AGM, HSCs emerge within the dorsal aorta as demonstrated by reconstitution of irradiated 
mice by cells from the dorsal aorta but not the UGRs (Taoudi and Medvinsky, 2007b; de Bruijn et al., 
2000). Their emergence (E10.5-11.5 in mouse) is concurrent with the appearance of clusters of 
haematopoietic cells adhering to the ventral endothelial cells of the dorsal aorta and budding into the 
lumen referred to as intra-aortic haematopoietic clusters (IAHCs) (Fig.3) (Medvinsky et al., 1996). 
IAHCs are considered to contain the emerging HSCs and haematopoietic progenitors. The close 
positional relationship with the endothelium and their expression of both endothelial (CD31, VE-
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Cadherin) and haematopoietic (CD45) markers suggests that these cells, like the second wave 
haematopoietic cells, derive from the endothelial cells themselves in a process called endothelial-to-
haematopoietic transition (EHT), evidence of which has been shown in several organisms (Fig.3b). In 
the chick, IAHCs are traced from endothelial cells by intra-aortic labelling with low-density lipoproteins 
before IAHCs appear (Jaffredo et al., 1998).  In zebrafish live imaging shows KDR+ endothelial cells 
change morphology becoming more rounded in shape,  budding into the lumen and begin expression 
of transcription factors (TFs) required for haematopoiesis (Runx1, cMyb) (Bertrand et al., 2010; Kissa 
and Herbomel, 2010). This live change in cell fate occurred without cell division but a marked 
morphological change and movement away from the endothelium thus demonstrating EHT. Strong 
evidence for mammalian EHT has been provided by ES cell cultures in which endothelial cells, derived 
from a mesodermal cell intermediate, were shown to lose their tight junctions, become less adherent 
and gain a rounded haematopoietic morphology as they concomitantly upregulated haematopoietic 
markers and downregulated endothelial markers (Eilken, Nishikawa and Schroeder, 2009; Lancrin et 
al., 2009). Furthermore, in the mouse freshly cut thick transverse sections of the dorsal aorta from 
Sca1-GFP mice, which marks HSCs, showed single GFP+ cells budding from the ventral endothelium 
(Boisset et al., 2010). The frequency of EHT events per embryo was originally estimated to be 1.7  in 
line with estimations for the number of HSCs in an AGM (Boisset et al., 2010). However, a recent study 
visualising EHT in a similar way but with expression of the TF Gata2 marking HSCs, estimated ~20 EHT 
events per embryo(Eich et al., 2018). This higher number is more in line with IAHC numbers in the 
embryo and the numbers of HSC pre-cursors which are discussed in greater detail in section 1.6.  
  
 
Figure 3. Intra-aortic haematopoietic clusters (IAHCs) appear in the dorsal aorta adherent to the ventral 
endothelium. a) IAHCs appear at E10.5 in the mouse and express endothelial (VE-Cadherin, VC) and haematopoietic 
markers (Runx1 and CD45). D = Dorsal, V= Ventral, Ao = Dorsal Aorta. Arrows indicate IAHCs. b) IAHCs contain 






















Questions remain over how the endothelium is specified to become haematogenic. As HSC and IAHC 
emergence is predominantly spatially polarised to the ventral portion of the dorsal aorta, what makes 
the ventral endothelium haematogenic and the dorsal not? In the avian model the ventral floor and 
the dorsal roof of the aorta have distinct origins, deriving from the lateral and somitic mesoderm 
respectively, intimating that differing ancestral origins distinguish haematogenic from non-
haematogenic endothelium (Pardanaud et al., 1996). In the mouse, in vivo labelling has shown that 
the endothelium of the dorsal aorta and IAHCs derive from the lateral plate mesoderm (LPM) as does 
the endothelium of the other sites of haematopoiesis; the vitelline artery and its clusters and the 
placenta (Zovein et al., 2010). No clear dorsal-ventral differences in mesodermal origins of the dorsal 
aorta suggest either a later divergence in haematogenic vs non-haematogenic fate or in situ 
haematopoietic competence specified by the niche. In zebrafish there is evidence of haematogenic 
specification in the mesoderm. The mesoderm starts upregulating endothelial (Flk1, Fli1) markers 
followed by haematopoietic markers (Scl, Gata2, Lmo2) even before migration below the notochord 
and formation of the dorsal aorta (Dooley, Davidson and Zon, 2005; Gering et al., 1998). Furthermore, 
Notch signalling between migrating posterior lateral mesoderm cells destined to become endothelium 
and the somites is required for the later emergence of haematopoietic cells in the dorsal aorta 
suggesting that haematogenic endothelium may be specified, at least in part, en route (Kobayashi et 
al., 2014). 
 The HSC hierarchy   
 HSCs in the AGM mature from pre-HSCs 
There are an estimated 1-3 HSCs in the AGM as determined using a limiting dilution transplantation 
analysis (Kumaravelu et al., 2002). Importantly, 1 HSC is sufficient to reconstitute the haematopoietic 
system of an irradiated recipient. Several dilutions of low cell numbers are required to quantify the 
numbers of HSCs, based on the ratio between repopulated and non-repopulated animals (Szilvassy et 
al., 1990). Explant cultures of the AGM region are able to expand HSC numbers indicating their 
maturation from precursor cells (Medvinsky and Dzierzak, 1996). The development of a reaggregate 
culture system has greatly facilitated investigation into these potential precursors to HSCs or ‘pre-
HSCs’ (Taoudi et al., 2008; Rybtsov et al., 2011). This involves dissociation of the AGM and either all 
cells are used or labelled cell populations are selected by FACS so that their fate can be tracked later. 
The cells are co-aggregated into balls with the AGM stromal cells or supportive OP9 stromal cells. 
These aggregates are then cultured on a membrane floating on pro-haematopoietic media including 
the cytokines SCF, IL-3, and Flt-3 which allow pre-HSCs to mature which can be then tested by 
transplantations using a long-term repopulation assay. 
Direct transplantations into adult irradiated recipients showed that AGM HSCs are within the 
population of VC+CD45+ cells (Taoudi et al., 2005)(Fig.4). Floating aggregate cultures of E11.5 AGMs 
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for 4 days dramatically increased numbers of HSCs from 1 per AGM to ~150 (Taoudi et al., 2008). 
Analysis of the division rates of cells in the cultures showed that the majority of HSCs are dividing 
slowly and could not account for the large increase in HSC numbers. This demonstrated that rather 
than high proliferation of the single initial HSC there is recruitment of precursor cells into HSCs. These 
pre-HSCs, termed pre-HSC II, were also within the VC+CD45+ compartment. There has since been 
discovery of even earlier precursors which sequentially develop into HSCs called, in order of 
development, pro-HSC and pre-HSC I (Rybtsov et al., 2011; Rybtsov et al., 2014). Pre-HSC I were 
discovered through the observation that although E10.5 AGMs do not reconstitute irradiated mice in 
the repopulation assay, indicating a lack of HSCs, 4 day ex vivo aggregate culture generated HSCs from 
the VC+CD45- fraction (Rybtsov et al., 2011). These cells were subsequently shown to mature into 
HSCs via a pre-HSC II intermediate and express at low levels the haematopoietic marker CD41, 
distinguishing them from the VC+CD45- endothelial cells. Pro-HSCs emerge at E9.5 and required a 
longer culture period of 7 days in order to derive HSCs from them consistent with their development 
through pre-HSC I and pre-HSC II intermediates (Rybtsov et al., 2014). These cells are VC+CD45-CD41lo 
and are distinguishable from pre-HSC I by the lack of CD43 expression.  
 
 
Figure 4: Murine HSCs develop from haematogenic endothelium (HE) through stepwise production of 
precursors. Taken from Rybtsov et al, 2014. A schematic of HSC development shows endothelial-to-
haematopoietic transition through precursor intermediates; pro-HSCs at E9 which upregulate CD41 but lack 
CD43/CD45 expression, pre-HSC I at E10-11 which have low CD41 expression but begin to express CD43 and 
finally, pre-HSC II which upregulate expression of CD45 are immunophenotypically similar to HSCs which appear 
at E11. Runx1, VE-Cadherin, and cKit are expressed throughout.  
 
 Quantification and dynamics of pre-HSCs 
Limiting dilution analyses quantified the numbers of pre-HSCs through HSC development identifying 
only 1 or 2 pro-HSCs at E9.5, 20-30 pre-HSCs at E10.5 and 65 at E11.5, dropping down to 10 at E12.5 
(Rybtsov et al., 2016). Notably, the extra-embryonic vitelline and umbilical arteries also contain pre-
HSCs capable of maturing into adult-type HSCs (Gordon-Keylock et al., 2013). The foetal liver does not 
contain any pre-HSCs further demonstrating that HSC maturation is localised to the AGM and extra-
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embryonic vessels prior to migration to the foetal liver (Rybtsov et al., 2016). The expansion of pre-
HSCs in the AGM region is more in line with the numbers of definitive HSCs (50-60) found in the foetal 
liver than the 1-3 AGM HSCs which would have to undergo intensive proliferation within too short a 
time (Kumaravelu et al., 2002; Ema and Nakauchi, 2000). These proliferation dynamics were visualised 
with Fucci dual reporter mice which differentially label cells in G0/G1 and S/G2/M phases (Batsivari et 
al., 2017). Pro-HSCs at E9.5 arise from actively cycling endothelial cells but are slowly cycling 
themselves. At E10.5 and 11.5 the pre-HSC I and II populations are both actively cycling which 
corresponds to the expansion seen at this stage. Finally, HSCs are slowly cycling, corresponding to their 
low number in the AGM. Single cell analyses of the E11 pre-HSC populations resolved their dynamics 
further, demonstrating populations of actively proliferating and relatively quiescent pre-HSCs which 
were CD168+ and CD168- respectively. Notably the proliferating cells gave higher chimerism 
reconstitution in vivo indicating that proliferating pre-HSCs are predisposed to become HSCs (Zhou et 
al., 2016). 
  Dynamic gene expression across the EHT 
 Master transcription factors specifying HSC generation 
There are several transcription factors (TFs) involved in specifying HSC generation from the 
haematogenic endothelial cells and various combinations of these have been used to reprogram cells 
into HSCs (discussed in greater detail in section 1.10.2). The TFs described in this section are 
considered master regulators due to their critical roles upstream of many other haematopoietic TFs 
and their loss of function results in serious haematopoietic defects. 
The earliest specification towards adult-type HSC generation occurs in the lateral plate mesoderm 
(LPM). These TFs include FLI1, ETV2, GATA2 and SCL/TAL1. In the Xenopus model, these TFs are 
responsible for specification of the LPM to become hemangioblasts; cells which will later migrate to 
the midline to form the dorsal aorta and give rise to haematogenic endothelium and HSCs (Ciau-Uitz 
et al., 2013). Fli1 and Etv2 induce expression of Gata2 which in turn activates the expression of the 
vascular endothelial growth factor (VEGF) receptor Flk1. This allows cells to become responsive to 
VEGFA signalling, a pathway required for activation of SCL expression and, in turn, specification of the 
hemangioblast  (Ciau-Uitz et al., 2013; Ciau-Uitz et al., 2010). In the mouse, SCL patterns the mesoderm 
to become blood-forming extraembryonic and LPM over paraxial mesoderm (Ismailoglu et al., 2008).  
During migration of the hemangioblast cells to the midline to form the dorsal aorta SCL and Gata2 
expression is reported to be lost (Ciau-Uitz, Walmsley and Patient, 2000). However, they both have 
additional critical roles in the generation of HSCs. In zebrafish, one isoform of SCL, scl-β was required 
for formation of the haematogenic endothelium whereas the second isoform, scl-α was required for 
the maintenance of HSCs after EHT (Zhen et al., 2013). GATA2-/- human embryonic stem cell (ESC) 
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culture directed to HSC fate was used to model its effects on EHT and found that GATA2 was not 
required for the haematogenic endothelium specification but is a critical regulator of EHT (Kang et al., 
2018). In vivo imaging of thick transverse sections of the dorsal aorta provided live imaging of Gata2 
cells undergoing EHT (Eich et al., 2018; Nottingham et al., 2007). Gata2 is also required for the 
continued survival of HSCs following EHT (de Pater et al., 2013).  
Gata2 and SCL act upstream of the TF Runx1 (Nottingham et al., 2007). Runx1 is a well-studied TF with 
an essential role in the generation of HSCs. It is expressed in the mesoderm of the murine YS blood 
islands as well as the haematogenic endothelium and IAHCs of the dorsal aorta and extra-embryonic 
vessels (North et al., 1999) which corresponds with its involvement in specification of both 
haematopoietic progenitors and HSCs from endothelial cells. Runx1 knock out resulted in an absence 
of IAHCs in the dorsal aorta suggesting that is involved in EHT (Yokomizo et al., 2019; Yokomizo et al., 
2001; North et al., 1999). This has been demonstrated with live imaging in zebrafish where a 
morpholino knock down (KD) of Runx1 inhibited EHT and any cells that did attempt to emerge from 
the aortic endothelium were abortive and disintegrated soon after (Kissa and Herbomel, 2010). A 
conditional knock out (cKO) of Runx1 in the dorsal aorta endothelium of mice prevented HSC 
emergence suggesting a similar critical role in EHT regulation (Chen et al., 2009). However, unlike 
Gata2, Runx1 was not necessary for cell survival following specification and HSC formation. Runx1, has 
been shown to regulate not only key haematopoietic genes but also those involved in cell adhesion 
and migration, a key part of the EHT process(Lie et al., 2014). 
The above factors form part of a network of highly interconnected TFs. Fli1, despite being expressed 
later than SCL during directed ES cell differentiation towards haematopoietic cells, has been shown to 
induce expression of SCL as well as Runx1, Gata2 and other HSC specification TFs Lmo2 and Etv2 
putting it at the top of the HSC specification hierarchy (Liu et al., 2008; Lichtinger et al., 2012). Runx1 
expression in HSCs is controlled by an enhancer region that recruits Fli-1, SCL and Gata2 (Nottingham 
et al., 2007). Interesting dynamics in binding patterns of the TFs have been shown in an ES culture 
model of EHT (Lichtinger et al., 2012). In response to RUNX1 expression, SCL and Fli1 shift their 
enhancer binding patterns in the haematogenic endothelium to the haematopoietic precursor cells 
where they bind the motifs of genes involved in HSC specification including GATA2 and RUNX1 sites. 
RUNX1 then binds the original SCL and FLI1 binding sites, which it was proposed, have been primed 
for rapid activation by RUNX1. This highlights the finely controlled and inter-woven regulation by these 
master TFs in the specification of HSCs from their mesodermal origins.  
 Acquisition and loss of arterial cell fate 
HSC development in the embryonic blood vessels occurs exclusively in the arteries and not in the veins 
(Taoudi and Medvinsky, 2007a; de Bruijn et al., 2000). The relationship between arterial fate and HSC 
emergence has been shown to be closely coupled as several upstream regulators of arterial over 
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venous identity including Notch and Hedgehog signalling are required for HSC specification(Gering and 
Patient, 2005; Burns et al., 2005). Similarly, Sox17 expression is required for both arterial specification 
and HSC formation (Clarke et al., 2013; Corada et al., 2013). However, although arterial specification 
is required for EHT, the arterial fate program must then be repressed in order to allow transition 
towards the haematopoietic fate, visualised by a Sox17 downregulation in the IAHCs(Lizama et al., 
2015). Sox17 was found to directly bind Runx1 and Gata2 upstream 5’ untranslated regions, inhibiting 
their expression. Conversely Sox17 deletion induced at E9.5 at the onset of EHT increased Runx1 and 
Gata2 expression and reduced other arterial markers such as Dll4. Downregulation of Notch has also 
been shown to be important for EHT (Souilhol et al., 2016b). Furthermore, it was shown recently that 
the regulated mRNA decay of arterial genes Notch and rhoca allows progression to haematopoietic 
fate (Zhang et al., 2017). 
 Single cell analyses reveal EHT dynamics 
The explosion in single cell RNA-Seq analyses in recent years has facilitated the investigation into the 
molecular underpinnings of EHT. A single cell analysis of E11 AGM EHT populations (Endothelial cells, 
pre HSC I/II, E12 and E14 foetal liver HSCs) revealed enrichment of the mTOR pathway in pre-HSC I, 
which regulates cell metabolism, growth, proliferation and survival (Zhou et al., 2016; Laplante and 
Sabatini, 2009). It was subsequently shown that endothelial disruption of the core mTORC2 
component, Rictor, prevented HSC emergence from AGM explant cultures. It was also found that pre-
HSC II expressed the highest amount of long non-coding RNAs (lncRNAs). The same group recently 
performed single cell analyses of the EHT populations but focused specifically on the differential 
expression of lncRNAs (Zhou et al., 2019). They found highly distinctive lncRNA expression profiles 
resolved to each population and through a functional screening determined H19 lncRNA as a key 
mediator of the transition from endothelial cells to pre-HSC I. The heightened methylation levels at 
the promoters of key HSC development genes in H19 mutants led the authors to suggest the lncRNA 
helps regulate EHT via demethylation of haematopoietic program promoters. These studies highlight 
the power of single cell analyses to inform on the multi-layered mechanisms of HSC. 
Another single cell dataset was acquired from multiple sorted cell populations across the EHT at E10 
and E11 (Baron et al., 2018). Hierarchical clustering of TF expression across the dataset highlighted TF 
dynamics across the EHT pseudotime including endothelial Sox17 and Hey2 expression, haematogenic 
endothelial Elk3, Jun and Mecom expression, EHT or pre-HSC TFs Gfi1, Runx1, Ikzf2 and lastly 
haematopoieis and differentiation TFs including Myb, Zpfm1 and Lyl1. Another single cell study of the 
EHT populations in the mouse AGM elucidated CD44 as a new marker of EHT with low expression on 
pro-HSCs and pre-HSC I and higher expression on pre-HSC II (Oatley et al., 2020). A recent study 
profiled single cells from the early human dorsal aorta which also indicated CD44 as an enrichment 
marker for the human haematogenic endothelium (Zeng et al., 2019).  
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 Signalling in the aorta-gonad-mesonephros region 
During embryonic development, HSCs emerge and mature under the influence of differentiation cues 
from an environment that is in a constant state of growth and morphological change. Rather than 
receiving niche signals from mature neighbouring cells as is the case in many adult stem cell niches, 
the embryo stem cell is likely to be in the vicinity of many other stem cells with alternative lineage 
trajectories which also require a unique set of cues. These cells must act synergistically with one 
another to form the dynamic structures of the developing embryo. To achieve this high level of co-
ordination each cell must have an exact positional and temporal identity. Often, in the embryo this is 
achieved with overlapping signalling gradients across tissues and the intersection of broad and local 
signals. The result is that the developmental stem cell niche is often complex, multi-layered and 
overlapping with other niches. This sub-section explores what is known about signalling in the AGM 
and how these pathways intersect  
 Polarisation of the niche.    
As previously mentioned, HSC emergence in the AGM is polarised to the ventral domain of the dorsal 
aorta both in mice and in humans (Ivanovs et al., 2014; Taoudi and Medvinsky, 2007a).  Efforts to 
determine how these spatial cues are provided revealed the important role of polarised signalling from 
the tissues surrounding the aorta (Peeters et al., 2009). Transplantation of the AGM with the ventral 
tissues, including the gut, generated higher CFU-S numbers than the AGM alone. Conversely, co-
transplantation with the dorsal tissues significantly reduced CFU-S numbers. Correspondingly, only 
early E10 AGM explants cultured with the ventral tissues gave repopulation following transplantation, 
compared to AGM alone and AGM cultured with the neural tube (Peeters et al., 2009).  
Signalling from the niche is more complicated than supportive ventral signals and inhibitory dorsal 
signals however. An elegant study from Souilhol et al., demonstrated how the interplay of signals from 
the dorsal, ventral and urogenital ridges fosters an enhancing environment for HSC generation 
(Souilhol et al., 2016a). The dorsal and ventral portions of the dorsal aortae from GFP and wild-type 
(WT) mice were sub-dissected and cultured together as aggregates in different combinations; 
ventral/ventral, dorsal/dorsal or ventral/dorsal and transplanted intro irradiated mice. The GFP 
allowed relative contributions of each subdomain to be tracked. Notably, although the majority of HSC 
contribution came from the ventral domain, at E10.5 this effect was greatly enhanced by the presence 
of the dorsal domains compared to culture of ventral alone. However, this effect was no longer evident 
by E11.5 (Fig.5). Furthermore, culturing with UGR gave enhanced HSC production than without.  
The same study defined some polarised signalling molecules across the AGM and proposed a model 
where the intersection of their gradients creates an optimal zone for HSC emergence in the ventral 
aorta (Souilhol et al., 2016a) (Fig.5). This includes a gradient of Stem Cell Factor (SCF) from the ventral 
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domain which, in culture, was able to stimulate increased HSC production from the dorsal domain. 
SCF has also previously been shown to support maturation of HSCs from E9 pro-HSCs (Rybtsov et al., 
2014). Sonic hedgehog (Shh) was dorsally polarised, as can be expected from its production in the 
notochord located dorsally above the aorta and could enhance HSC generation from the ventral 
domain. BMP signalling and downstream effector P-Smads,1,5 and 8 were ventrally enriched in the 
sub-aortic-mesenchyme but downregulated in the clusters and in the progression from pre-HSC I to 
pre-HSC II. Shh induced Noggin, a BMP inhibitor providing a potential link between these pathways in 
regulation of HSC emergence. Intriguingly, two types of HSCs are found in the AGM – BMP-activated 
HSCs and non-BMP activated/Hedgehog regulated HSCs – highlighting the complexity of signal control 
in the microenrvironment (Crisan et al., 2016).  Such gradients of signalling are a classic example of 
how cells in the embryo are given their identity in space and time. 
 
 
A comprehensive investigation into polarised signalling in the mouse AGM niche at E9.5-E10.5 has 
recently been carried out through RNA-Seq analysis of the sub-dissected ventral and dorsal domains 
of the dorsal aorta (AoV and AoD respectively) and UGRs (McGarvey et al., 2017). The spatially 
resolved transcriptome elucidated genes and signalling pathways polarised to each of these domains. 
There were several pathways enriched in the E10.5 AoV as compared with E9.5 AoV (to indicate signals 
required for pro-HSC maturation) and the E10.5 AoD. These included pathways with already implicated 
signalling roles in the niche including pro-inflammatory pathways, SCF/Kit, VEGF and TGF-β. In line 
Figure 5 Polarised signalling in the mouse AGM region, taken from (Souilhol et al., 2016a). HSC emergence is 
localised to the ventral domain of the dorsal aorta but signalling from the dorsal domains and urogenital ridges 
(UGRs) enhances HSC emergence. This is a proposed model of how polarised signalling pathways in the AGM may 
intersect to create an optimal development zone for HSCs in the ventro-lateral region of the dorsal aorta. 
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with the above mentioned ventral enrichment of BMP effectors but down-regulation in the IAHCs 
(Souilhol et al., 2016a) BMP signalling was ventrally enriched in this dataset including both BMP ligands 
and inhibitors. Critically, one of these inhibitors BMPER, enhanced HSC generation in culture as 
demonstrated with a repopulation assay. This is a good example of how spatially resolved data can be 
used to inform on important niche signals supporting HSC generation. 
 Signalling in the HSC developmental niche 
 The studies described in the above section highlighted some of the signalling molecules in the HSC 
niche which interact to enhance HSC production, including SCF, Shh, Noggin and BMP4 (Rybtsov et al., 
2014; McGarvey et al., 2017; Souilhol et al., 2016a). Additional key signalling pathways have also been 




Figure 6. Signalling in the HSC developmental niche taken from (Ciau-Uitz A, 2016). Schematic of the complex, 
highly interactive signalling within the AGM that act synergistically to activate key transcription factors and 
promote HSC emergence. This includes Notch, Wnt and inflammatory signalling pathways, signalling from 
catecholamines and hormones as well as signals initiated by blood flow shear stress forces through the dorsal 





As discussed previously the Notch family members are involved in specification of arterial over venous 
fate (Lawson et al., 2001) but must be down-regulated for HSCs to emerge (Zhang et al., 2017; Souilhol 
et al., 2016b). Notch1 expression is downregulated from pre-HSC I to II and further in HSCs. 
Correspondingly, co-culture with OP9s with active Notch signalling impaired maturation of pre-HSC I 
to II (Souilhol et al., 2016b). Taken together this highlights how haematogenic endothelium 
specification is de-coupled from pre-HSC to HSC maturation through precisely controlled regulation of 
signalling molecules. Notch signalling is a central pathway within the HSC specification process at 
multiple stages and, as demonstrated below, is highly connected with other niche signalling pathways. 
 Wnt signalling 
Wnt signalling is another pathway with documented roles at several time points along the HSC 
production pathway demonstrating both temporal and Wnt-family member specific regulation. In 
zebrafish, Wnt16 was shown to be required for the production of HSCs in the dorsal aorta, but 
intriguingly, the mechanism of action took place before the dorsal aorta had even been formed 
(Clements et al., 2011). Wnt16 acts through the non-canonical signalling pathway triggering Notch 
signalling in the somites which acts on vascular precursors as they migrate across the somites 
bestowing them with the ability to become HSCs in the dorsal aorta (Kobayashi et al., 2014). This 
reinforces the idea that HSCs are at least in part specified before EHT and highlights another spatio-
temporally defined role of Notch signalling. In mouse, Wnt signalling also has a role in specifying HSCs 
from the endothelium itself, acting through its canonical pathway effector β-catenin at E10.5 but with 
little or no effect by E11.5 (Ruiz-Herguido et al., 2012). Although in that study Wnt was acting 
specifically on the endothelial cells and not the HSC progenitors, a zebrafish study showed that 
independently of HSPC specification Wnt9a amplifies HSPCs in the dorsal aorta prior to migration to 
the CHT (Grainger et al., 2016).  
 Hedgehog signalling 
Hedgehog (Hh) signalling is also required at multiple stages in the early development of HSCs from the 
mesoderm. It is required for the migration of mesodermal endothelial progentiors to the midline to 
form the dorsal aorta (Gering and Patient, 2005). It is then also required for specification of the 
endothelial cells to become arterial which, with VEGF, act upstream of Notch (Lawson et al., 2001). 
Although Hh signalling from the dorsally located notochord counteracts a ventrally derived Bmp4 
signal to maintain dorsal-ventral polarity in the dorsal aorta (Wilkinson et al., 2009), there is evidence 
to suggest that gut-derived sonic hedgehog (Shh) may also promote HSC emergence (Peeters et al., 
2009).   
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 Inflammatory Signalling 
Pro-inflammatory signalling pathways also have a key role in supporting HSC development. Several 
reports indicate the involvement of a range of cytokines - small peptides that are usually secreted in 
response to infection and tissue damage to activate and mobilise immune cells (Dinarello, 2000). 
Primitive neutrophils provide a source of Tumor necrosis factor α (TNFα) which binds to the cell 
receptor TNFR2 on endothelial cells  and stimulates EHT in the zebrafish dorsal aorta (Espin-Palazon 
et al., 2014). This process was upstream of Notch, acting via the Notch ligand Jag1. 
Type I and II Interferons, which are another class of potent inflammatory cytokines, also play a role. 
IFN-α and IFN-γ in mouse and IFN-γ and IFN-ϕ in zebrafish have been shown to support HSC emergence 
(Sawamiphak, Kontarakis and Stainier, 2014; Li et al., 2014). In zebrafish this regulatory role was shown 
to control EHT, acting this time downstream of Notch (Espin-Palazon et al., 2014). This seems to 
suggest that Notch has a role mediating the influence of inflammation in the HSC developmental niche. 
The studies of the role of TNFα and Interferons indicated that they are produced by myeloid cells 
deriving from the primitive haematopoietic wave, more specifically neutrophils in the case of TNFα, 
showing that primitive haematopoietic cells are also an integral part of the definitive HSC niche 
(Sawamiphak, Kontarakis and Stainier, 2014; Li et al., 2014). Furthermore, macrophages interact with 
emerging intra-aortic clusters and may provide important pro-inflammatory signals (Mariani et al., 
2019).  
 Retinoic Acid 
In mice, retinoic acid (RA) signalling has been shown to have a critical role in supporting HSC generation 
as only HSCs with active aldehyde dehydrogenase activity, which synthesises RA, gave repopulation in 
transplanted mice and E11.5 AGMs with inhibited RA signalling in the haematogenic endothelium gave 
no repopulation(Chanda et al., 2013). This signalling effect was realised through inhibition of Wnt, 
highlighting once again the interconnected nature of signalling pathways in the HSC niche. 
Furthermore, a study which added RA receptor agonist to differentiating hESC cells found an increase 
in expression of arterial markers (DLL4, HEY2, SOX17) in hESC-HSPCs (CD45+CD34+CD90+) (Dou et al., 
2016). At low levels, RA enhanced HSPC production from human pluripotent stem cells whereas high 
RA blocked HSPC production suggesting RA signalling levels must be tightly controlled (Ronn et al., 
2015). 
 Shear stress and NO signalling  
In contrast to a flat cell culture an embryo has a complex tissue architecture with multiple forces and 
tensions acting on cells. These varied forces have a well-documented influence on cell fate(Vining and 
Mooney, 2017). The cells of the dorsal aorta are subjected to an array of forces including the shear 
stress of blood flow and the tensile, contractile forces generated by the perivascular cells of the vessel 
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wall and interactions with the extracellular matrix. There is a growing body of evidence to suggest that 
these forces inform and influence HSC emergence, with a focus on the haemodynamic forces 
generated by the flow of blood through the vessels. In mice and zebrafish the shear-stress forces of 
blood flow through the dorsal aorta have been shown to promote HSC emergence via nitric oxide 
signalling (Wang et al., 2011; North et al., 2009; Adamo et al., 2009). Intriguingly, Notch has a 
described role as a mechanosensor to arterial over venous blood flow which, in turn, maintains arterial 
identity (Weijts et al., 2018). It has been proposed that the haematogenic endothelium senses shear 
stress through cilia structures as these transduce Notch signalling to endothelial cells facilitating HSPC 
specification(Liu et al., 2019). Furthermore, shear-stress has been shown to promote HSC emergence 
through not only Notch signalling but other pathways with known documented pro-haematopoietic 
roles including Wnt and prostaglandin signalling, placing mechanosensing high in the hierarchy of 
signalling in the HSC niche (Diaz et al., 2015).  
 Signalling neuropeptides and hormones 
The sympathoadrenal progenitors found close to the dorsal aorta in ventro-lateral positions support 
HSC development through the release of neurotransmitter catecholamines (Fitch et al., 2012). These 
cells of the developing sympathetic nervous system express Gata3 which acts upstream of tyrosine 
hydroxylase, an enzyme required for the biosynthesis of catecholamines. It was proposed that the 
catecholamines may act directly on aortic HSCs, as they express the β2-adrenergic receptor, 
supporting their emergence from the haematogenic endothelium. In zebrafish another 
neurotransmitter, serotonin, has been shown to promote HSPC formation via a cascade of secreted 
hormones beginning in the brain called the hypothalamic, pituitary, adrenal (interrenal) axis signalling 
to gluococorticoid receptors on the haematogenic endothelium and HSPCs (Kwan et al., 2016). A 
zebrafish screen also identified the hormone-like prostaglandin E2 (PGE2) as a potential promoter of 
HSC formation by a demonstrated increase of runx1+/cmyb+ AGM following incubation with a long-
acting derivative of PGE2 and a decrease following incubation with an inhibitor (North et al., 2007). A 
mechanism of action whereby PGE2 exerts its influence on HSPC emergence via Wnt signalling was 
shown in a later publication (Goessling et al., 2009). PGE2 expanded the number of HSCs derived from 
mouse BM as shown by a competitive repopulation assay, highlighting how lessons from development 
may be of clinical use for expanding HSCs for treatment (North et al., 2007).  
 Neural Crest  
There is an emerging role for the neural crest cells in the support of HSC generation in the dorsal aorta. 
The neural crest are multipotent cells originating in the neural tube which give rise to a diverse array 
of cell types including sympathetic and parasympathetic neurons, medulla cells of the adrenal gland, 
pigment cells and head skeletal and connective tissues (Gilbert, 2000). In zebrafish it was discovered 
that the neural crest cells migrate ventromedially and associate with the dorsal aorta just before the 
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onset of haematopoiesis in the dorsal aorta (Damm and Clements, 2017). This association was 
mediated through platelet-derived growth factor (pdgf) signalling and disruption of the association 
using morpholinos against neural crest migration genes impaired HSPC emergence from the 
haematogenic endothelium. 
This section illustrates the diverse signalling in the AGM niche that comes together to create the 
correct inductive environment for HSCs to emerge including a range of cell types and signalling centres. 
It is clearly not a trivial task to be able to adequately recreate these conditions to generate HSCs ex 
vivo but a full understanding of the niche, particularly of those factors at the top of the signalling 
hierarchy, will facilitate this. The application of our current understanding of the developmental niche 
has already informed on and improved culture conditions for derivation of HSCs from other cell types, 
which is discussed in greater detail in sub-section 1.10. 
 HSC development in the human embryo 
Due to the relative scarcity of human embryos and legal restrictions in some countries, the 
development of HSCs in the human system is comparatively less well studied than in mouse and 
zebrafish. However, important work has shown that many of the processes behind HSC development 
in the model organisms are conserved in humans. There are however some critical differences which 
make the specific study of human developmental haematopoiesis of great fundamental and clinical 
importance. This sub-section details the current state of our understanding in the field. 
 Human HSC emergence occurs in the AGM and is polarised to the ventral domain of 
the dorsal aorta. 
As in the mouse, the first wave of haematopoiesis is initiated in the YS blood islands at Carnegie Stage 
(CS) 7-8 (16 – 18.5 days post-conception (dpc)) producing primitive erythrocytes and a few 
macrophages and megakaryocytes (Tavian et al., 1996; Tavian, Hallais and Peault, 1999; Bloom and 
Bartelmez, 1940; Fukuda, 1973; Luckett, 1978) (Fig.7). The blood islands are present until CS11 (24 
dpc) at which stage primitive erythroid cells expressing glycophorin-A are found in the embryo proper 
indicative of the onset of blood circulation (Tavian, Hallais and Peault, 1999). IAHCs in the dorsal aorta 
appear later, first as a few scattered CD34+ cells at CS12 (27 dpc) growing in size to peak at CS14/15 
(30 – 33 dpc) before declining in size again until CS16/17 (40 dpc) (Tavian, Hallais and Peault, 1999). 
The IAHCs were exclusively located in the ventral domain, in contrast to the mouse which has a few 
dorsally located IAHCs (Taoudi and Medvinsky, 2007b; Taylor, Taoudi and Medvinsky, 2010; Yokomizo 
and Dzierzak, 2010). Large clusters were also seen in the vitelline artery (VA) and particularly at the 
bifurcation of the dorsal aorta with the VA (Tavian, Hallais and Peault, 1999). These IAHCs express 
markers of haematopoiesis including CD45+, CD43+, the TFs c-myb, Gata2, Gata3, SCL/TAL1 as well as 
endothelial markers CD34 and VC (Tavian et al., 1996; Tavian, Hallais and Peault, 1999; Watt et al., 
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2000; Labastie et al., 1998). The close relationship and association with the dorsal aorta suggest that 
HSCs arise through EHT. However, imaging of an IAHC sometimes shows a disrupted endothelium at 
the base of the IAHC and an association with the sub-aortic mesenchyme. This could be indicative of 
a mesenchymal contribution to the IAHCs but does not exclude the possibility that the cells pass 
through an endothelial intermediate (Tavian, Hallais and Peault, 1999). Endothelial cells sorted from 
the dorsal aorta gave rise to haematopoietic colonies from CS12-13 (28dpc) indicating the presence of 
haematogenic endothelium(Oberlin et al., 2002). Furthermore, directed differentiation cultures 
towards an HSC-like fate indicates progression through an endothelial-like intermediate suggestive of 
EHT (Pereira et al., 2013; Ayllon et al., 2015; Ditadi et al., 2015; Ronn et al., 2015; Slukvin, 2013). 
The AGM as the site of emergence of HSCs was confirmed by transplantation into irradiated NOD.Cg-
Prkdcscid Il2rgtm1Wjl/Sz  (NSG) mice (Ivanovs et al., 2011). The embryonic haematopoietic tissues from 
CS12 (26 days post-conception (dpc)) to CS17 (41 dpc), including the AGM, YS, liver, umbilical cord and 
placenta, were assayed in this way for the presence of HSCs. Between Carnegie Stages (CS) 14 – 17, 
HSCs were present in the AGM providing long-term multilineage repopulation. A small number of mice 
repopulated from the YS in the later stages at CS16 and 17. The foetal liver first gave repopulation at 
CS17 but this was uni-lineage T-cell repopulation indicating that true adult-type HSCs have not yet 
migrated here at this stage. Furthermore, there were no HSCs present in the umbilical cord or placenta 
until later stages as demonstrated by long-term repopulation from a 15 week old placenta. Taken 
together, HSCs emerge in the AGM around 5 days earlier than any other haematopoietic tissue 
consistent with it being the site of HSC initiation. Further sub-dissections identified that HSC 
generation occurs within the dorsal aorta, between the rostral bifurcation of the aorta and the 
umbilical arteries and localised to the ventral domain (Ivanovs et al., 2011; Ivanovs et al., 2014; 
Easterbrook et al., 2019). In the mouse, HSC emergence has also been localised to the central third of 
the AGM (Mascarenhas et al., 2009). Polarised specification of HSCs in the dorsal aorta along the 





Figure 7. Timeline of haematopoiesis in the human embryo adapted from (Ivanovs et al., 2017). Human 
embryonic haematopoiesis initiates in the yolk sac blood islands around Carnegie stage (CS) 7 – 8 (~18 days post 
conception, dpc). Yolk sac erythroid and CD45+ cells enter the circulation around CS11 (24dpc). Between CS12 
and CS13 (~27-29dpc) haematogenic endothelial cells are present in the dorsal aorta concurrent with the 
appearance of intra-aortic haematopoietic clusters (IAHCs). This is just earlier than the emergence of HSCs in the 
AGM which begins at CS14 (~30dpc). HSCs emerge in the AGM earlier than in the yolk sac, liver and placenta. 
 
 
 The phenotype and properties of HSCs in the human AGM 
There is no set of markers that exclusively identify HSCs in the AGM separately from lower potency 
progenitors. Efforts to refine and whittle down the population in which HSCs reside are therefore of 
great importance for investigation into their defining characteristics.  The most comprehensive 
immunophenotype analysis of HSCs in the AGM defines them as 
CD34+VC+CD45+KIT+THY1+endoglin+RUNX1+CD38−/loCD45RA−CD43+ (Ivanovs et al., 2014).  A human 
AGM has approximately only one HSC although these cells have a large regenerative capacity with one 
AGM HSC giving rise to at least 300 daughter HSCs as demonstrated by serial transplantations with 
limiting dilutions (Ivanovs et al., 2011). UCB samples do not have such high potency (Ivanovs et al., 
submitted). This regenerative potential makes generation of AGM-like HSCs an attractive target for 
clinical applications. 
Notably, the phenotype of human AGM HSCs is not the same as in the mouse. As previously discussed, 
HSCs in the mouse AGM emerge from the haematogenic endothelium via precursor intermediates 
which sequentially upregulate expression of CD41, CD43 and CD45. Although, human AGM HSCs do 
express CD45 and CD43, CD41 does not capture the HSC compartment (Ivanovs et al., unpublished). 
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The differences between mouse and human are exemplified through the lack of success in setting up 
an explant or reaggregate culture system that expands human AGM HSCs, although recent attempts 
have now succeeded in maintaining them in culture (Easterbrook et al., 2019).  Though the mouse 
model of developmental haematopoiesis is highly conserved with human and studies in mouse are 
very informative, it is important to study the human system to identify the clinically important human-
specific traits of the first HSCs.  
The Renin-Angiotensin pathway component Angiotensin-converting enzyme (ACE) has also been 
suggested to be a marker of HSCs in the AGM (Tavian, Hallais and Peault, 1999). Prior to the 
development of IAHCs, ACE marks scattered CD34-CD45- cells in the paraaortic splanchnopleure (P-
Sp) as early as CS8-9 (19 – 21 dpc), which is the presumptive AGM. Between days 24 and 26 these 
CD34-CD45-ACE+ are able to generate haematopoietic colonies in vitro indicating a haematopoietic 
potential in the mesoderm prior to HSC generation in the dorsal aorta (Sinka et al., 2012) which may 
indicate the presence of pre-HSCs. ACE then marks scattered cells in the mesenchyme around the 
dorsal aorta and from CS12 marks the endothelium and IAHCs (Jokubaitis et al., 2008; Sinka et al., 
2012). ACE+ cells in the AGM have not been validated as HSCs with repopulation assays, however 
foetal liver HSCs at later stages (14 – 18 weeks tested) are entirely within the ACE+ fraction, and 
recently have been shown to mark highly proliferative HSCs in the foetal liver (Sinka et al., 2012; Zhang 
et al., 2019). However, ACE is also expressed in the YS in blood islands so it is not a specific marker of 
adult-type HSCs (Sinka et al., 2012).  
Not much is known about signalling within the human AGM niche and the pathways required for HSC 
formation, although components of the Notch, WNT and RA signalling pathways have been shown to 
be expressed on AGM endothelial cells and HSPCs (Ng et al., 2016). A deeper understanding of the 
human HSC signalling niche will be of great use to the field and potentially provide key information 
that is missing from our studies with model organisms.  
  Generating HSCs in vitro – current progress  
There is a huge amount of work in the field going into generating bona fide HSCs in culture, usually 
from pluripotent stem cells (PSCs). As discussed in chapter 1.3, the therapeutic implications of 
generating a patient-specific, unlimited source of fast and long-term repopulating HSCs are 
monumental for the treatment of numerous clinical disorders, namely malignancies of the blood 
system. Furthermore, in the same way that studies in developmental biology can influence HSC 
derivation culture conditions, the cultures can provide insights into the mechanisms behind HSC 
development in vivo. Many differentiation protocols for derivation of blood cells from PSCs (iPSCs/ ES 
cells) recapitulate changes that parallel in vivo haematopoietic development. There is therefore a loop 
of gaining understanding from the embryo and applying it to the culture system and vice versa which 
propels the field forwards. Thus far, bona fide HSCs have not yet been generated without transgenic 
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manipulations as depending on the protocol they lack one or more defining characteristics including, 
multipotency, long-term self-renewal and engraftment capacity (Wahlster and Daley, 2016). 
 Directed differentiation of HSC-like cells from pluripotent stem cells 
The production of HSC/HSPC-like cells from PSCs typically involves recapitulation of the developmental 
progression through mesodermal followed by haematogenic endothelial intermediates (Chadwick et 
al., 2003; Pick et al., 2007; Ng et al., 2016). As described in the preceding chapters, lessons from 
developmental biology show that HSC specification happens at multiple stages including both at the 
haematogenic endothelium and earlier in the LPM. A sequential protocol enables the fine-tuning of 
each intermediate cell type to optimise HSC generation. These intermediate steps are controlled by 
agonists and antagonists for signalling pathways in the embryo niche (Chadwick et al., 2003; Pick et 
al., 2007; Ng et al., 2016). The mesoderm is specified using FGF, Wnt, BMP4, VEGF, SCF and activin 
signalling which, at this stage, must be patterned to differentiate between primitive and definitive 
haematopoiesis (Ng et al., 2016; Wang and Nakayama, 2009; Nostro et al., 2008; Kennedy et al., 2012; 
Sturgeon et al., 2014). This is a critical juncture as earlier protocols succeeded in generating only 
primitive-like haematopoieic progenitors (Ditadi, Sturgeon and Keller, 2016). Specification of the 
definitive program, as defined by T cell production, requires an increase in Wnt signalling and/or 
inhibition of activin and generates KDR+CD235a+ and KDR+CD235a- primitive and definitive-fated 
mesoderm respectively(Sturgeon et al., 2014; Ng et al., 2016; Kennedy et al., 2012). This suggests that 
primitive and definitive waves of human haematopoiesis derive from subsets of cells from patterned 
mesoderm and not from the same progenitors which sequentially upregulate the primitive and 
definitive programs.  
The haematogenic endothelium is then specified with additional cytokines and growth factors 
including FLT3L, TPO, IL6, IGF2 and FGF2 and is marked by the expression of SOX17. SOX17 expression 
is lost and RUNX1 is upregulated during the endothelial to haematopoietic transition in this culture 
system(Ng et al., 2016). The HSPCs subsequently produced are considered to be more of a definitive 
type as they express HOXA genes similarly to repopulating HSCs from UCB samples(Ng et al., 2016; 
Dou et al., 2016). However, these cells do not provide long-term engraftment in irradiated NSG hosts 
and are therefore not true HSCs.  
 Reprogramming with transcription factors 
An alternative approach to directed differentiation with cytokines and morphogens is to enforce 
expression of certain TFs in the PSCs. One study transfected human (h)ESC and iPSC derived CD34+ 
cells with HOXA9, ERG, RORA, SOX4 and MYB and achieved generation of HSPCs with short-term 
engraftment and myeloerythroid output (Doulatov et al., 2013). Follow up to this work led to the 
recent breakthrough whereby HSPCs with myeloid, B and T cell potential were capable of engrafting 
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both primary and secondary mice. The haematogenic endothelium again derived from hPSCs was 
transfected with a different combination of TFs; ERG, HOXA5, HOXA9, HOXA10, LCOR, RUNX1 and SPI1 
determined through data mining of mouse and human foetal liver HSC datasets (Sugimura et al., 2017). 
Alternative attempts were made to produce HSCs directly from somatic cell types bypassing the 
pluripotent intermediate. A group succeeded in generating HSC-like cells by direct reprogramming of 
human umbilical vein endothelial cells with the transcription factors FOSB, GFI1, RUNX1 and SPI1 and 
co-culture with vascular niche-like endothelial cells which generated long-term engrafting multi-
potent cells but with limited T cell capacity (Sandler et al., 2014). The same group have since achieved 
full multi-lineage reconstitution with a similar strategy using mouse endothelial cells but are yet to 
show this with human cells (Lis et al., 2017).  
These are exciting results but are not without their limitations. Some of the genes used for re-
programming are oncogenes and may remain expressed in differentiated cells posing a heightened 
cancer risk (Hu et al., 2011). Furthermore, random retroviral integration of the transgenes may result 
in malignant transformations (Guibentif and Göttgens, 2017). Although Lis et al., found no sign of 
cancer in mice engrafted with their mouse endothelial cell-derived HSCs (Lis et al., 2017), a transgene 
free approach will be safer and more likely to move to clinic. Furthermore, the protocols are not very 
efficient as some recipient mice transplanted with reprogrammed cells were not repopulated. The 
HSCs produced with these methods were heterogenous and not yet identical to in vivo HSCs (Guibentif 
and Göttgens, 2017) so further efforts are required to generate sufficient quantities of reproducible 
HSCs. However, the promising results from these groups make the artificial generation of HSCs seem 
a feasible prospect. Lessons from development, particularly in the human embryo will help shape and 
refine these protocols to advance them to the clinic. 
 The rationale and goals for this thesis with an overview of the structure 
This introduction provided an overview of the lessons learned from model organisms of the processes 
and signalling behind the spatiotemporally controlled development of adult-type HSCs in the embryo. 
The current understanding of HSC development in the human embryo was described and hopefully 
asserted that there is much to learn regarding the signalling behind human-specific HSC development. 
This incomplete picture has prohibited recapitulation of normal haematopoietic development in 
cultures of pluripotent stem cells and generation of bona fide adult-type HSCs with long-term 
multilineage engraftment. The aim of this thesis project was to generate a fuller picture of the 
signalling milieu in the human developmental HSC niche and in doing so, reveal potential key players 
which influence and promote HSC emergence.  
This project utilises a multi-layered transcriptomics approach to generate a spatially resolved map of 
the gene expression and signalling pathways in the human AGM. First, laser capture microdissection 
(LCM) is coupled with RNA-Sequencing to generate a spatial transcriptome map of the dorsal aorta 
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and surrounding mesenchyme from human embryos within the window of HSC emergence. In short, 
this means that the positional identity of gene expression is not lost as with FACS sorted cells. This is 
particularly important as stem cells emerge in the context of the cells and signals around them and as 
signalling and HSC emergence in the AGM is polarised along the dorsal-ventral axis, retaining the 
positional information of niche signals is of particular importance. A spatial transcriptome also allows 
genes and pathways that are differentially expressed along the dorsal-ventral axis to be defined in a 
non-biased way and thus highlight putative signals that promote ventral HSC emergence. A spatial 
transcriptome approach was already shown to be useful in mouse with the elucidation of the BMP 
inhibitor BMPER as a novel regulator of HSC generation(McGarvey et al., 2017).  
Single cells and FACS sorted haemato-endothelial populations from the dorsal aorta were also 
sequenced and further resolve niche signals to cell types and states as well as enable modelling of the 
interactions between the niche and the haematogenic endothelium and nascent HSC/HSPCs. This 
approach, which allows transcriptome profiling of the dorsal aorta at the spatial, cell population and 
single cell level is key to having an in-depth analysis of the dynamic HSC developmental niche.  
 Furthermore, our analysis identified two candidates with a potential role in influencing HSC 
emergence, Renin (Ren) and Endothelin-1 (ET-1). With the addition of Endothelin-2 (ET-2), these 
factors were functionally shown to increase HSC production in mouse reaggregate culture. This 
highlights the value of the spatial transcriptome datasets obtained in this project. This is an important 
resource for the scientific community in uncovering novel players in the development of true, adult-
type HSCs.  
The data and analysis from this project are organised across 3 chapters with a discussion of the results 
at the end of each chapter and a final conclusion at the end. An overview of the results chapters (3-5) 
is as follows: 
Chapter 3: A spatial transcriptome map of the human CS17 and CS16 HSC developmental niche 
As LCM coupled with RNA-Sequencing (LCM-Seq) is not a very well-established technique and there 
are a number of technical difficulties, the first part of this chapter details the optimisation steps taken 
to establish it in a reproducible manner. This will hopefully inform and aid future users. 
The second part of this chapter details the strategies used to sub-dissect, with LCM, the dorsal aorta 
and surrounding mesenchymal cells from CS17 and CS16 embryos into ventral and dorsal domains 
which were then sequenced. The differential gene expression (DGE) analysis and Gene Set Enrichment 
Analysis (GSEA) provides a comprehensive map of gene expression and signalling pathways that are 
polarised along the dorsal-ventral axis and at sites proximal and distal to the dorsal aorta and location 
of IAHCs. This chapter also identifies REN (Renin) and EDN1 (Endothelin 1) as an example of ventrally 
enriched genes.  
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Chapter 4: Resolution of the spatial transcriptome through single cell and FACS sorted population 
sequencing. 
In this chapter, endothelial, HSPC and haematopoietic populations were sorted from the ventral and 
dorsal domains of the dorsal aorta (CS15-16) and the transcriptomes were sequenced. This allowed 
elucidation of the dynamic changes in gene expression across the endothelial-haematopoietic 
transition (referred to as the EHT axis) as well as definition of an HSPC gene ‘signature’ with specific 
TFs, cell surface receptors and secreted factors. Furthermore, known interactions between niche 
(LCM-Seq) genes and EHT population genes were used to identify potential communication 
mechanisms between the niche and the haematogenic endothelium/HSPCs.  
Single cell sequencing of the ventral dorsal aorta and niche cells explore in greater detail the dynamics 
and heterogeneity of the endothelium, identify potential haematogenic endothelium and important 
signalling populations. LCM-Seq niche signals are resolved to different cell types. Furthermore, renin 
and endothelin pathways components are resolved to distinct cell populations which facilitates 
modelling of how they may interact with the niche and haematopoietic cells. RNAScope and 
immunostaining also resolves gene and protein expression in the dorsal aorta revealing concentrated 
EDN1 signalling below the IAHCs. 
 
Chapter 5: Functional assessment of the role of Ren, ET-1 and ET-2 in promoting HSC emergence  
Due to the scarcity of human tissue and the variability between samples, functional validation assays 
were carried out in mouse, which is a more tangible model for experimental analysis of HSC 
development. Gene expression of Ren, Edn1 and Edn2 were all found to be ventrally enriched in the 
mouse AGM as determined from a previously published dataset (McGarvey et al., 2017) and the 
protein equivalents were added to a reaggregate and explant culture system from E9.5 and E10.5 
respectively. Addition of each of these factors increased the complexity of haematopoietic colonies 
and, furthermore, was shown to increase HSC production compared to control as assayed by 




2. Materials and Methods 
 General Solutions 
Dissection Buffer: Dulbecco’s phosphate buffered saline (PBS) solution with Ca2+ and Mg2+ (Sigma-
Aldrich), 4% foetal calf serum (FCS)(Gibco) and 50 units(U)/ml penicillin and streptomycin (P/S Gibco). 
FACS buffer: PBS without Ca2+ and Mg2+, 2% Foetal Calf Serum (FCS), and 50 U/ml P/S.   
OP9 culture medium: Iscove’s modified Dulbecco’s medium (IMDM, Invitrogen), 20% FCS, L-glutamine 
(4 mM), P/S (50 U/ml). 
Aggregate culture medium: IMDM (Invitrogen), 20% head-inactivated FCS (HyClone), L-
glutamine/pyruvate (4mM), P/S (50 U/ml), 100ng/ml SCF, 100ng/ml IL3, 100ng/ml Flt3l (all 
Peprotech). 
 Human material  
Human embryonic samples of Carnegie stages (CS) 15-17 were provided from two valuable resources, 
the MRC Centre for Reproductive Health and the MRC-Wellcome Trust Human Developmental Biology 
Resource. This study was approved by the Lothian Research Ethics Committee. The embryos were 
obtained immediately after elective termination of pregnancy for which each patient gave informed 
consent in writing. The embryos were dissected in dissection buffer. The embryos were dissected from 
the placenta and the heads removed for a different research group. The embryo bodies were either 
snap frozen in Optimal Cutting Temperature compound without prior fixation and stored at -80°C for 
later use in laser capture microdissection (LCM) and/or histology experiments or the embryo was 
dissected further. For experiments requiring dorsal-ventral (D-V) dissections of the dorsal aorta, the 
embryos were dissected in a similar manner to what has been described in the mouse (Medvinsky et 
al., 2008). Generally, the body at the level of and including the heart was dissected away and 
discarded. Next, the neural tube was dissected off, followed by the ventral tissues including the gut 
and liver. Then, the ribs and limbs were dissected off followed by the mesonephros. Using the ventral 
branching vessels as a guide the dorsal aorta was sub-dissected into ventral (AoV) and dorsal (AoV) 
parts.  
 Animals 
All mouse experiments were performed under a Project License granted by the Home Office (UK), 
University of Edinburgh Ethical Review Committee, and conducted in accordance with local guidelines. 
Animals were housed within the University of Edinburgh adhering to the Animals Scientific Procedures 
Act, UK, 1986. All mouse experiments were carried out by researchers with a personal licence granted 
by the Home Office. Mice were kept in stable light cycling conditions (14 hours light and 10 hours dark) 
with a regular supply of chow food and water. Embryos were used from C57BL/6 (CD45.2/2) (Jackson 
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Laboratories) mice and C57BL/6-Ly5.1 (CD45.1) mice were used as hosts for transplantation 
experiments. Flk1-GFP BAC transgenic mice were used in one LCM experiment (Ishitobi et al., 2010).  
To obtain embryos of the correct stage paired matings were set up and the morning of discovery of a 
vaginal plug is considered embryonic day (E) 0.5. The embryos were collected at E9.5 and E10.5. 
Following schedule 1 culling of the pregnant dam, the uterine horns were removed and the embryos 
dissected out of the extra-embryonic tissues including the yolk-sac and the amniotic sac. The embryos 
were then more accurately staged by counting the somite pairs (SPs) (E9.5 = 25 -29 SPs, E10.5 = 35 – 
39 SPs). For E9.5 experiments the caudal parts were taken which includes everything below the heart. 
For E10.5 experiments the AGM region, comprising the dorsal aorta and mesonephros, were dissected 
as described for human.  
 Laser Capture Microdissection (LCM) 
 Cryosectioning 
Before the experiment a cryotome FSE cryostat (Thermo Scientific) was sterilised with Leica Cryofect 
(Leica) and a paintbrush and microtome blade (MB22 Premier microtome blades (Thermo Scientific) 
were made nuclease-free using RNase AWAY (Thermo Scientific). Human and mouse embryonic 
samples frozen in OCT and stored at -80°C were equilibrated in the cryostat at a temperature of -24°C 
for one hour to prevent the tissue from being too brittle when sectioning. The embryo was sectioned, 
using the paintbrush to stop the tissue from rolling, in a caudal-to-rostral direction to a thickness of 
7µm using MB22 Premier microtome blades (Thermo Scientific) and transferred to SuperFrost Plus 
slides (VWR). Frequent checks under the microscope verified the level reached along the rostral-caudal 
axis as defined by anatomical landmarks. Once the appropriate level had been reached the 
cryosections were transferred onto nuclease-free polyethylene napthalate (PEN) membrane slides 
(Zeiss). At intervals, a sister section would be transferred to a SuperFrost slide for future 
immunohistochemical analysis. During sectioning the PEN slides were always kept within the chamber 
at -24°C to prevent nuclease activity. To facilitate section transfer to the slide the region of the slide 
was warmed using a finger for 10 seconds. The completed slide was kept in the cryostat for > 5 mins 
and < 20 mins. The sections were then stained immediately. 
 Staining 
Where possible nuclease-free reagents were acquired or aqueous solutions were made nuclease-free 
using diethyl pyrocarbonate (DEPC) (Sigma-Aldrich). Each step of the Cresyl Violet and Haematoxylin 
and Eosin (H&E) stains were carried out in sterile 50ml falcon tubes, 2 slides at a time, to minimise 
introduction of nucleases. For human LCM-Seq experiments the rapid H&E stains were used. 
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Cresyl Violet stain:  PEN slides with tissue sections were fixed in ice-cold 70% ethanol for 3 min. The 
slides were then dipped in ice-cold DEPC treated H2O for 1 min including 10 dips up and down to fully 
remove the OCT. The slides were dipped in cold 1% Cresyl Violet Acetate (dissolved in 50% ethanol, 
(Acros Organics)) for 30 sec. Additional 1 min incubations in cold 50% ethanol before and after the 
Cresyl Violet staining step were used in the enhanced protocol. The slides were then dipped in cold 
70% ethanol followed by room temperature 100% ethanol for 1 min. The slides were air-dried within 
a PCR hood for 3 min then sealed in sterile falcon tubes and stored on dry ice for transfer to the LCM 
microscope. 
Rapid Haematoxylin and Eosin stain: PEN slides with tissue sections were fixed in ice-cold 70% ethanol 
for 3 min. The slides were then dipped in ice-cold DEPC treated H2O for 1 min including 10 dips up and 
down to fully remove the OCT. The staining steps were as follows; cold Mayer’s Haematoxylin Solution 
(Sigma-Aldrich) for 4 min, cold DEPC-treated tap water for 2 min, cold Eosin Y (Sigma-Aldrich) 15 sec, 
cold 70% ethanol 1 min, cold 90% ethanol 1 min, room temperature 100% ethanol 3 mins. The slides 
were air-dried within a PCR hood for 3 min then sealed in sterile falcon tubes and stored on dry ice for 
transfer to the LCM microscope. 
Immunostain: PEN slides with tissue sections were fixed in ice-cold 70% ethanol for 3 min. All staining 
steps were carried out on a staining tray sterilised with 70% ethanol and RNAse Away (Thermo 
Scientific). Sections were washed in PBS 3x 1 min then protein blocked in 1% Bovine Serum Albumin 
(BSA)/PBS (Sigma Aldrich) for 1 min. Sections were incubated with rat anti-mouse CD31 (BD 
Pharmingen, 0.2µg/ml) for 1 hour, washed 3x 1 min in PBS, incubated in secondary antibody goat anti-
rat AlexaFluor (AF) 488 (Invitrogen, 10 µg/ml) for 1 hour and dehydrated in an ethanol series (75%, 
90% and 100% ethanol) 30 sec each. The slides were air-dried within a PCR hood for 3 min then sealed 
in sterile falcon tubes and stored on dry ice for transfer to the LCM microscope. 
Rapid Immunostain: PEN slides with tissue sections were fixed in ice-cold 70% ethanol for 3 min, 
protein blocked in 1% BSA for 1 min and washed in PBS 3x 1 min as before. Sections were incubated 
with a rat anti-mouse CD31-FITC (clone: 390, eBioscience, 5mg/ml) conjugated antibody at high 
concentration for 15 min. Finally, sections were dehydrated in an ethanol series (75%, 90% and 100% 
ethanol) and transferred to the LCM microscope straight away.  
Alkaline phosphatase stain: PEN slides with tissue sections were fixed in 5% Dimethyl Sulfoxide 
(DMSO)(Sigma-Aldrich) in methanol (VWR) for 10 mins at room temperature. Sections were blocked 
in 1% BSA for 15 min and immunostained with anti-mouse CD31 (BD Pharmingen 0.5µg/ml)for 15 min, 
washed in 0.05% Triton X-100 (Sigma-Aldrich)/PBS (PBT) 3x 1 min, incubated with goat anti-rat IgG-AP 
(Cambridge Bioscience, 0.5 µg/ml) for 15 min, washed in PBT 3x 1 min, stained with the Vector® Blue 
Alkaline Phosphatase (Blue AP) Substrate Kit (Vector) according to the manufacturer’s instructions. 
Finally, sections were washed 2x (30 sec) in PBS and dehydrated with an ethanol series (75%, 90%, 
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100%, 30 sec each). The slides were air-dried within a PCR hood for 3 min then sealed in sterile falcon 
tubes and stored on dry ice for transfer to the LCM microscope. 
 LCM 
The LCM microscope used for the majority of the experiments was the PALM microbeam (Zeiss). The 
stained sections were transported to the LCM microscope sealed in falcon tubes on dry ice and brought 
to room temperature before opening the tubes to avoid condensation on the slides which enhances 
nuclease activity. The microscope and surrounding area were sprayed down with RNase AWAY to get 
rid of nucleases. Up to 3 slides were processed at a time and the time on the microscope stage was 
kept to under 40 minutes to minimise exposure to atmospheric nucleases. The sections were viewed 
and microdissected in brightfield using a 10X objective. The microdissected regions were collected into 
the caps of AdhesiveCap 500 opaque (Zeiss) 500µl PCR tubes. 15µl lysis buffer was added directly on 
top of the dissected tissue in the tube caps and the tubes closes in an inverted position – the lysis 
buffer used was determined by the RNA isolation method used (see next section). The inverted tubes 
were then kept on dry ice until all the sub-dissected regions had been collected into different tubes. 
For the analysis of thick sections, 60 µm cryosections from Flk1-GFP transgenic mice were transferred 
onto PEN membranes mounted onto a steel frame (Leica). These were micro-dissected using a Leica 
LMD6 LCM fluorescent microscope which collects the sub-dissected regions by gravity.  
 RNA purification, quantification and quality analysis.  
During the LCM-Seq optimisation different methods of RNA isolation and purification were trialled 
depending on the down-stream analysis. The RNeasy Micro Kit (Qiagen) was used to purify RNA from 
whole tissue sections and large LCM microdissected regions for subsequent RNA degradation analysis. 
The PicoPure RNA Isolation Kit (Thermo Fisher) was used to purify RNA from LCM microdissected 
samples for subsequent cDNA library preparation. Alternatively, the LCM samples were lysed using a 
mild hypotonic buffer (0.2% Triton X-100, 2U/µl RNase inhibitor, PBS (Nichterwitz et al., 2016)) or lysis 
buffer from the CellsDirect One-Step qRT-PCR Kit (Thermo Fisher). The quality of the RNA was assessed 
using a TapeStation 2200 (Agilent) and High Sensitivity RNA reagents which provided an RNA Integrity 
Number (RINe). When concentrations of RNA were high enough, they were quantified using a Qubit 
fluorometer (Thermo Fisher Scientific) and Qubit RNA HS Assay Kit. 
 Two-step PCR 
LCM lysates were amplified using the CellsDirect One-Step qRT-PCR Kit (Thermo Fisher). The 
housekeeping gene, murine TATA-binding protein (TBP) was amplified (Fwd: 
GGGGAGCTGTGATGTGAAGT, Rev: CCAGGAAATAATTCTGGCTCA). 25µl 2X Reaction Mix (CellsDirect, 
Invitrogen) and 0.2 μl RNase inhibitor (SUPERase-In Ambion) was added to 11.8 μl lysate/purified RNA. 
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1μl of Superscript III/Taq mix (CellsDirect) and 12μl of 10μM primers brought the reaction mix to 50μL. 
The thermal cycling conditions were 50oC for 15 min, 95oC for 2 min and 18 cycles of 95 oC for 15 secs 
and 60 oC for 4 min. Quantitative Real Time (qRT)-PCR was performed on triplicate dilutions of the 
cDNA using the Lightcycler 480 probes mastermix kit (Roche). Real Time PCR cycling conditions were 
as follows: 95oC for 5 min, 45 cycles of 95oC for 10s and 60oC for 18s, followed by 60oC for 10 min.  For 
an RT-PCR positive control, whole E10.5 embryos were digested with collagenase as before and total 
RNA was extracted using the RNeasy Mini Kit (Qiagen). This was either diluted first to a 200 cell 
approximate concentration (57pg/µl) to be used as a pre-amplification control or SuperScriptVILO 
cDNA Synthesis (Invitrogen) was used for first strand synthesis of the undiluted RNA. 
 FACS-sorting human cells 
Human dissected AoV and AoDs were dissociated to single cells in 1mg/ml Collagenase-Dispase 
(Roche) and 0.12 mg/ml of DNase I (Roche) for 35 min in a 37 oC rotating water bath. The cells were 
washed once in FACS buffer. Cells were immunostained with conjugated antibodies, anti-human Ve-
Cadherin-PE (Beckman Coulter, 5µg/ml), anti-human CD45 –v450 (Clone: HI30, BioLegend, 6µg/ml) 
and anti-human CD235A – APC (BD Bioscience, 0.2µg/ml) for 1 hour at 4 oC. Cells were then washed 
twice and 7AAD was added. Cells were sorted using a FACS Aria-II sorter (BD Bioscience). Fluorescence 
minus one (FMO) staining was used to gate negative populations. Dead cells and erythroid cells were 
excluded by 7AAD and CD235A staining respectively. Sorted VC+CD45-, VC+CD45+ and VC-CD45+ 
populations were collected into Eppendorf tubes containing RLT buffer from the RNeasy Micro kit 
ready for RNA purification. Data acquisition and analysis was performed using FlowJo software (Tree 
Star).  
For the 10X single cell sequencing, following AoV cell dissociation, CD34+ cells were isolated using the 
human CD34 MicroBead Kit and LS MACS Columns (both Miltenyi Biotec). This procedure was carried 
out as per the manufacturer’s guidelines.  
 RNA-Seq Library Preparation 
Two alternative RNA-Seq library preparation methods were used in this project. For CS17 LCM-Seq 
experiments and sorted population sequencing experiments the SMARTer® Stranded Total RNA-Seq 
Kit v2 -Pico Input Mammalian kit (Takara) was used. Input RNA was purified using the PicoPure RNA 
Isolation Kit and the protocol was followed according to the manufacturer’s guidelines.  
For CS16 LCM-Seq experiments a Smart-Seq2 protocol adapted for use with LCM was used (Picelli et 
al., 2014; Nichterwitz et al., 2016). 15μl hypotonic lysis buffer (See 2.4.4) was added on top of the LCM 
microdissected material in the caps of LCM collection tubes and pipetted up and down 5 times before 
closing the tube onto the lid in an inverted position. The cap side of the tube was vortexed for 15 
seconds and spun in a tabletop centrifuge (8000g) for 5 min. 5μl lysate was added to 2μl 10mM dNTP 
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mix (Invitrogen) and 1μl 10μM oligodT (5′-
AAGCAGTGGTATCAACGCAGAGTACTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTVN-3′, (IDT)). This was 
vortexed briefly and spun in a microcentrifuge for 30 sec (700g) then incubated at 72°C for 3 min and 
immediately snap cooled on ice. To each reaction, 2 μl SSRTII 5 × buffer, 0.5 μl 100 mM DTT, 0.5 μl 
200 U μl−1 SSRTII (all LifeTechnologies), 2 μl 5 M betaine (Sigma-Aldrich), 0.1 μl 1 M MgCl2 (Sigma-
Aldrich), 0.25 μl 40 U μl−1 RNase inhibitor (Takara) and 0.1 μl 100 μM TSO-LNA-oligo 5′- 
AAGCAGTGGTATCAACGCAGAGTACATrGrG+G -3′, Exiqon) was added. The reverse transcription 
reaction was performed in a thermal heat cycler with the following conditions; 90min 42°C, 10 cycles 
of (2 min 50°C, 2 min 42°C) and 15 sec 70°C. For the amplification reaction 12.5 μl 2X KAPA HiFI Hotstart 
Mix (KAPA Biosystems), 0.2 μl 10 μM ISPCR primers (IDT, 5’ - AAG CAG TGG TAT CAA CGC AGA GT – 3’) 
and 2.3 μl nuclease-free H2O (Invitrogen) was added to each reaction. This was heat cycled as follows: 
3 min 98°C, 18 cycles of (20 sec 98°C, 15 sec 67°C, 6 min 72°C) and 5 min 72°C. After bead purification 
using AMPure XP beads (Beckman Coulter), the concentration of the cDNA library was measured with 
an Agilent 2200 TapeStation using the High Sensitvity DNA 5000 kit (Agilent).  1 ng of cDNA from this 
reaction was amplified and barcoded using the Nextera XT DNA sample preparation kit and Nextera 
XT index kit (Illumina) following the manufacturer’s protocol. The libraries were purified again using 
AMPure XP beads, analysed on the Tapestation 2200 using High Sensitivity DNA 100 Kit and quantified 
using the Qubit fluorometer and Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific).  
 RNA Sequencing 
LCM-Seq and bulk-sorted population RNA sequencing was carried out at Edinburgh Genomics on a 
NovaSeq SP flowcell generating 50 base pair (bp) or 75 bp paired end reads. LCM-Seq samples were 
sequenced at a read depth of approximately 29 million reads per sample. Bulk-sorted population 
samples were sequenced at a read depth of approximately 47 million reads per sample. 10X samples 
were sequenced on a NovaSeq S1 flow cell with a 26/8/91 cycle set up at a read depth of approximately 
70,000 reads per cell.  
 Read quality control, alignment and counting 
The quality of the reads including Phred quality score (quality of the identification of nucleobases 
during sequencing) adapter contamination, GC content, duplicate levels was assessed using the tool 
FastQC (Andrews, 2010). Illumina adapter sequences were trimmed off reads using the tool Flexbar 
(Dodt et al., 2012). Reads were mapped to the human reference genome hg38 (Ensembl version 85) 
using STAR (Dobin et al., 2013). SAMtools (Li et al., 2009) was used to sort and index the aligned reads. 
The multicov function of BEDtools (Quinlan and Hall, 2010) was used to count the read fragments per 





 Differential gene expression (DGE) analysis 
 In R, the tool DESeq2 (Love, Huber and Anders, 2014) was used for DGE analysis which provides log2 
fold change of genes between two conditions. Per embryo batch effects were corrected for using the 
following design: ~embryo + population. The p. value is dependent on the statistical test used within 
the tool which was either the Wald test or the likelihood ratio test (LRT) as indicated throughout the 
results chapter. P values were adjusted for by multiple hypothesis correction with the Benjamini and 
Hochberg method to produce adjusted p. values (p.adj)(Benjamini and Hochberg, 1995). Genes were 
considered significant with a p.adj < 0.05. Principle component analyses were carried out on variance 
stabilizing transformed datasets using in-built R statistical tools and visualised using ggplot2 (Wickham, 
2019). Heatmaps were also carried out on variance stabilizing transformed datasets using in-built R 
statistical tools and visualised using the R package pheatmap. Volcano plots were generated using 
EnhancedVolcano (Blighe, 2018).  
 Pair-wise Gene Set Enrichment Analysis 
Enriched gene sets were found from ranked lists of differentially expressed (DE) genes between two 
conditions using the GSEA tool from the broad institute (Subramanian et al., 2005). DE genes lists were 
ranked by log2 fold change. Annotated gene sets from the following databases were used; Hallmark 
gene sets (Liberzon et al., 2015), BioCarta (Nishimura, 2004), KEGG (Kanehisa and Goto, 2000), 
Reactome (Croft et al., 2011) and Gene ontology (GO) (Ashburner et al., 2000; 'The Gene Ontology 
Resource: 20 years and still GOing strong,' 2019). Genes were input as a ranked list and pathways were 
considered significant with a false discover rate (FDR) of <0.25. 
   Finding protein association networks 
The String-DB was used to find interactions between proteins from lists of genes (Szklarczyk et al., 
2015; Szklarczyk et al., 2019). These interactions are both direct (physical) and indirect (functional) 
interactions. The tool determined interactions between proteins by known interactions from curated 
databases or that had been experimentally determined, predicted interactions from gene 
neighbourhood, gene fusions and gene co-occurrence databases, and by text mining publications, co-
expression and protein homology databases. Interactions were given a confidence score scaled 
between 0 and 1 which is a combined score for each type of evidence given and is the estimated 
likelihood that a given interaction is ‘biologically meaning, specific and reproducible’. Only high 
confidence score (0.7) interactions were used. The network matrices generated in the string-db web 
interface were opened in the Cytoscape software (Shannon et al., 2003) for production of figures and 






 10x Single Cell Sequencing  
Libraries from 10,000 CD34+ AoV cells were prepared using the Single Cell 3’ Reagent Kit v2 (10x 
Genomics) across two lanes of the Chromium™ Single Cell Chip (10x Genomics). The libraries were 
prepared according to the manufacturer’s protocol.  
 10x Single Cell Analysis 
The Cell Ranger 2.1.0 (10x Genomics) analysis pipeline was used to process the 10x single cell RNA-
Seq output by aligning reads to GRCh38 human transcriptome (Ensembl), generating feature-barcode 
matrices and performing t-SNE clustering. The single-cell gene expression data were converted into a 
loom file using the python tool Loompy (https://github.com/linnarsson-lab/loompy). SCANPY (Wolf, 
Angerer and Theis, 2018) was used for the follow steps 1 – 13. 1) Filtering out cells with less than 200 
genes. 2) filtering out genes that were in less than 3 cells. 3) Filtering out cells with a) high percentage 
mitochondrial genes (>0.05) and b) a high number of genes (> 3500). 4) Normalising reads per cell to 
70,000. 5) Logarithmise the data. 6) Regress out the effects of total counts per cell and the percentage 
mitochondrial genes. 7) Regress out cell cycle effect. 8) Principal component analysis. 9) Compute the 
neighbourhood graph (n_neighbours = 18). 10) Embed the neighbourhood graph in 2 dimensions using 
Uniform Manifold Approximation and Projection (UMAP) (McInnes, Healy and Melville, 2018). 11) 
Clustering the neighbourhood graph using Louvain method (Levine et al., 2015). 12) Finding marker 
genes per cluster using a Wilcoxon rank-sum (Mann-Whitney-U) test. 13) Mapping gene expression 
onto the UMAP embedding. Partition-based graph abstraction (PAGA) (Wolf et al., 2019) was used to 
make lineage inferences from the neighbourhood graph, using the Louvain clustering. scVelo 
(https://github.com/theislab/scvelo) was used to estimate the direction of RNA Velocity (Manno et 
al., 2018) across the UMAP embedding and in turn infer lineage trajectories from the PAGA-inferred 
cluster relationships.  
 Immunohistochemistry 
SuperFrost Plus (VWR) slides with 7µm cryosections were taken out of -20 oC storage and placed 
immediately in cold 4% PFA (Sigma Aldrich) for 10 min. Staining steps were as follows; 3x wash in PBS, 
5 min each. 10 min permeabilisation in PBS/0.5% Triton-X100 (Sigma Aldrich). 2x 5 min PBS wash. 30 
min PBS/10% FCS protein block. Overnight incubation with a primary antibody diluted in PBS/2% FCS. 
2x 5 min PBS wash. 2 hour incubation with secondary antibody diluted in PBS/2% FCS at room 
temperature. 2x 5 min PBS wash, 5 min 30nM DAPI (ThermoFisher) incubation. 1x 5 min PBS wash. 
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Mount in Prolong Gold Antifade (ThermoFisher) and coverslip of thickness 1.5 (VWR). Slides were left 
at room temperature in the dark overnight before imaging. Anti-human primary antibodies are 
described in Table 1. Anti-mouse primary antibodies are described in Table 2. Secondary antibodies 
are described in Table 3. Imaging was done using a 5 laser Confocal TCS SP8 (Leica) and an Axio 
Observer Z1 Inverted Microscope (Zeiss).  For each staining experiment there was a negative control 
with no primary antibodies and all secondary antibodies or with an isotype control and all secondary 
antibodies.  
Antigen Clone Isotype Conjugate  Supplier  
Working 
conc. 




CD31  Sheep 
NA R&D 2µg/ml 
Runx1 EPR3099 Rabbit NA Abcam 1.6 µg/ml 




Renin  sheep 
NA Abcam 4 µg/ml 
Endothelin-1 TR.ET.48 Mouse NA Abcam 10 µg/ml 
Endothelin Receptor A 485711 Mouse NA R&D 5 µg/ml 
Endothelin Receptor B  Rabbit 
NA Abcam 10 µg/ml 
Table 1. Human primary antibodies 
Antigen Clone Isotype Conjugate  Supplier  
Working 
conc. 
CD31 MEC13.3 Rat NA R&D 2 µg/ml 
cKit  Goat 
NA R&D 5 µg/ml 
Endothelin-1  Rabbit 
NA abcam 8 µg/ml 
Table 2 Mouse primary antibodies 
Antigen Clone Isotype Conjugate  Supplier  
Working 
conc. 
sheep IgG  Donkey NL557 R&D 
2 µg/ml 
mouse IgG  Goat AF488 Invitrogen 
2 µg/ml 
rabbit IgG  Donkey AF647 abcam 
1.9 µg/ml 
Rat IgG  Donkey AF546 Life tech. 2 µg/ml 
Goat IgG  Donkey AF488 Invitrogen 2 µg/ml 
Table 3 Conjugated secondary antibodies 
 RNAScope 
RNAScope was carried out using the RNAscope® Multiplex Fluorescent Reagent Kit v2 (bio-techne) 
largely following the manufacturer’s instructions for use with fresh frozen samples. Differences were 
an initial 30 min fixation of the 7µm cryosections in 4% PFA at 4oC and 30 min incubation at 37 oC 
following dehydration. Protease IV was applied for 10 min at RT. The fluorophores used were all OpalTM 
Dyes (Perkin Elmer); Opal 520, Opal 570 and Opal 690. The probes used were all human RNAscope® 
Probes; Hs-EDN1, Hs-EDNRA-C2, Hs-EDNRB-C3, Hs-REN-C3. Stained slides were imaged using a 5 laser 
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Confocal TCS SP8 (Leica) and an Axio Observer Z1 Inverted Microscope (Zeiss). Positive and negative 
control slides were also stained using positive and negative probes supplied in the kit. 
 
 Image analysis 
All image analysis was done using ImageJ FIJI software (Schindelin et al., 2012). To quantify RNAScope 
EDN1 hotspots (clusters of probe signals) the image threshold was first adjusted to filter out weak and 
background signals and a binary colour image of probe signal vs. non-signal was generated. Process  
Binary  Watershed was used to help separate merged signals. The analyse tool was then used to 
highlight any signal clusters that were 300 pixels or larger. 
 Ex vivo floating membrane aggregate and explant cultures 
E9.5 caudal parts from CD45.2/.2 BL6J mice were dissociated in 1mg/ml Collagenase-Dispase (Roche) 
and 0.12 mg/ml of DNase I (Roche) for 35 min in a 37 oC rotating water bath. FACS buffer was added 
to neutralise the collagenase and cells were centrifuged for 5 min at 300g. Supernatant was aspirated 
and tissues mechanically dissociated by gentle pipetting up and down in FACS buffer. Cells were then 
centrifuged and washed again. Cells were then resuspended in IMDM/20% heat inactivated FCS 
(Hyclone) with addition of one of the recombinant proteins; Endothelin-1 (LS-Bioscience), Endothelin-
2 (Sigma Aldrich), Renin (Sigma Aldrich) at a concentration of 10ng/ml or 100ng/ml. A no-protein 
control was also included. Dissociated cells were distributed into p200 pipette tips sealed at the ends 
with paraffin; 1 embryo equivalent (ee) per tube in 20µl. Tips were centrifuged at 460g for 12 min to 
form a pellet. The pellets were carefully deposited onto 0.8µm nitrocellulose membrane filters 
(Millipore) floating on Aggregate Media (control or + 1 recombinant protein at 10ng/ml or 100ng/ml). 
A maximum of 5 aggregates were cultured per membrane at the gas-liquid interface for 7 days at 37°C, 
5% CO2. E10.5 AGMs were cultured as whole explants on floating membranes as before. After 7 days 
culture the colonies or explants were dissociated into single cells in 1mg/ml Collagenase-Dispase 
(Roche) and 0.12 mg/ml of DNase I (Roche) for 35 min in a 37 oC rotating water bath. 
 Haematopoietic colony-forming unit assays 
After 7 days reaggregate or explant culture, collagenase dissociated cells were plated at a 
concentration of 0.05 and 0.01 ee of the starting culture in MethocultTM GF M3434 (StemCell 
Technologies Inc.). Plates were incubated at 37°C, 5% CO2 for 7 days. Haematopoietic colonies were 
counted and scored after 7-11 days of differentiation following described standard criteria (Pereira, 
Clarke and Damen, 2007). For this study, Colony-forming unit-macrophage (CFU-Mac), colony-forming 
unit-granulocyte, macrophage (CFU-GM), colony-forming unit-granulocyte, erythroid, macrophage, 
megakaryocyte (CFU-GEMM) were counted. 
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 Long-term repopulation assay 
Collagenase dissociated cells from E9.5 7 day aggregate cultures were washed and resuspended in 
FACS buffer with heat-inactivated FCS (hyclone). CD45.1/.2 mice were irradiated prior to 
transplantation with a dose of 9.5 Gy, split in two doses with a 3-hour gap in between and delivered 
by a sealed Cs source at a rate of 21.6 rad/min. 0.5ee were injected with a 30-gauge syringe needle 
into the lateral tail veins of pre-irradiated CD45.1/.2 mice with 100,000 bone marrow carrier cells 
isolated from the femurs of CD45.1/.1 mice. Blood was collected from the tail vein by superficial 
incision of the tail vein at 8 and 18 weeks post-transplantation to analyse blood chimerism. At 18 
weeks the mice were culled and haematopoietic tissues taken for multilineage analysis including the 
spleen, bone marrow, thymus and blood. Bone marrow was flushed from the femur with FACS buffer 
using a syringe and 30-gauge needle. Thymus and spleen were chopped with dissection scissors into 
fragments and pipetted up and down to flush out the haematopoietic cells before filtering out the 
remaining tissue. Red blood cells in the blood were lysed with Red Blood Cell Lysis Buffer (bioRad) for 
15 min at room temperature. Cells were then stained as described below. 
 Flow cytometric analysis of cells 
After 7 days reaggregate or explant cultures collagenase dissociated cells were immunophenotypically 
analysed by flow cytometry on a BD LSR Fortessa (BD). Cells were washed in FACS buffer and 
centrifuged for 5 min at 300g. Two panels of antibodies were used to stain cells shown in Table 4 and 
Table 5. Cells were incubated with the antibodies for 1 hour at 4°C, centrifuged and washed as before 
then stained with BV711 Streptavidin (BD Horizon) for 1 hour at 4°C. Cells were centrifuged and 
washed again. 1µM 7AAD (Invitrogen) was added to the cell suspensions before flow cytometric 
analysis. 
Antigen Clone Isotype Conjugate  Supplier  Working conc 
CD41 MWReg30 Rat BUV379 BD Horizon 0.6µg/ml 
CD44 IM7 Rat bv421 BioLegend 1 µg/ml 
cKit ACK2 Rat bv510 BioLegend 1 µg/ml 
CD45 30-F11 Rat V650 BD Horizon 2 µg/ml 
EPCAM G8.8 Rat biotin eBioscience 2 µg/ml 







VE-Cadherin eBioBV13 Rat e660 Invitrogen 2 µg/ml 
Table 4: Panel 1 antibodies for flow cytometry analysis of haematopoietic cultures 
For the assessment of donor contribution in reconstituted mice at 8 weeks and 18 weeks post-
transplantaion of E9.5 aggregates, rat anti-mouse CD45.1-APC (Invitrogen, 2 µg/ml, Clone: A20) and 
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Antigen Clone Isotype Conjugate  Supplier  Working conc. 







Ter119 TER-119 Rat bv510 BD Horizon 2 µg/ml 
CD11b M1/70 Rat V500 BioLegend 0.03 µg/ml 
b220 RA3-6B2 Rat V650 BD Pharmingen 2 µg/ml 
CD3 145-2C11 Rat biotin  
2 µg/ml 
Gr1 RB6-8L5 Rat PE  
1 µg/ml 
CD11c N418 Rat PEcy7 BioLegend 2 µg/ml 
CD335 29A1.4 Rat e660  
4 µg/ml 
Table 5: Panel 2 antibodies for flow cytometry analysis of haematopoietic cultures 
Antigen Clone Isotype Conjugate  Supplier  
CD45_1 A20 Rat V450 BD Horizon 
CD45_2 104 Rat V500 BD Horizon 
b220 RA3-6B2 Rat APC-cy7 eBioscience 
CD11c N418 Rat PE-cy7 BioLegend 
Ter119 TER-119 Rat FITC eBioscience 
Gr1 RB6-8C5 Rat PE eBioscience 
CD335 29A1.4 Rat BV711 BioLegend 
CD3e 145-2C11 Rat APC eBioscience 
CD4 GK1.5 Rat APC eBioscience 
CD8 53.67 Rat BV711 eBioscience 
Table 6:  Antibodies used for multilineage analysis of mice with donor reconstitution 
For the multi-lineage analysis 18 weeks after transplantation of E9.5 aggregate cultures, cell 
suspensions from the thymus, spleen, bone marrow and blood were stained with antibodies as above. 
The antibodies used are found in Table 6. In all cases, FMOs were used to gate negative populations. 
OneComp and UltraComp beads (both ThermoFisher) were stained with single antibodies for 




3. Spatial transcriptome mapping of the human AGM 
In order to map the spatial transcriptome the technique of laser capture microdissection (LCM) 
coupled with RNA-Seq (LCM-Seq) was employed. The Zeiss PALM LCM microscope uses a laser to finely 
dissect out regions of interest from tissue sections on a histology slide. Using a pulse of energy, it then 
catapults the dissected region into the cap of a collection tube directly above. By adding lysis buffer, 
you can then extract the RNA from the tissue and, from this, generate libraries for RNA-Sequencing. 
Differential gene expression analysis (DGEA) between different sub-dissected regions allows you to 
define gene expression patterns and molecular gradients across the region of interest.  
In this study, LCM-Seq will explore patterns of gene expression in the human HSC developmental 
niche, the AGM region. The tool is used to assess dorsal-ventral (D-V) differences in signalling within 
the AGM region, both at close range to the dorsal aorta and more distant, broader signalling patterns 
throughout this domain. The goal was to sub-dissect the endothelial layer into domains along the D-V 
axis and, in later experiments, additional sub-dissections of the underlying perivascular and 
mesenchymal cells.  
In setting up the technique, there were a number of challenges to overcome: 
1)  RNA is highly susceptible to degradation 
I. The embryo must be sectioned on to slides, stained for visualisation of the cells, 
transferred to the LCM-Microscope and exposed on the microscope stage during 
microdissection – all without too much RNA degradation.  
II. Histological staining of the sections must therefore be adequate to identify cells by 
morphology or immunohistochemistry without severely impacting RNA quality.  
2) Quantities of RNA are very low 
I. Sufficient RNA must be extracted from the dissected lysed tissues to prepare RNA-
Seq libraries.  
 
 LCM-Seq optimisation 
The LCM-Seq technique was optimised using E11.5 mouse embryos snap frozen in OCT without 
fixation in PFA as formaldehyde cross-links with macromolecules in the tissue reducing the yield of 
extracted RNA (Evers et al., 2011). These embryos were then sectioned onto PEN slides (specialised 
nuclease-free slides with a membrane to facilitate LCM) in a cryostat sterilised using low temperature 
disinfectant and with blade, brush and slides made nuclease free with RNAse Away. The tissue sections 
were always kept within the cryostat at -24°C and stained within 20 minutes of being sectioned.  
A critical optimisation step was to stain the tissue sections to achieve visualisation of the endothelial 
cells of the dorsal aorta and other structural components of the AGM without impacting the RNA 
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quality too severely. The membrane on the slides for LCM worsens the cell morphology under the 
microscope and the lack of mountant or coverslip makes high quality imaging particularly difficult to 
attain. 
 Histology staining optimisation for LCM 
Four different staining methods were tested for their suitability for LCM-Seq. The precise details of 
each method are in the ‘Materials and Methods’ section 2.4.2. Each method was streamlined to be as 
quick as possible, and reagents were fresh, non-contaminated and DEPC-treated where possible. The 
impacts of the staining protocol were assessed by extracting RNA from freshly sectioned, stained or 
unstained tissue sections using the RNeasy Micro Kit. The purified RNA was then run on a TapeStation 
2200 to get an RNA Integrity Score (RINe ) out of 10 based on the ratio of 18S and 28S ribosomal RNA 
(rRNA) peaks on the electropherogram as well as the appearance of degraded products. 
Cresyl Violet (CV) staining is recommended by Zeiss for use in LCM with subsequent RNA-extraction as 
all the solutions contain high ethanol concentrations which minimise RNA degradation. The stained 
tissue sections showed an average reduction in RINe of only 0.5 (n=3) from the RINe of the non-stained 
control (Fig.8e). However, the morphology of the cells was very poor when the tissue sections were 
stained on the LCM membrane slides with indistinct pale staining and no definition of the endothelial 
layer and IAHCs (Fig.8ai). Increasing the time of CV staining from 30 seconds to 2minutes and/or 
reinforcement with 50% Ethanol pre and post CV as suggested in the Zeiss Manual (Fig.8aii) which, 
although made the stain darker, did not greatly improve visualisation of cell morphology.  
A Haematoxylin and Eosin stain was also trialled. This gave an average reduction in RINe of 0.3 (n=3) 
(Fig.8e) and furthermore, greatly improved the cell morphology and resolution of the anatomical 
structures in the surrounding tissues (Fig.8bi, ii). However, although visualisation of the dorsal aorta 
endothelial layer was enhanced compared to the CV stain it was not clearly defined. 
An immunostain with a CD31 antibody and AF488 secondary antibody was used to mark the 
endothelial layer which did improve visualisation of the endothelial layer (Fig.8c.i) but caused a severe 
reduction in RINe of 6.2 (n=3), which may in part be due to the 2 hour total staining time compared 
with 15 mins and 12 mins for CV and H&E stains respectively. A more rapid immunostain was devised 
with a conjugated CD31-AF488 antibody which takes 19 mins in total. This in fact, resulted in an even 
larger decrease in RINe (7.6, n=1). By measuring the RINe of a tissue section after each step in the 
staining protocol it appeared that the blocking step in 1% BSA gave the largest RINe reduction of 5.5 
(Fig.8f) Removing this step may have improved the RINe but as the signal strength from this method 
was very weak, it wasn’t pursued further (Fig.8cii). Another drawback of using fluorescence was that 
the LCM microscope could only dissect in the brightfield which meant locating the cells under 
fluorescence then switching back to brightfield to dissect which added significant time to the 
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dissection of multiple tissue sections. This time needs to be kept to a minimum to reduce RNA 
exposure to nucleases.  
The fourth stain was an alkaline phosphatase stain against CD31 antibody. This showed the endothelial 
cells well under the brightfield setting, however all other cell morphology and tissue structures were 
lost (Fig.8di, ii). Furthermore, the reduction in RINe after staining was high at 5.8 (Fig.8e). An H&E stain 
was thus considered to be the most suitable for LCM-Seq as it provided decent cell morphology and a 





Figure 8. Optimisation of LCM staining protocols. (a-d) are representative images of individual staining 
protocols trialled for LCM-Seq; (ai) Cresyl Violet and (aii) Cresyl Violet enhanced stain, NT = neural tube. Ao = 
Dorsal Aorta. Nc = Notochord. Mn = Mesonephros (b) Rapid Haematoxylin and Eosin stain, (ci) anti-CD31 + 
AF488 Immunostain and (cii) CD31-AF488 conjugate rapid Immunostain, (d) Alkaline phosphatase anti-CD31 
Immunostain. (e) shows the amount of change (∆) in RINe for each staining protocol compared to the RINe of a 
sister section without any staining. (f) shows the RINe for each step in the rapid Immunostain, EthOH = Ethanol, 
AB = antibody. (g) Adapted from: https://www.leica-microsystems.com/products/light-microscopes/p/leica-
lmd7/. It shows the leica system of microdissection with collection of the sub-domains by gravity into a tube 
below. (h) shows representative images of 60µm Flk-1-GFP cryosections before h)i and after h)ii laser 





 Optimisation of low quantity RNA extraction 
The quantities of RNA from microdissected samples is in the picogram range and is below the threshold 
of reliable detection of most RNA quantification equipment. It is therefore difficult to test whether 
there are sufficient quantities of quality RNA in microdissected samples for RNA-Seq. Real-Time PCR 
(RT-PCR) was used to verify RNA extraction from microdissected samples and thus to optimise the 
protocol.  
A two-step RT-PCR was carried out with initial cell lysis, cDNA synthesis of total RNA and pre-
amplification steps using the CellsDirect one step qRT PCR Kit (Invitrogen) followed by a UPL real-time 
PCR assay of the house-keeping gene TATA-binding protein (TBP). Quantitative real time(qRT)-PCR was 
carried out on LCM microdissected dorsal aorta (Ao) endothelial cells from 7µm E11.5 CV stained 
cryosections. To test whether successful RNA extraction is dependent on the size of area 
microdissected, samples of approximately 200 (n=3) and 300 cells (n=3) (about 30000µm2 and 
45000µm2 respectively) were dissected as well as large rectangular dissected areas (~150,000µm2) 
(n=3). A pre-amplification control was used including RNA extracted from a whole E10.5 embryo then 
diluted to 57pg/µl, a concentration estimated for 200 cells, to confirm that the initial pre-amplification 
step worked. Undiluted whole embryo RNA was used as a second step RT-PCR control for which the 
first strand cDNA synthesis was carried out but not pre-amplification (Ctrl +). Finally, there was also a 
control without the initial reverse transcription reaction, to check that contaminating DNA wasn’t 
being amplified.  
No amplification was observed in LCM samples 1 and 2 from 200 and 300 cells respectively (Fig.9a). 
There was amplification seen however in the pre-amplification control and the RT-PCR control (Ctrl +) 
indicating that both steps of the RT-PCR are working correctly. Sample 3, from a large microdissected 
area, showed amplification for 1 in 10 and 1 in 100 dilution factors. Despite no RNA detection in the 
undiluted sample this indicates that from larger amounts of microdissected starting material RNA, 
there is sufficient RNA to enable target gene amplification. The cycle threshold value (Ct), which is the 
number of PCR cycles required to reach a signal threshold at the beginning of the exponential phase, 
was quite high however, with an average of 36.3, indicating a low amount of starting material. Prior 
to LCM the RINe of whole tissue sections were assessed following CV staining and gave a high value of 
9.2. This indicates that either the RNA has degraded dramatically during LCM that time or that the 
method of RNA extraction from the cells is inefficient.  
Therefore, four methods of RNA extraction were trialled side by side including the RNeasy Micro Kit 
(Qiagen), the PicoPure RNA Isolation Kit (Thermo Fisher), direct lysis using a mild hypotonic buffer and 
RNase Inhibitor  and the method used previously – direct lysis and amplification using the CellsDirect™ 
kit (Thermo Fisher). 50,000µm2 (around 350 cells) were microdissected from 7µm E11.5 CV stained 
cryosections, RNA was extracted using one of the four methods and a two-step RT-PCR for TBP was 
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carried out as previously. Three replicates were run for each condition with three PCR technical 
replicates for each condition replicate. The direct lysis method using the CellsDirect kit this time had 
an amplification product but had the highest mean Ct value, 33, (Fig.9b) indicating the lowest initial 
yield of RNA, followed by the RNeasy Micro Kit at 31.8. Direct lysis using a mild hypotonic buffer had 
a lower mean Ct of 30 and the PicoPure RNA Isolation Kit had the lowest mean Ct of 29.5. These two 
latter RNA extraction methods were used in subsequent RNA-Seq library preparation depending on 
the method of library preparation used. 
 
Figure 9 qRT-PCR analysis of RNA from E10.5 LCM microdissected cryosections. a) Mean cycle threshold. (Ct) 
values for 2-step RT-PCR of LCM cells. S1 = ~200 cells, S2 = ~300 cells, S3 = ~1000 cells in 3 dilutions; no dilution 
(1), 1/10 dilution (0.1) and 1/100 dilution (0.01). NT = No template control (H2O). N=1.  (b) Mean Ct values for 2-
step RT-PCR of ~350 LCM cells after RNA extraction by different methods.  Error bars show standard deviation 
around the mean, N=3.  
 
 Trial with thick sections and LCM with gravitational collection 
To address the issue of low cell numbers and RNA yield obtained using Zeiss PALM LCM from thin 
(7µm) sections another strategy was devised using thicker sections of 60µm. The catapulting 
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microscope from Leica was trialled (Leica LMD6). In this system the tissue is placed on top of a 
membrane in a frame. The laser microdissects around the tissue and the membrane and it is collected 
by gravity into a collection tube below (Fig.8g). Flk1-GFP embryos were used to visualise the 
endothelium of the dorsal aorta. Flk1 is a receptor to the angiogenic vascular endothelial growth factor 
(VEGF)-A and is essential for blood vessel development and organisation (Shalaby et al., 1995).  
60µm cryosections were placed onto the framed membranes and visualised under the microscope. 
The GFP signal of the tissue section was indistinct, possibly due to high background autofluoresence 
from the tissue which retained moisture (Fig.8hi-ii) but the endothelium could still be visualised. The 
main issue with this technique was that the endothelial lining was not exactly perpendicular to the 
membrane and lies at an angle which can be visualised in Fig.8hi-ii. As the laser cannot cut at an angle 
but only directly down, it is difficult to define exactly what has been dissected beneath the top layers 
of cells. This problem is much less exaggerated with thin sections. For these reasons this technique 
was abandoned.   
 Optimisation of LCM-Seq library preparation with human embryonic samples 
Due to the sensitivity and rarity of early stage human embryo samples along with the high cost of RNA-
Seq library preparation kits it was not appropriate to lose resources optimising the human LCM and 
RNA-Seq library preparation. The tools and techniques for these steps were therefore improved upon 
and made more efficient as experiments progressed.  
In all cases, the trunk of the human specimens without the heads, were snap frozen in OCT without 
fixation and kept at -80°C until sectioning. 7µm sections were then cryosectioned onto 5 PEN 
membrane slides for the initial CS17 experiments and 3 PEN slides for the later CS16 experiments with 
6 sections on each slide. Each spatially defined sub-dissected region of interest is referred to as a sub-
domain. Equivalent microdissected sub-domains from each tissue were pooled into the same 
collection tube. 6 slides were required initially to get a sufficient quantity of cells for earlier library-
prep methods (detailed below) whereas later more efficient methods meant only 3 slides were 
required. Slide number was kept to a minimum to reduce microdissection time and prevent too much 
RNA degradation. Zeiss recommends 30 minutes maximum tissue exposure on the microscope stage 
which is roughly how long it takes to microdissect 3 slides. Additional slides increase quantity of RNA 
at the cost of RNA integrity.  
The sections were stained with a rapid H&E stain and microdissected according to the dissection 
strategy for that experiment (detailed in section 3.2). Each sub-domain was dissected using LCM and 
collected into different collection tubes. The equivalent sub-domains from sister sections were pooled 
into the same tube and, when all slides had been completed, lysis buffer was immediately added. In 
order to get an idea of the RNA quality, large rectangular regions of tissue section (~150,000µm2) were 
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also microdissected into another collection tube (Fig.10ai-ii). RLT lysis buffer from the RNeasy Micro 
RNA extraction kit was then added to extract RNA. This provides enough RNA for analysis on the 
TapeStation to get a RINe score (Fig.10b). The material collected in this tube had been exposed on the 
stage for longer than the microdissected subdomains so should represent the most degraded material. 
The RINe was also compared to the RNA RINe from a whole tissue section taken at the time of 
cryosectioning to assess how much degradation was due to the LCM procedure or due to degradation 
already in the initial frozen specimen. ∆RINe ranged from 0.2 to 1.9 indicating that the LCM protocol 
had minimal impacts on the RNA integrity of the samples. 
 
 
Figure 10: (a.i) Large rectangles of human LCM dissected material for measuring RINe  of the tissue at the end of 
the LCM experiment, (a.ii) view of collected rectangles of tissue in the cap of the collection tube. (b) RINe of a 
whole tissue section taken during the cryosectioning step and after the complete LCM protocol prior to RNA-Seq 
library preparation. Electropherograms show the ratio between the 18S and 28S ribosomal RNA (rRNA) products. 
 
For the CS17 experiments RNA was extracted and purified using the PicoPure RNA Isolation kit and the 
SMARTer® Stranded Total RNA-Seq Kit - Pico Input Mammalian Kit from Takara (version 1 for embryos 
n1-2, version 2 for sample n3) for RNA-Seq library preparation (Fig.11A). The SMARTer® kit manual 
suggests input of at least 250pg of RNA. For the initial experiment subdomains were pooled from 3 
slides of 6 sections. ~70% of tissue sections were useable i.e. good morphology of cells and intact 
tissue architecture around the dorsal aorta therefore ~13 sections * ~25 cells per subdomain = ~325 
cells per subdomain. 325 cells should give >3250pg of RNA.  
The initial experiment included purified RNA from 2 LCM samples, a negative no RNA control and a 
250pg of positive RNA provided in the kit. Library size distribution and quantification was assessed 
using the TapeStation (Fig.12a-d). A good library should be about 4000pg/ul and have a smooth curved 
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distribution peaking around 300 – 400bp. The negative control (Fig.12a) showed a small peak at 141bp 
indicating amplification of adapter dimers. The 2 LCM samples (Fig.12b, c) had extremely low 
quantities of 20.9 and 27.8 pg/ul whereas the positive control (Fig.12d) had 4330pg/ul with a smooth 
curve peaking at 311bp. This indicates that cells from microdissected tissue sections either do not yield 
as much RNA or that substantial RNA is lost during the RNA extraction and purification process. 
Increasing the slide number to 5 (~525 cells per subdomain) provided enough RNA to generate libraries 
(Fig.12e) although primer dimer peaks at around 140bp were often seen. Adapter dimers can be an 
indication of insufficient starting material but also that concentrations of adapter are too high and/or 
cDNA fragment size selection using Solid Phase Reversible Immobilisation (SPRI) beads insufficiently 
filtered out fragments of shorter length. Adapter dimers are sequenced so reduce the overall depth of 
the rest of the library. It is desirable therefore to remove them. Furthermore, after sequencing, these 
libraries showed very high levels of duplicates, often above 90% (Fig.14A). Duplicates are identical 
reads, which are unlikely to happen by chance. High levels can be caused by low complexity of the 
input RNA (low quantity of molecules) and PCR over amplification (Parekh et al., 2016).  Biases like 
these reduce the precision of differential gene expression (DGE) analysis. However, removal of 
duplicated reads does not improve accuracy of DGE and have been left in to the analysis (See Chapter 
3 Discussion).  
For the subsequent experiments with CS16 samples a different library preparation method was used 
taken from Nichterwitz et al, 2016 based on Smart-seq2(Picelli et al., 2014) (Fig.11B). This uses 
individually purchased reagents rather than a kit which is more cost-effective. The mRNA is reverse 
transcribed and amplified directly from the hypotonic lysis buffer tested on mouse LCM samples (see 
section 3.1.2) which removes the requirement to extract and purify the RNA first which can lead to 
loss of RNA. Tagmentation (Tn5 transposase fragmentation), final amplification and barcoding is then 
done using the Illumina Nextera XT DNA sample preparation kit. To test the sensitivity of the protocol, 
libraries were prepared from regions of E11.5 mouse sections laser capture microdissected at 
increasing size; 20 cells (n=2), 10,000µm2 (~66 cells, n=2), and 50000µm2 (~330 cells, n=2) (Fig.13a). 
The pre-amplification step prior to fragmentation allows assessment of the success of protocol to that 
point and quality of the initial sample using the tapestation bioanalyzer. Mean library size should be 
around 1.5-2kb and lower base pair (bp) peaks indicates shorter fragments suggesting degradation of 
the initial sample (Picelli et al., 2014). All samples had amplification products except for 50,000um2 
replicate (n) 1 (Fig.13ai-vi). However, the final tagmented/amplified and barcoded samples were also 
analysed on the TapeStation and showed successful libraries from all samples (Fig.13b) indicating that 
the absence of 50,000μm2 n1 was a TapeStation issue. The pre-amplification curves had a size 
distribution peaking around 1.8kb showing that libraries could be generated from just 20 cells – a 
significant improvement on the SMARTer-Seq® method. Most curves were relatively free of shorter 
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fragments except for 50,000μm2 n2 where a few shorter fragment peaks indicate some minor initial 
degradation of the RNA.  
The final amplified libraries had smooth curves peaking at ~450bp although a primer dimer peak at 
around 40bp was also seen (Fig.13b). This peak was removed in subsequent experiments by more 
efficient SPRI bead size selection (Fig.13c) achieved by decreasing the ratio of beads to cDNA (0.8:1 to 
0.7:1) which selects larger fragments. The quantities of the libraries were 0.8 – 0.96ng/µl (measured 
on a Qubit) showing good reproducibility of the tagmentation and final amplification steps. The output 
quantities were levelled as 1ng of pre-amplified cDNA is required as input to the tagmentation reaction 
for maximum efficiency.  
Figure 11 Schematic of protocol for two methods of RNA-Seq library generation from LCM material. A: 1) 
LCM material is collected in the cap of a collection tube. 2) Lysis buffer from the PicoPure kit is added on top 
of the material in the collection tube cap for cell lysis. 3) RNA is purified using the PicoPure RNA Isolation Kit. 
4) RNA-Seq libraries are prepared using the SMARTer® Stranded Total RNA-Seq Kit – the main steps are 
provided in order. B: 1) LCM material is collected in the cap of a collection tube. 2) Hypotonic lysis buffer is 
added on top of the material in the collection tube cap for cell lysis. 3) The mRNA in the lysis buffer is directly 
reverse transcribed using oligo(d)T primers to select only polyA-tailed mRNA and pre-amplified. 4) The Nextera 
XT library prep kit is used to complete library preparation from the pre-amplified cDNA – the main steps are 
provided in order. 
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The protocol was shown to be effective down to at least 20 cells but to make sampling more equivalent 
across embryos, subdomains from 3 slides of 6 sections each were pooled to get signals averaged 
across the region. Reducing slide number to 3 slides helped streamline the LCM process and prevent 
unnecessary RNA degradation. This provided extra time to take additional subdomains from the tissue 
sections. The libraries generated had smooth peaks with average ~350 – 400bp and no adapter dimer 
peaks (Fig.13c). After sequencing, a lower percentage of reads were detected as duplicates than from 
the SMARTer-Seq® kit prepared libraries (Fig.14B). However, as fragmentation in the second protocol 
occurs after pre-amplification, duplicated reads may be fragmented in different positions and 
therefore not detected as duplicates computationally.  
 
 
Figure 12. SMARTer® RNA-Seq library QC and quantification (a-d) shows library size distributions after 
preliminary CS17 LCM-Seq library preparation using the SMARTer® Stranded Total RNA-Seq Kit - Pico Input 
Mammalian Kit; (a) is a negative control, (b,c) are ~325 cells from CS17 LCM microdissected dorsal aortas. (d) is a 
positive control of 250pg initial RNA quantity. (e) representative image of the library size distribution prepared 
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Figure 13. Smart-Seq2 RNA-Seq library QC and quantification. (a) Fragment size and distribution following first-
round amplification of E11.5 LCM cells using the Smart-Seq2 protocol. n = replicate number. Peaks marked as lower 
and upper are tapestation markers and not cDNA. (b) Library size distributions following tagmentation and final 
amplification steps – consistent peak at ~450bp for all samples and ~40bp primer dimer peak. (c) Representative 





Figure 14. Percentage of sequenced reads that are duplicates and number of amplification cycles for each 





 Spatial transcriptome profiling of the CS17 dorsal aorta 
 CS17 LCM-microdissection strategy 
To investigate dorsal-ventral (D-V) differences in gene expression and signalling patterns in the dorsal 
aorta, 3 CS17 human embryos were transcriptionally profiled. In order to take an equivalent region 
from each embryo along the rostro-caudal axis and thus reduce variation, anatomical landmarks in the 
histology sections were used as a point of reference. Sections for LCM were taken in the pre-liver 
region between the midgut loop (caudal limit) and the duodenum/superior mesenteric artery (Fig.15a-
bii) as this region is reported to have a high number of IAHCs during the HSC developmental window 
(Tavian et al., 1996; Tavian, Hallais and Peault, 1999).  
The LCM microdissection strategy was to sub-dissect the wall of the dorsal aorta, composing the 
endothelial and perivascular layer, into 4 sub-domains along the D-V axis including ventral (V), ventro-
lateral (VL, 1 from each side), dorsal-lateral (DL, 1 from each side) and dorsal (D) (Fig.15c). As the 
endothelial cells are not immune-labelled it is likely that additional mesenchymal cells are included in 
the sub-dissected regions. A pink layer of eosin staining around the dorsal aorta was used to guide 
dissections of the vessel wall (Fig.15d.ii). Sub-dissecting in the exact same pattern between embryos 
and even tissue sections of the same embryo was made complicated due to differing morphologies of 
the dorsal aorta (Fig.15di-iv) and branching vessels. Although the sub-domains vary slightly in position 
from section to section and their boundaries may overlap, pooling same sub-domains across tissue 
sections will average the signals and is expected to strengthen polarised differences. 
 Validation of the presence of IAHCs in the ventral domain of the dorsal aortas within 
the regions taken for LCM-Seq 
The goal of finding D-V polarised gene expression is to identify signals that may promote 
haematopoiesis in the AGM region. It was therefore necessary to validate the presence of IAHCs in the 
ventral domain of the dorsal aorta in the regions subdissected for RNA sequencing. During 
cryosectioning for LCM, when one PEN membrane slide had been completed an additional section was 
transferred to a glass slide for immunohistochemistry. These sections were stained with antibodies for 
CD31 and Runx1 to label IAHCs. In each embryo there is a ventrally localised IAHC (Fig.16). Embryos 
N2 and N3 have quite large IAHCs whereas in N1 only 2 cells are visible. This might indicate that N1 is 
a slightly later stage than N2/3 or simply that a larger IAHC hasn’t been captured in this section. It 
could also be due to genetic variation between samples. As ventral IAHCs were confirmed in all 3 
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Figure 15. CS17 LCM-Seq microdissection strategy. (a) CS17 embryo schematic with yellow bar indicating the 
region within which sections were taken for LCM-Seq. Ao = Dorsal aorta, Duo = duodenum, UC = umbilical cord, 
MG = mid gut, SMA = superior mesenteric artery. (b) The histology images indicate the caudal (b.i) and rostral (b.ii) 
limits of the embryo taken for LCM-Seq with the use of anatomical landmarks to define position along the rostral-
caudal axis. Ao = Dorsal Aorta, Mn = Mesonephros, MG = Mid Gut, UC = Umbilical cord, Duo = Duodenum.  (c) 
shows the CS17 LCM-Seq microdissection strategy of 4 domains along the dorso-ventral axis (1 = Dorsal, 2 = Dorsal-
lateral, 3=Ventral-lateral, 4=Ventral). (d) Representative images from the PALM laser capture microscope of the 
CS17 dorsal aorta from different sections. Any coloured lines mark the sub-domains directing the laser where to 




Figure 16 Validation of the presence of IAHCs in the ventral domain of the CS17 dorsal aortae. Dorsal aortae 
from sister sections of sections taken for the CS17 LCM-Seq experiment. Ventrally localised clusters are 
validated by their expression of Runx1. (i-iii) are zoomed in images of regions indicated by squares in the top 
row. Nx = replicate number. Scale bars are 50µm. D = Dorsal, V = Ventral. 
 
 Visualisation and quality assessment of the transcriptome by sample clustering 
analysis 
The principle component analysis of the RNA-Seq datasets shows no clear clustering of samples by 
subdomain or embryo number (Fig.17ai-ii). It is of note that samples V2, D1, D2 and VL2 were shifted 
to the positive loading of PC1 and these samples had a mean of 8.5% less duplicates than the other 
samples (Fig.14A) indicating that lower levels of duplicates may allow other genes to be more highly 
expressed. This pattern of clustering by duplicate level is seen on the heatmap of top 500 genes by 
expression level (Fig.17b). The heatmap clusters into 3 main groups which corresponds to duplicate 
level ranges of 79.8 – 89% (V2, D1, D2) 89.7 – 94.1% (V3, DL3, D3, DL1) and 94.3 – 95% (V1, VL1, VL3, 
DL2). Furthermore, the heatmap of sample-to-sample distances shows clustering of the 2 groups with 
lower duplicate ranges, whereas the group with high duplicate levels have low similarity to the other 
samples indicating high duplicate level may obscure true variations in gene expression (Fig.17c). VL2 
clusters alone, which may be to do with the much higher sequencing depth for this sample compared 
to others (data not shown). This high sequencing depth probably resulting from an erroneously high 
input amount of this sample for sequencing. The lack of expected clustering proved not critical as 





Figure 17. CS17 LCM-Seq visualisation and clustering of samples a) Principle component analysis (PCA) of CS17 
LCM-Seq showing PC1 and PC2 (a.i) and PC1 and PC3 (a.ii). (b) Heatmap of the 500 top genes by mean expression 
level with hierarchical sample clustering. (c) Heatmap of sample-to-sample distances with hierarchical clustering. 
 

























 Differential gene expression analysis reveals genes enriched for each subdomain along 
the dorsal-ventral axis 
Differential gene expression analysis was carried out for each subdomain vs. the other 3 subdomains 
and revealed significant positive upregulation for genes in each subdomain. D had a particularly high 
number of enriched genes at 774, with 352, 64, and 159 enriched genes for the DL, VL and V domains 
respectively (Fig. 18b). To identify pathways enriched for each sub-domain, Gene set enrichment 
analysis (GSEA) was carried out on differentially expressed (DE) genes ranked by log2 fold change using 
Hallmark, BioCarta, Reactome and KEGG databases (Fig.18a). ‘TNFR1’ and ‘FAS’ pathways enriched in 
D, and ‘Ceramide’ pathway enriched in DL are all involved in regulation of apoptosis, specifically 
induction of apoptosis. ‘TGFβ signalling’, which is known to be involved in promoting HSC emergence, 
is enriched in V but down-regulated in VL suggesting a more confined localisation of this signalling to 
the most ventral part of the dorsal aorta. VL is also enriched for ‘neuroactive ligand receptor 
interactions’, which is consistent with the VL localisation of sympathetic ganglia known to be an 
important component of the AGM HSC niche (Fitch et al., 2012). This analysis highlights that the dorsal 
aorta is a dynamic niche with different signalling roles along the D-V axis.  
 Gradients of gene expression along the dorsal-ventral axis 
To identify gradated changes in gene expression along the D-V axis using RNA-Seq analysis of the sub-
dissected regions, a likelihood ratio test (LRT) was used instead of the default Wald test during DESeq2 
(Love, Huber and Anders, 2014). This tool is frequently used for elucidating changes in gene expression 
along a time series, so here, by modelling the axis of the dorsal aorta as a time series from dorsal to 
ventral or vice versa, DE genes along the D-V axis could be revealed.  
This analysis gave only 3 significant genes with expression gradients along the D-V axis (p.adj<0.05, 
Fig.18c). In the dorsal-to-ventral direction there was the highly significant gene REN, which encodes 
the blood pressure regulator Renin (REN) and the gene SLC26A7, which encodes the sulfate/anion 
transporter Solute Carrier Family 26 Member 7. In the ventral-to-dorsal direction, the gene PCDH18 





Figure 18 : Differentially expressed genes and pathways along the CS17 dorsal aorta dorsal-ventral axis. a) GSEA 
of differentially expressed genes for each sub-domain vs. the other 3. X-axis shows normalised enrichment score 
(NES) with positive values for upregulated pathways and negative values for downregulated pathways (b) Number 
of genes significantly upregulated in each domain vs. the other 3, p.adj<0.05. (c) Genes significantly differentially 
expressed along the dorsoventral axis (test = Likelihood Ratio Test (LRT), p.adj<0.05) 
 
 Pooled ventral and dorsal analysis reveals spatially polarised gene expression patterns 
To determine whether a simpler D-V split would reveal additional spatially polarised genes and 
pathways, D and DL and V and VL subdomains were combined to dorsal_all and ventral_all domains 
respectively (Fig.19a). 93 genes were significantly upregulated in the ventral_all domain compared to 
825 genes in the dorsal_all domain. The top ventral gene was the lncRNA ENSG00000279310. REN, 
which was previously revealed as a gene with a gradient of gene expression towards the ventral 




Figure 19: CS17 ventral_all vs dorsal_all analysis.  a) Grouping of ventral and ventro-lateral subdomains 
(ventral_all) and dorsal and dorso-lateral (dorsal_all) for differential gene expression analysis. (b) Heatmap of 
top 200 differentially expressed (DE) genes between ventral_all and dorsal_all. (c)  3 top ventral_all upregulated 
genes vs dorsal_all (p.adj<0.05). (d) Volcano plot of DE genes between ventral_all and dorsal_all. In red = Log2 
fold change > 1.5 and p.adj<0.05 (e) GSEA of DE genes between ventral_all and dorsal_all. f) Genes contributing 





GSEA showed four pathways enriched in the dorsal_all domain compared with just one in the 
ventral_all domain (Fig.19e). ‘Apoptosis’ pathway enrichment in the dorsal_all domain is not surprising 
since this pathway was enriched in both D and DL sub-domains separately. The other three pathways 
enriched in dorsal_all are ‘Haemostasis’, ‘Oestrogen Response’, and ‘Interferon Gama Response’. The 
only pathway enriched in the ventral_all domain was the Gene Ontology (GO) pathway 
‘Developmental Maturation’ (GO:0021700). This pathway describes broadly “A developmental 
process, independent of morphogenetic (shape) change, that is required for an anatomical structure, 
cell or cellular component to attain its fully functional state” and includes top DE genes such as REN 
and RET (Fig.19f).  
In total, fewer genes and pathways were found from the ventral_all vs. dorsal_all analysis compared 
with the four sub-domain analyses. This indicates the utility of precisely resolving the spatial 
transcriptome to smaller regions along the D-V axis as it reveals additional localised signalling 
pathways.   
 Correcting for duplicate clustering effect on differential gene expression between 
dorsal and ventral domains of the dorsal aorta   
The DGE analyses in sections 3.2.4 – 3.2.6 were carried out by first correcting for per embryo 
differences in gene expression before contrasting subdomains. As the sample clustering analysis 
described in section 3.2.3 indicated potential batch bias by levels of duplication a separate analysis 
was run correcting first for duplication level batch effects instead of by embryo to see if it provided 
more meaningful data.  
DGE analysis of ventral_all vs. dorsal_all gave 181 and 147 upregulated genes respectively (p.adj<0.05) 
indicating that the high number of dorsal_all genes in section 3.2.6 may have been influenced by 
duplicate bias. The most significantly (i.e. smallest adjusted p.value) upregulated for ventral_all was 
PI16, Peptidase Inhibitor 16 which was also significantly ventrally upregulated in the previous analysis 
(Fig.20a, b). 
GSEA of the enriched genes showed no pathway enrichment. As correcting for batch based on 
duplicate level rather than embryo didn’t give much new meaningful data, the ‘per embryo’ batch 
corrected dataset is considered the principal analysis. This may risk false positives, particularly with 
the high number of genes upregulated in the dorsal_all domain but this was preferable to losing data 
through over-conservative batch correction. Furthermore, the elucidation of pathways in the original 
analysis indicates concordant DE of genes within pathways whereas this analysis gave no pathway 






 Spatial transcriptome profiling of the CS16 AGM region 
 CS16 LCM microdissection strategy 
Three CS16 embryos were used to spatially map the transcriptome of the human AGM region with 
LCM-Seq. Three concentric rings radiating away from the dorsal aorta were microdissected and for 
each ring the dorsal and ventral domains were sub-dissected and collected separately (Fig.21c). This 
approach was designed to allow signalling pathways for different cell layers of the HSC niche to be 
revealed, proximal and distal to the IAHCs, as well as to investigate D-V differences. The 3 layers are 
referred to as Inner (I), Mid (M) and Outer (O) which contain mainly I) endothelial and perivascular 
cells, M) sub-aortic mesenchymal cells and O) cells termed ‘outer mesenchymal’ cells respectively 
(Fig.21c, Table 7). Due to the nature of the technique these layers will not be made exclusively of these 
cell types. The Outer layer will likely include some endothelial cells of branching vessels and 
macrophages captured in the sub-aortic mesenchyme. This will be taken into account when analysed. 
However, in this project the aim is to determine primarily the proximity of the signalling to the dorsal 
aorta and the spatial polarisation of the signalling. Signals can be resolved to cell types through later 
experiments.   
Dorsal/Ventral Layer Description Shorthand  
Ventral Inner Endothelial/Perivascular V_Inner 
Dorsal Inner Endothelial/Perivascular D_Inner 
Ventral Mid Sub-aortic mesenchyme V_Mid 
Dorsal  Mid Sub-aortic mesenchyme D_Mid 
Ventral  Outer Outer mesenchyme V_Outer 
Dorsal Outer Outer mesenchyme D_Outer 












Figure 20: : CS17 ventral_all vs dorsal_all differential expression analysis following removal of 
duplicate bias effects (a) Most significant (p.adj = 2.29E-24) ventral gene, PI16 and (b) volcano plot 




Figure 21 Sub-dissection strategy for LCM-Seq of the CS16 dorsal aorta and surrounding mesenchyme (a) 
Representative CS16 embryo. The blue line indicates the boundary of the region taken for LCM-Seq transcriptome 
analysis of the CS16 AGM. (b) The histology image indicates anatomical features used to define correct region for 
LCM along the rostral – caudal axis. (Ao = Dorsal Aorta, Mn = Mesonephros,, UC = Umbilical cord, Duo = 
Duodenum). (c) shows the CS16 LCM-Seq microdissection strategy (d) Representative images from the laser 
capture microscope of the CS16 AGM indicating Inner (i), Mid (ii), and Outer (iii) layers. (e) Immunostaining for 
CD31, CD45 and Runx1 validates the presence of ventralised intra-aortic haematopoietic clusters (IAHCs) in each 
of the CS16 dorsal aortae taken for LCM-Seq. White arrowhead indicates IAHC. Ao = Dorsal aorta. D=Dorsal 
V=Ventral. Scale bar = 50μm.  
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Embryo N3 had two regions along the rostral-caudal axis taken for LCM-Seq. As the embryos were 
supplied externally and arrived pre-embedded, exact orientation of the embryo in the OCT block was 
not controlled. This made it difficult to determine the exact anatomical location of the first sections 
taken for LCM-Seq (C1) and upon staining it appeared that they were too caudal in position and were 
lacking obvious Runx1+ IAHCs (Appendix Fig.1). More rostral sections were taken for the second LCM-
Seq (C2), at the region of the vitelline artery, and this time ventral IAHCs were verified (Fig.21e, 
N3_C2). cDNA libraries were sequenced from both LCM-Seq libraries for this embryo and included in 
the principal component analysis. Only N3_C2 was used for differential expression analysis.  
 Validation of the presence of IAHCs in the ventral domain of the dorsal aortae within 
the regions taken for LCM-Seq  
Once again, sister sections of those microdissected for LCM-Seq were stained for CD31, Runx1 and 
CD45 to verify the presence of IAHCs in the ventral domain. Each embryo showed ventrally localised 
IAHCs (Fig.21e) with the exception of embryo N3_C1, as discussed above, which was not included in 
the DGE analysis. As with CS17, the IAHCs varied in size between embryos which may be due to genetic 
variability or just variable sizes of IAHCs along the rostral-caudal axis. Although Runx1+ cells were seen 
in the dorsal domain (Fig.21e, N3_C2), these rarely co-expressed endothelial CD31 and never seemed 
integrated into the endothelium indicating that IAHCs are exclusively found in the ventral domain.  
 Visualisation and quality assessment of the transcriptome by sample clustering 
analysis 
CS16 LCM-Seq sample similarity was analysed using dimension reduction principal component analysis 
(PCA). Plotting of the first 2 principal components (PCs) show clustering by embryo number indicating 
that biological variability is stronger than variability between subdomains (Fig.22ai). This is also visible 
on the sample distances heatmap with a large central cluster of N3 samples (both C1 and C2), a smaller 
left-hand cluster for N2 and the remaining samples belonging to N1 with the exception of VM-2 
(Fig.22b).  
PC2/PC3 plotting shows clustering of the samples into layers with Inner samples shifted towards the 
PC3 negative loading, Mid samples around 0 and Outer samples shifted towards the positive loading 
(Fig.22aii). This indicates that within the AGM niche there are robust differences in gene expression 
depending on proximity to the dorsal aorta.  
Expression levels of endothelial and perivascular markers were visualised for all samples to validate 
the cell types within each layer (Fig.22c). The Inner layer had the highest expression of the endothelial 
markers CD31 (PECAM1), VE-Cadherin (CDH5) and CD34 as expected as well as highest expression of 
perivascular cell markers smooth muscle alpha (α)-2 actin (ACTA2), cardiac muscle alpha (α)-1 actin 
(ACTC1), and NG2 (CSPG4). Mid layer samples had lower expression of endothelial markers than Inner 
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but still expressed perivascular markers indicating either that the Mid layer also contains perivascular 
cells or that the sub-aortic mesenchyme also expresses these markers. Outer layer samples had low 
expression of both endothelial and perivascular markers as expected.  
 
Figure 22. CS16 LCM-Seq visualisation and clustering of samples: (a) PCA; (ai) shows PC1 and PC2, (aii) shows 
PC2 and PC3. (b) heatmap of sample-to-sample distances with hierarchical clustering. (c) heatmap of normalised 
expression for select endothelial and perivascular cell markers. 
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 Spatial dorsal-ventral gene expression polarisation across the dorsal aorta and 
surrounding mesenchymal tissues 
DGE analysis was used to compare the dorsal and ventral subdomains for each subdissected layer 
(Inner, Mid, Outer), (Table 7). The numbers of significantly (p.adj<0.05) enriched genes for each 
concentric layer (subdomain) were: 
 Inner: 52 Ventral and 53 Dorsal 
 Mid: 129 Ventral and 100 Dorsal 
 Outer: 17 Ventral and 47 Dorsal 
There is only one gene with consistently polarised expression in every layer, the forkhead transcription 
factor Forkhead Box F2 (FOXF2). FOXF2 is upregulated in the dorsal subdomain of the Inner, Mid and 
Outer layers (Fig.23, indicated by *, Fig.24, Fig.25b), along with FOXF1 in the outer domain. These TFs 
have been shown to be activated by sonic hedgehog (Shh) which may be found more highly in the 
dorsal domain due to its proximity to the notochord where SHH is expressed (Echelard et al., 1993). 
The area within the microdissected sub-domains from the CS17 analysis are roughly equivalent to the 
CS16 Inner + Mid layers combined. Spatially polarised genes were compared from the two analyses 
and there was little overlap which may represent differences between stages but as the library 
preparation method was different for each analysis this may also be a technical issue. When comparing 
the ventrally upregulated genes vs. the dorsal counterparts in both the CS17 and CS16 analyses, the 
CS17 ventral_all subdomain has 1 and 4 overlapping genes with the ventral Inner and Mid layers 
respectively (Fig.25a). REN was one of these genes and is one of the top ventrally enriched genes in 
both the CS17 dorsal aorta and CS16 Mid layer (log2FC=11.3, log2FC=5.8). GATA3, a factor known for 
promoting HSC emergence (Fitch et al., 2012), was also enriched at both stages. The CS17 dorsal_all 
subdomain has only 3 and 4 overlapping genes with the dorsal Inner and Mid layers respectively 
despite the high number of upregulated genes (Fis.25b). This includes FOXF2 further indicating that it 
may be an effector of Shh in the dorsal region of the dorsal aorta. As CS17 is at the end of the window 
of HSC and IAHC appearance in the AGM the different gene expression profiles between CS16 and 





Figure 23. Polarised gene expression along the dorsal-ventral axis both close to the dorsal aorta and deeper 
into the underlying mesenchymal cells. Heatmap of top 30 differentially expressed genes between ventral and 
dorsal domains for each layer (Inner, Mid, Outer)(p.adj<0.05). NA = genes without an official gene name. * 





Figure 24. FOXF2 is dorsally enriched in each concentric layer. Normalised log10 expression levels for FOXF2 
across each sub-domain; V = Ventral Inner, D = Dorsal Inner, VM = Ventral Mid, DM = Dorsal Mid, VO = Ventral 
Outer, DO = Dorsal Outer 
 
 
Figure 25 : Polarised genes overlapping between CS17 and CS16 analyses. (a) shows the number of ventrally 
upregulated genes compared to the dorsal counterpart for CS17 ventral_all, CS16 Inner and CS16 Mid, and the 
number of genes overlapping between the analyses. (b) shows the number of dorsally upregulated genes 
compared to the ventral counterpart for CS17 dorsal_all, CS16 Inner and CS16 Mid, and the number of genes 





 Gene Set Enrichment Analysis (GSEA) reveals both layer specific and dorsal-ventral 
polarised signalling pathways in the dorsal aorta 
GSEA allows signalling pathways to be resolved to each concentric layer radiating away from the dorsal 
aorta as well as to determine D-V polarised signalling within each layer.  
1) Inner vs. Outer layers. This analysis reveals signalling pathways enriched in the vessel wall 
which may be involved in such processes as angiogenesis, blood vessel wall maintenance or 
HSC generation (Fig. 26).  
2) Inner + Mid vs Outer layers. Finding shared pathways enriched in the Inner and Mid layers 
compared with the Outer layer reveals cross talk between these layers (Fig.27). 
3) D-V Inner analysis. This reveals polarised pathways across the D-V axis of the vessel wall 
which may influence polarised processes such as specification of the haematogenic 
endothelium or HSC/HSPC emergence (Fig.28). 
4) D-V Mid analysis. This reveals polarised pathways across the D-V axis of the sub-aortic 
mesenchyme which may also influence polarised processes independently or through direct 
signalling interactions with the Inner layer (Fig.29).  
5) D-V Outer analysis. This reveals polarised pathways across the D-V axis of the outer 
mesenchyme which, although at a greater distance from the site of HSC emergence, may 
influence this process and other polarised processes by means of secreted molecule 
diffusion, cell migration or signalling interactions with the Mid and Inner layers (Fig.30).  
 
1) Inner vs. Outer layers 
Pathways enriched for both the ventral and dorsal Inner layers (endothelial + perivascular cells) vs. the 
respective outer layers (Fig.26) reveals pathways enriched in the vessel wall that are not necessarily 
polarised. The V_Inner and D_Inner sub-domains had 270 and 227 pathways enriched when 
contrasted with the V_Outer and D_Outer respectively (Fig.26b). Of these pathways, 124 are the same 
and represent signalling pathways found along the length of the dorsal aorta D-V axis (Fig.26b, c). Top 
enriched pathways for this Inner layer include ‘TNFA signalling via NFκB’ (Hallmark), ‘TGFβ signalling’ 
(Hallmark) and ‘Smooth Muscle Contraction’ (Reactome) (Fig.26c).   
2) Inner + Mid vs. Outer layers 
The Inner and Mid layers can be considered to be the most important cell layers for supporting HSC 
generation and interactions between these two layers may be essential for this process. For this 
reason, it is useful to compare differentially enriched pathways for both the Inner and Mid layer with 
the Outer layer so that overlapping signalling pathways between the two can be established (Fig.27). 
In the ventral domain the V_Inner + V_Mid layers have 270 and 189 pathways enriched compared with 
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the V_Outer layer respectively (Fig.27a). Of these pathways, 105 were shared between V_Inner + 
V_Mid layers indicating a high degree of interactivity and possibly co-cooperativity of these layers with 
regard to processes occurring in the AGM region. In the dorsal domain compared to the Outer layer, 
the D_Inner layer has 227 pathways enriched whereas the D_Mid layer has only 33 (Fig.27b). Of these 
33, 27 are shared with the D_Inner layer indicating less signalling interactions between D_Inner + 
D_Mid layers than in the ventral domain and greater Inner layer specific signalling in the dorsal 
domain. Indeed, pathways from DE genes between D_Inner + D_Mid layers show 68 Inner pathways 
and 14 Mid pathways. The same analysis in the ventral domain show much fewer differentially 
enriched pathways with 12 and 24 pathways enriched for V_Inner + V_Mid respectively.  
Top pathways for the overlap of Inner + Mid vs Outer in both dorsal and ventral domains included 
‘TGFβ signalling’ (Hallmark), ‘Epithelial-Mesenchymal Transition’ (Hallmark), ‘TNFA signalling via NFκB’ 
(Hallmark), and ‘Smooth Muscle Contraction’ (Reactome) indicating that these signalling pathways are 
required across the full D-V axis of the aorta (Fig.27a,b). There are however, D-V differences, and 
whether these are significant or not was determined through D-V differential gene expression analysis 
of each layer and subsequent GSEA. 
3) D-V Inner analysis 
GSEA of V_Inner vs D_Inner differentially expressed genes revealed polarised signalling pathways with 
10 pathways enriched in the ventral domain and 22 enriched in the dorsal (Fig.28). Interestingly, ‘TGFβ 
pathway’ (Hallmark, Biocarta) and ‘TNFA signalling via NFκB’ (Hallmark), are ventrally enriched despite 
being enriched in both dorsal and ventral domains when contrasted with the outer layer. This 
demonstrates a gradient of these pathways towards the ventral domain suggesting that they are more 
active there. Conversely, ‘Angiogenesis’ (Hallmark), ‘IL6 JAK STAT3 Signalling’ (Hallmark), ‘Formation 
of Fibrin Clot Clotting Cascade’ (Reactome), ‘AMI Pathway‘ (Acute Myocardial Infarction pathway, 
Biocarta), ‘Inflammatory Response’ (Hallmark) and ‘Coagulation’ (Hallmark) are found in both domains 
of the Inner layer vs . Outer layer but are dorsally enriched revealing a gradient of signalling towards 
the dorsal domain. Gene sets to do with transcription are ventrally enriched including ‘RNA Pol I 
Transcription’ (Reactome), and ‘RNA Pol I Promoter Opening’ (Reactome). Strangely, ‘Meiosis’ 
(Reactome) is also enriched in the ventral domain but a closer look at the genes contributing to this 
pathway enrichment reveals they are mainly encoding histone subunits and not meiosis specific 
proteins. This gives further evidence for higher transcriptional activity in the V_Inner domain. In the 
dorsal domain such inflammation pathways as ‘Inflammatory Response’ (Hallmark), ‘Cytokine-
Cytokine Receptor Interaction’ (KEGG), ‘IL6 JAK STAT3 Signalling’ (Hallmark) and ‘NKT Pathway’ 




4) D-V Mid Analysis 
In order to investigate whether signalling is polarised in the sub-aortic mesenchyme GSEA of the DE 
genes between V_Mid and D_Mid layers was carried out and revealed many spatially polarised 
signalling pathways (Fig.29). In the ventral domain, ‘TGFβ pathway’ (Hallmark, Biocarta) and ‘TNFA 
signalling via NFκB’ (Hallmark) are again enriched. The top (lowest FDR) ventral pathway is ‘Oxidative 
Phosphorylation’ suggesting cells are more metabolically active in this domain. ‘Protein Secretion’ 
(Hallmark) is also ventrally enriched which may indicate there is more inter-cellular communication in 
this domain. Other notable ventral pathways include pathways regulated by the oncogene MYC; ‘MYC 
Targets V1’ (Hallmark) and tumor suppressor P53; ‘P53 Pathway’ (Hallmark), indicative of controlled 
cell proliferation in this domain. In the dorsal domain the ‘Olfactory Signalling Pathway’ (Reactome) is 
the top enriched pathway which was also enriched in the dorsal Inner domain (Fig.28). ‘KRAS Signalling 
DN’ (Genes downregulated by KRAS activation, Hallmark) was also dorsally enriched in both Inner and 
Mid domains suggesting k-RAS could be polarising gene expression in the dorsal aorta.  
5) D-V Outer Analysis 
GSEA for DE genes between V_Outer and D_Outer subdomains revealed ventral enrichment of several 
pathways associated with haematopoietic factors such as TPO (‘TPO Pathway’, Biocarta), EPO (‘EPO 
Pathway’, PID and Biocarta), PDGF (‘PDGF Pathway’, Biocarta and ‘PDGFRA Pathway’, PID) and IL3 (‘IL3 
Pathways’, Biocarta) (Fig.30). It is conceivable that ventral layers distal to the dorsal aorta can 
contribute to the haematopoietic niche by emanating long-range signals. In the dorsal domain, 26 out 
of 103 enriched pathways were directly related to regulation of cell cycle and mitosis indicating high 
levels of proliferation in this domain.  There are several enriched pathways involved in cell metabolism 
and transcription but these are cell processes rather than classical signalling pathways suggesting that 
cell-cell communication is reduced in the dorsal domain compared to the ventral.  
This analysis demonstrates that there are both non-polarised and D-V polarised signalling pathways 
enriched in the dorsal aorta vessel wall. The high number of overlapping enriched pathways between 
V_Inner and V_Mid, indicates high levels of crosstalk between these two layers. The signalling in these 
layers close to the dorsal aorta are quite distinct from V/D_Outer pathways. Nonetheless, the Outer 
layer demonstrated D-V polarised pathways including ventrally enriched pathways involving 
haematopoietic factors. Taken together, this suggests that cells both proximal and distal to the dorsal 





Figure 26 Top pathways enriched in the Inner layer compared to the Outer layer reveals signalling of the 
dorsal aorta vessel wall. a) Schematic of contrast for GSEA a vs. b and a’ vs. b’. b) Number of pathways enriched 
in the Ventral Inner vs Ventral Outer and the Dorsal Inner vs Dorsal Outer and the number of shared pathways. 
c) Overlap between enriched pathways in the ventral and dorsal Inner domains compared to the respective 







Figure 27 (Previous page) Overlapping enriched pathways in the Inner and Mid domains vs. the outer domain 
highlight shared signalling pathways. i. Schematic of contrast for GSEA a vs. b and a’ vs. b’ for ventral a) and 
dorsal b) ii. Number of pathways enriched in Inner vs. Outer and Mid vs. Outer. iii. Top 20 (by Inner FDR) 
overlapping Inner + Mid vs. Outer pathways. FDR < 0.25, NES = Normalised Enrichment Score. Overlapping 





Figure 28 GSEA of differentially expressed genes between the ventral and dorsal sub-domains of the Inner layer. 






Figure 29. GSEA of differentially expressed genes between the ventral and dorsal sub-domains of the Mid 




Figure 30 GSEA of differentially expressed genes between the ventral and dorsal sub-domains of the Outer 
layer. FDR < 0.25, NES = Normalised Enrichment Score. 
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 Gradients of gene expression towards and away from the dorsal aorta  
To understand how signals in the AGM niche may be contributing to HSC generation, it is useful to 
know which expression of signalling molecules grow in intensity towards the dorsal aorta, the site of 
HSC emergence. For this, DESeq2 was used with a likelihood ratio test (LRT) as before.  
From the top 100 most significant genes, secreted molecules were identified by mapping Gene IDs 
with the Uniprot keyword Secreted [KW-0964]). This gave 23 secreted proteins, 10 of which were 
extracellular matrix (ECM) proteins (Fig.31a, bii) demonstrating that the composition of the ECM 
changes towards the dorsal aorta. The most differentially expressed secreted protein was EDN1, a 
vasoconstrictor protein (Fig.30a, bi) which is also significantly ventrally enriched in the Mid layer 
(p.adj<0.05).  
 
Figure 31 : Gradients of gene expression towards the dorsal aorta. (a) Secreted factors with gene expression 
increasing towards the dorsal aorta (OuterMid Inner) (Uniprot Keyword Secreted [KW-0964]). b) Normalised 
log10 counts of top 3 secreted proteins by log2 Fold Change. 
 Blood pressure regulatory genes are ventrally enriched 
The STRING database (Szklarczyk et al., 2019) was used to investigate interactions between the 
proteins encoded by significantly upregulated genes in the ventral domains of each layer with the aim 






Figure 32 (previous page). A protein interactome model of the CS16 LCM-Seq ventral Inner, Mid and Outer 
layers.  StringDB high confidence (0.7) interactions between significant (p.adj<0.05) ventrally enriched genes for 
each layer. Only nodes with connections to at least one other node are shown. Size of node increases with number 
of connecting edges to other nodes. Mid grid; Purple indicates “Interleukin-4 and Interleukin-13 signalling 
pathway”, (Reactome) components. Yellow nodes indicate proteins involved in regulation of blood pressure 
regulation. Outer grid; green nodes show GATA zinc finger as annotated by PFAM Protein Domains database (FDR 
0.00069) 
 
Inner layer. In the Inner layer, out of 52 enriched genes, 7 showed high confidence interactions 
(Interaction score ≥ 0.7) (Fig.32a). 3 of these were encoding histone proteins (HIST1H2BM, HIST1H3E, 
HIST1H3C). The presence of histone encoding genes suggests that new histones are required for 
correct packaging of newly replicated DNA therefore suggesting there is increased cell division in the 
V_Inner compared to D_Inner. There are no upregulated histone genes in D_Inner (Fig.32) HIST1H2BM 
had 2 further connections to the epigenetic regulators PRMT1 and CBX8.  
Mid layer. In the Mid layer, due to the high number of significant genes only the top 100 were analysed. 
This analysis yielded many more interacting genes than the Inner layer (Fig.32). Notably, genes 
involved in blood pressure regulation and/or smooth muscle contraction were present and highly 
connected to each other including components of the Renin-Angiotensin system REN and AGTR2 as 
well as NMB and EDN1. Components of the Reactome pathway ‘Interleukin-4 and Interleukin-13 
signalling pathway’ were enriched within this string network including activator protein (AP-1) TFs FOS 
and JUNB as well as CCL2, and GATA3. Of note, EDN1, CCL2, FOS and JUNB are all effectors of the TNFA 
signalling via NFκB pathway which is enriched in the V_Inner and V_Mid domains (Fig.28 and Fig.29) 
indicating overlap between blood pressure regulation and inflammatory signalling.  
The gene with the most network interactions is GNG2 (7 interactions), a G protein gamma subunit 
required for GTPase activity and for G protein-effector interactions (Uniprot). As G protein-coupled 
receptor signalling is a common mechanism of signal transmission it is perhaps unsurprising that it is 
a well-connected gene. Nonetheless, it may be an important signal effector in this cell layer. The 
chemokine CXCL2 and chemokine receptor CCR10 are also highly connected (6 interactions) to the 
same genes as one another.  
There is a highly connected cluster of genes involved in mitochondrial translation comprising MRPL46, 
MRPL38, MRPL24, ERAL1 and AURKAIP1. Translation within the mitochondria is largely for synthesis 
of oxidative phosphorylation complex subunits (Ott, Amunts and Brown, 2016). Indeed, oxidative 
phosphorylation is a ventrally enriched Mid pathway (Fig.29). As with the Inner layer there are 3 genes 
encoding histone proteins; HIST1H3H, HIST1H2BG and HIST1H3E also suggesting that V_Mid cells are 
dividing more than D_Mid cells. As cell division is a high energy process, mitochondrial biogenesis must 
increase which may explain the increase in mitochondrial translation. 
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Outer layer. In the V_Outer layer there were few interacting genes. However, the GATA zinc finger TFs 
are both present and linked to the BMP inhibitor Noggin which downregulates BMP4 signalling in 
developing HSCs (Souilhol et al., 2016a).  
 Discussion 
 Defining optimal conditions for LCM-Seq 
LCM with the aim of extracting RNA is tricky due to the high susceptibility of RNA to degradation and 
the multiple opportunities for exposure of the tissue to nucleases during the process. The most critical 
of these opportunities is the staining protocol as the tissue is submerged in solutions which may 
harbour nucleases and encourage their activity. A short protocol, with nuclease free, cold reagents is 
ideal. By trialling different staining protocols, the rapid haematoxylin and eosin stain was revealed to 
be the most optimal as the impact on RNA integrity could be kept to a minimum albeit at a trade-off 
with the enhanced cell identification using immunohistochemical methods. However, morphological 
information, such as the elongated endothelial cells, and staining patterns, e.g a pink layer of eosin 
demarcating the smooth muscle cells around the dorsal aorta, helped to define more precisely the 
cells taken for RNA-Seq analysis.  
The efforts to optimise the LCM-Seq protocol also revealed the PicoPure RNA Isolation Kit (Thermo 
Fisher) as the best kit (among tested) for extracting RNA from laser captured low cell numbers for 
preparation of RNA-Seq libraries. The most effective method overall was taken from Nichterwitz et al, 
2016 based on Smart-seq2(Picelli et al., 2014) which amplifies the RNA directly from the cell lysate 
without prior RNA purification. This method was far more efficient than a kit purification + SMARTer® 
kit method enabling libraries to be prepared from as little as 20 cells rather than ~525 cells.  
The measures described to optimise this technique have allowed application of a difficult technique 
to be applied successfully to important rare human embryo samples and to obtain meaningful spatial-
transcriptomics data of the human HSC developmental niche.  
  The duplicates dilemma 
An issue with generating RNA-Seq libraries from small input quantities is that the high number of PCR 
amplification cycles required often leads to a high number of duplicate fragments which was the case 
for the LCM-Seq datasets in this study. The effect of the duplicates was particularly apparent in the 
CS17 dataset where sample-to-sample distance clustering reflected level of duplication. Recent 
studies have investigated the effects of duplicates in datasets and weighed the consequences of their 
removal (Parekh et al., 2016; Klepikova et al., 2017). A critical issue is that duplicates are not totally 
the result of amplification bias but may result from a fragmentation bias as both enzymatic and heat 
fragmentation is not completely random, and natural sampling of independent molecules with the 
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same sequence termed ‘natural duplicates’ which are likely for highly expressed genes (Parekh et al., 
2016). Computational methods are therefore limited in defining what is a true PCR duplicate and 
removal has been shown to increase the false discovery rate and reduce the power in finding 
differentially expressed genes (Parekh et al., 2016; Klepikova et al., 2017). 
Of note, there was always 10-30% less duplicates in the 2nd read (R2) of sequenced libraries indicating 
that this portion of the duplicates were due to amplification of adapter sequences in the 1st read (R1). 
As these will not align to the genome, they will not be included in the analysis so will not have an effect 
on the differential expression analysis.  
 Spatial transcriptomics reveals signals polarised along the AGM dorsal-ventral axis 
It is well documented that the AGM is a complex niche for HSCs with many signalling pathways, cell 
types, ECM proteins and biochemical stimuli collaborating to provide a supportive environment for 
HSC generation and maintenance. Due to the interconnected nature of cells within the AGM niche, 
when profiling their gene expression, it is important to retain their spatial organisation. By contrast, 
profiling sorted cell populations loses critical region-specific gene expression and the ability to define 
signalling pathways contributing to the niche breaks down. As HSC emergence in the AGM is a process 
polarised to the ventral domain of the dorsal aorta, retaining this spatial context is particularly 
important. To this end, LCM-Seq was a very useful tool for generating spatial transcriptomes of the 
AGM.  
i. Evidence of compartmentalised signalling along the D-V axis 
The CS17 spatial transcriptome analysis of the dorsal aorta confirmed that expression of certain genes 
are polarised across a D-V split from the midline. Subdivision of the aortic vessel wall into 4 domains 
including additional lateral (side) subdomains revealed further localisation of gene expression levels 
for each subdomain indicating heterogenous functional roles of cells along the length of the D-V axis. 
TGF-β signalling, which has been found to be enriched in the ventral domain of the mouse dorsal aorta 
at the time of HSC emergence (Souilhol et al., 2016a; McGarvey et al., 2017), was enriched in the 
ventral domain of our dataset but in fact down-regulated in the ventro-lateral resolving this pathway 
to the most ventral cells. The involvement of TGF-β signalling in supporting HSC emergence is complex; 
in the bone marrow (BM) TGF-β signalling from Schwann cells and megakaryocytes maintains 
quiescence of HSCs which is critical for their long-term maintenance(Yamazaki et al., 2011; Zhao et al., 
2014)  and in vitro culture of BM CD34+ cells with TGF- β inhibits cell cycling and production of colony 
forming cells (Batard et al., 2000; Garbe et al., 1997; Sitnicka et al., 1996). In the zebrafish embryo 
higher levels of TGF- β were correlated with impaired HSPC generation, which was partly rescued by 
TGF- β inhibition, suggesting that TGF- β suppresses HSC generation (Yang et al., 2016). Furthermore, 
in mouse embryos, deletion of the TGF- β signalling effector Smad4 resulted in a dramatic increase in 
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the numbers of IAHCs (Lan et al., 2014). However, a recent report showed that Runx1+ cells 
undergoing EHT express tgf-β1b and null mutants for this gene have impaired generation of Runx1+ 
cells (Zhang et al., 2018). This was consistent with earlier reports that reduction in levels of the 
receptor Tgfβr2 reduced numbers of HSPC cells expressing runx1 and gata2b (Monteiro et al., 2016). 
It is conceivable that highly complex TGF-β/BMP signalling is subtly nuanced and may be involved in 
opposing regulatory roles in the AGM region. The concurrent upregulation and downregulation of TGF-
β signalling observed in the ventral and ventro-lateral domains of the human dorsal aorta may reflect 
this. 
Another striking difference between ventral and ventro-lateral domains was the ventro-lateral 
enrichment of ‘neuroactive ligand receptor interactions’ gene set suggesting that this subdomain may 
be particularly sensitive to secreted signals from the niche. Notably, the sympathetic ganglia are 
located in ventro-lateral positions to the dorsal aorta and provide signals that promote HSC emergence 
(Fitch et al., 2012). In the mouse, IAHCs emerge abundantly in the ventro-lateral domains and it has 
been proposed that this may be a region of optimal HSC development(Taylor, Taoudi and Medvinsky, 
2010; Souilhol et al., 2016a). There is no evidence of preferential ventro-lateral IAHC or HSC 
development in the human embryo but these data suggest at least that niche signalling pathways may 
be spatially resolved across ventral and ventro-lateral domains.   
In the dorsal and dorsal-lateral domains, there was enrichment of apoptosis related pathways such as 
‘TNFR1’, ‘FAS’ and ‘Ceramide pathways’. Controlled cell death is crucial during development for tissue 
remodelling suggesting more tissue remodelling in the dorsal domain. In E11.5 mice, apoptosis was 
shown to play a role in remodelling of the pharyngeal arch arteries in the head and neck region (Molin 
et al., 2002). In the dorsal domain, apoptosis may be clearing the way for angiogenesis and remodelling 
of dorsal intersegmental vessels. Indeed, dorsal enrichment of angiogenesis was detected in the CS16 
analysis.   
ii. Gradients of gene expression along the D-V axis 
During development, signalling gradients along the axes are a key mechanism defining a cell’s spatio-
temporal identity, thus co-ordinating the controlled growth of structures and specification of cell 
types. The archetypical example is of the dorsal-ventral polarisation of the neural tube by opposing 
gradients of Shh and BMPs resulting in the specification of cells along this axis to become different 
neuron types (BronnerFraser and Fraser, 1997). It has been demonstrated that the mouse AGM has 
opposing gradients of Noggin, SCF and Shh which were proposed to intersect to create optimal zone 
for HSC specification in the ventro-lateral dorsal aorta (Souilhol et al., 2016a). It was therefore of 
interest to investigate gradients of signalling across the human dorsal aorta that may contribute to 
specification of HSCs. Of the 3 significant genes, 2 had gradual gradients across the D-V axis. PCDH18, 
which encodes protocadherin-18, was upregulated towards the dorsal domain. Overexpression of 
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Pcdh18a in zebrafish inhibited cell migration during development impairing the proper development 
of certain structures including the hatching gland (Aamar and Dawid, 2008). Cells also appeared more 
tightly associated. This may suggest that PCDH18 is reduced in the ventral domain to allow for higher 
motility cell movements such as cell migration during EHT or for cell rolling along the vessel floor.  
REN which encodes Renin was the most significant gene with a gradient of expression from ventral to 
dorsal. Its expression is very high in the ventral and ventro-lateral domains and drops sharply in the 
dorsal-lateral and dorsal domains.  Renin is discussed more thoroughly in section 3.4.5. 
 Spatial transcriptomics reveals the complexity of signalling within the HSC 
developmental niche. 
Critical factors regulating haematopoietic specification and development in the dorsal aorta can be 
secreted by the endothelium. However, perivascular and smooth muscle cells adjacent to the 
endothelium as well as deeper cell layers can also be involved as has been shown in zebrafish and 
mouse models (Fitch et al., 2012; Souilhol et al., 2016a; Tamplin et al., 2015) . In order to explore both 
the near and longer-range signals, the region within the AGM including the dorsal aorta and 
surrounding mesenchyme as far as the gonad-mesonephros was microdissected into concentric layers 
radiating away from the dorsal aorta roughly comprising an endothelial/perivascular inner layer, a sub-
aortic mesenchyme mid layer and an outer mesenchymal layer. Each of these layers was sub-divided 
into dorsal and ventral domains. This approach allowed gene expression profiles of different sub-
domains to be contrasted in multiple paired combinations thus enabling differentially expressed genes 
to be determined between cells proximal and more distal to the dorsal aorta as well as polarised gene 
expression along the dorsal-ventral axis.  
i. Non-polarised pathways in the vessel wall 
In this analysis, niche signals can be broadly classified in 2 groups; non-polarised genes and pathways 
which provide ‘background’ signals that are important for the overall functioning of the niche cells and 
polarised genes and pathways which may contribute to the ventralisation and specification of HSC 
emergence. One role of the non-polarised signalling pathways would be to maintain the cells and 
structure of the vessel wall. For example, the IL-2 STAT5 signalling pathway is enriched in the Inner 
layer cells of the dorsal aorta. In adults, Interleukin-2 has been found to be sequestered to the 
endothelial and smooth muscle cells lining arteries by heparan sulfate proteoglycans (HSPG)(Miller et 
al., 2012). During trans-endothelial migration in the adult organism leukocytes release the enzyme 
Heparanase which cleaves the HSPGs and releases IL-2 stimulating lymphocytes to proliferate. 
Additionally, the aortas of adult IL-2 KO mice had small, compacted smooth muscle cells resulting in 
much thinner vessel walls and structural break down of the endothelial cells suggesting this cytokine 
is required for proper vessel wall maintenance and it is tempting to speculate that it has a similar role 
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in the embryonic dorsal aorta. This functional role does not necessarily decouple it from supporting 
HSC development, however. A recent study showed that HSCs in the bone marrow of Il2-/- mice lose 
their quiescence and undergo expansion but with progeny significantly biased towards the myeloid 
lineage (Giampaolo et al., 2017). This gives evidence for a further role of IL-2 in maintenance of 
haematopoiesis and regulation of differentiation. If these roles for IL-2 are found to be translatable to 
developmental haematopoiesis it would make IL-2 a candidate for manipulation of HSC derivation 
cultures to modulate expansion and skew differentiation to a preferred lineage. 
Analysis of the gradated changes in gene expression towards and away from the dorsal aorta revealed 
a high number of DE genes encoding components of the ECM. This suggests a significant change in the 
ECM composition in the cells near the dorsal aorta compared with the outer mesenchyme. Cell-matrix 
interactions are an important part of the niche influencing stem cell properties and culture systems 
that more closely mimic the 3-Dimensional (3D) architecture and ECM make-up of the native niche are 
being developed across the stem cell field (Discher, Mooney and Zandstra, 2009). One of the genes 
enriched towards the vessel wall, FN1, which encodes fibronectin, is frequently used in cell culture. 
Coating 3D scaffolds with fibronectin has been shown to improve expansion of UCB HSCs (Feng et al., 
2006; Mousavi et al., 2015). It would be interesting to investigate whether other aortic ECM proteins 
or proteoglycans such as HAPLN3 (Hyaluron and Proteoglycan Link Protein 3), BGN (Biglycan), ELN 
(Elastin) or COL4A1 (Collagen Type IV alpha) may improve HSC derivation or expansion cultures.  
ii. Dorsal-ventral polarised signalling in the dorsal aorta vessel wall and sub-aortic 
mesenchyme 
The data showed that there is a substantial overlap in signalling pathways between the Inner and Mid 
layers highlighting the importance of communication between the cells of the vessel wall and the sub-
aortic mesenchyme. This overlap was particularly pronounced in the ventral domain suggesting that 
this region of broader signalling patterns is conducive to promoting HSC generation. Furthemore, 
overlapping pathways including TGF-β and TNFα signalling via NFκB are ventrally enriched in both 
layers. This adds evidence for a role of the sub-aortic mesenchyme in signalling to the haematogenic 
endothelium and it is useful to study what signals are generated here.  
As the ventral domain of the dorsal aorta is the site of generation for HSCs, the dorsal domain could 
be expected to have reduced signalling activity in comparison. Far from this being the case, the dorsal 
domain has many more pathways enriched compared to the ventral domain. As previously discussed, 
data from Souilhol et al., shows signalling from the AoD is also important for promoting HSC generation 
(Souilhol et al., 2016a). The D_Inner and D_Mid domains have enrichment of inflammatory signalling 
pathways such as cytokine and chemokine receptor interaction pathways and IL6 JAK STAT3 signalling. 
Many cytokines contribute to the enrichments of these pathways (data not shown).  Given evidence 
in the literature that inflammatory pathways are involved in embryonic HSC development, the dorsal 
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domain may be an important source of relevant cytokines and it would be useful to investigate how 
these cytokines influence HSC emergence. 
The GSEA provides a wealth of information regarding the patterns of signalling pathways across the 
dorsal aorta and surrounding mesenchymal tissue. This signalling map of the HSC developmental niche 
highlights not only potentially important fundamental information but also will be a valuable resource 
for identification of potential molecular effectors for enhancement of haematopoietic differentiation 
of ES cell culture systems. It would also be useful to map the transcriptomes of AGMs from earlier 
embryos at CS13 when IAHCs first begin to appear as this may show the signalling patterns that specify 
the endothelial cells to become haematogenic which may be distinct from the cues that promote HSC 
emergence from the haematogenic endothelium.  
 Renin/Endothelin – Blood pressure regulators 
One gene with significant localisation to the ventral domain is REN which encodes Renin, a secreted 
protein component of the Renin-Angiotensin system (RAS). The classical physiological role of this 
system is of blood pressure regulation and fluid volumes balance (Sparks et al., 2014). In this system, 
renin, an aspartyl protease, is released from the kidney in response to changes in blood pressure and 
fluid volume. It cleaves the N-terminus of angiotensinogen (Ang), a protein predominantly generated 
in the liver and found abundantly in blood serum, to convert it to angiotensin I (AngI). Angiotensin-
converting-enzyme (ACE) then converts AngI to AngII by cleaving additional amino acids from the C-
terminus. AngII then acts through 2 receptors AT1 and AT2 to stimulate vasoconstriction of blood 
vessels thereby modulating blood pressure or release of aldosterone from the adrenal glomerulosa 
triggering reabsorption of sodium into the kidneys (Sparks et al., 2014)(Fig.33). The effect of RAS on 
blood pressure has made it an important target of pharmacological modulation for cardio-vascular 
therapies and ACE inhibitors have been extensively used to treat hypertension, heart failure, coronary 
artery disease, diabetes and chronic kidney disease (Messerli et al., 2018).   
In addition to regulation of blood pressure and hydro-electrolyte balance, roles for RAS in regulation 
of angiogenesis and inflammation have also been documented (Duprez, 2006). Importantly, there is 
an emerging role of RAS in the haematopoietic niche. In the bone marrow, AngII stimulates release of 
arachidonic acid which mediates haematopoietic progenitor apoptosis and proliferation (Richmond et 
al., 2004). ACE-KO mice revealed that ACE regulates myeloid and erythroid proliferation and 
maturation via AngII (Lin et al., 2011) and, consistently, lack of ACE results in anemia in the adult mice 
(Lin et al., 2011; Cole et al., 2000). Accordingly, ACE was found to be expressed in the chick yolk sac 
endoderm and pharmocological inhibition disrupted primitive erythropoiesis by reducing erythroblast 





Figure 33. The classical Renin-Angiotensin system (Encylopaedia Britannica Inc.). Renin is released from the 
kidney in response to a detected drop in blood pressure or fluid volume. It acts on angiotensinogen to convert it 
to angiotensin I which is in turn converted to angiotensin II by the enzyme angiotensin-converting enzyme (ACE). 
Angiotensin II stimulates vasoconstriction of the blood vessels or stimulates release of aldosterone from the 
adrenal glands. Aldosterone acts on the kidneys to stimulates reabsorption of NaCl and H2O.   
 
As discussed in the introduction, ACE has been reported to mark migrating cells from the P-Sp (the 
presumptive haematogenic endothelium) which colonise the ventral endothelium of the dorsal aorta 
and specify or directly contribute to emerging HSCs (Jokubaitis et al., 2008). The role of ACE in 
supporting HSC development was further investigated using a human embryoid body (hEB) 
haematopoeitic differentiation culture system (Zambidis et al., 2008). Blast colony-forming cell (BL-
CFC) colonies were derived only from the ACE+ fraction of hEBs and, interestingly, inhibition of both 
ACE and AGTR2 significantly reduced the number of colony forming units (CFUs) and replated blast 
colonies produced predominantly endothelial cells. Conversely, AGTR1 inhibition greatly enhanced 
CFU production and replated cells gave rise to haematopoeitic progeny. This suggests opposing 
receptor signalling is critical for determining an endothelial vs. haematopoietic fate to haematogenic 
endothelial cells.  
Taken together, these data suggest a role of RAS in promoting HSC emergence in the AGM region. 
However, thus far only ACE and downstream effectors have been investigated and not Renin itself. 
Notably, REN and the receptor AGTR2 were most highly expressed in the ventral sub-aortic 
mesenchymal layer. This position, not directly adjacent to the endothelial ACE+ cells but deeper into 
the underlying cells, suggests Renin may not act exclusively on the ACE+ clusters adhering to the 
endothelium. Indeed, Renin-prorenin receptor mediated signalling has been shown to have roles 
independent of AgtII generation stimulating TGF-β signalling and subsequent increases in matrix 
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proteins fibronectin, collagen-1 and plasminogen activator inhibitor-type 1 (Huang et al., 2006). 
Expression of the prorenin receptor (ATP6AP2) is seen throughout the region of the AGM mapped in 
this analysis (data not shown).  
The gene EDN1 encoding another blood pressure regulating peptide endothelin-1 (Edn1) increased in 
expression towards the dorsal aorta and was also significantly enriched in the ventral sub-aortic 
mesenchymal cells. Endothelin-1 (ET-1) is a potent vasoconstrictor which acts through the G-protein 
coupled transmembrane receptors ETA and ETB (Haque, Welch and Loizidou, 2013). There are 
significant overlaps in the RAS and Edn1 pathways;  both AngII and Edn1 stimulate arachidonic acid 
release and subsequent prostaglandin synthesis (Richmond et al., 2004; Yousufzai and AbdelLatif, 
1997), and AngII has been reported to upregulate TNF-α synthesis (Lin et al., 2011; Yamada et al., 
2010) which is known to stimulate ET-1 production (Haque, Welch and Loizidou, 2013). Indeed, there 
have been several reports of induction of Edn1 expression and protein production by adding AngII to 
endothelial (Chua et al., 1993; Imai et al., 1992) and vascular smooth muscle cell cultures (Hahn et al., 
1990; Sung et al., 1994). Conversely, Edn1 has been shown to inhibit Renin production in the main 
Renin producing cells, the juxtaglomerular cells, in the kidney (Ackermann et al., 1995; Beierwaltes 
and Carretero, 1992; Lin et al., 1993). Endothelin-1 can also stimulate aldosterone production as 
potently as AngII (Rossi et al., 1997). There is clearly crosstalk between the two pathways and the 
ventral enrichment of both Renin and Endothelin-1 makes a localised and co-ordinated role for the 
two in the AGM an intriguing possibility.  
Interestingly, Edn1 is ventrally localised in the pharyngeal arches and, along with BMP, is required for 
conferring cells their positional identiy along the dorsal-ventral axis and enabling development of the 
ventral craniofacial structures (Alexander et al., 2011). It is interesting that it is also ventrally localised 
in relation to the dorsal aorta, as is BMP, and a ventralising effect of Edn1 in the dorsal aorta would 
be worth investigating. The spatial polarisation of both Renin and Edn1 along with the implications of 
the RAS in haematopoiesis and the involvement of both factors in ventrally enriched pathways (TGFβ 





4. Resolution of the spatial transcriptome to defined cell populations  
 Transcriptome analysis of spatially resolved, sorted haemato-endothelial 
populations from the human dorsal aorta. 
The spatial transcriptome dataset provided a map of signalling across the aortic HSC niche. In order to 
understand how these niche signals may interact with the haematogenic endothelium to influence 
HSC emergence, it is necessary to define the molecular signature of the cells along the EHT axis. 
Although LCM is a useful tool to interrogate the transcriptome of cells without losing their spatial 
identity, the phenotype of the cells taken is not certain. For example, the Inner layer of the CS16 LCM-
Seq (Fig.21) contains both endothelial and perivascular cells and we do not know which of the genes 
expressed derive from which cell type. To resolve these signals to cell populations of the haematogenic 
endothelium the dorsal aortae from 2 embryos (N1 = CS15, N2 = CS16) were sub-dissected manually 
into dorsal and ventral portions (indicated by D and V) and sorted based on VC and CD45 expression 
giving VC+CD45- endothelial cells, VC+CD45+ Haematopoietic Stem/Progenitor Cells (HSPCs), and VC-
CD45+ haematopoietic cells (Fig.34). From these cells, the bulk RNA was extracted and RNA-Seq 
libraries were prepared and sequenced and DGE and GSEA analysis was carried out. This dataset not 
only allows the dynamics of gene expression during EHT to be elucidated but also to resolve signalling 
pathways from the LCM-Seq analysis such as the renin and endothelin pathways. 
 
Figure 34. Sorting strategy for transcriptome analysis of haemato-endothelial populations from the dorsal 
aorta. The dorsal aortae from CS15/16 embryos (n=2) were sub-dissected into ventral and dorsal domains and 
sorted based on the expression of VE-Cadherin (VC) and CD45 to give (A) VC+CD45- endothelial, (B) VC+CD45+ 
haematopoietic stem/progenitor population (HSPC) and (C) VC-CD45+ haematopoietic population for subsequent 
RNA-Sequencing. 
 Visualisation and quality assessment of the sequenced read data by sample clustering 
analysis 
The low cell numbers and subsequent high number of PCR amplification cycles resulted in high 
duplicate levels (Table 8). Duplicate levels are the highest for the D_VC+CD45+ populations which also 
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low starting complexity of the amplification reactions (Parekh et al., 2016). On the whole, duplicate 
levels do not seem to greatly affect the molecular signatures of the cell populations as different cell 
types from 2 embryos cluster together on the PCA analysis with the exception of  D_VC+CD45+ which 
differ greatly from each other and the other cell populations along PC1 and PC2 (Fig.35a). Along the 
PC3 axis they split to cluster most closely with either the VC+CD45- or VC-CD45+. This indicates that 
the cells in the 2 D_VC+CD45+ populations are not at all similar and have been excluded from DGE 
analysis. The heatmap of sample-to-sample distances and of the top 500 genes by expression level 
also indicates the lack of correlation between these samples (Fig.35b, c). The V_VC+CD45+ HSPC 
population clusters more closely to the VC-CD45+ haematopoietic populations along PC2 but falls 
directly between the VC+CD45- and VC-CD45+ populations along PC3 demonstrating its intermediate 
position in EHT (Fig.35a). There is no strong indication of D-V differences on the PCA analysis except 
for between V_VC+CD45+  and D_VC+CD45+ populations and, as mentioned, this may be a duplication 
level artefact. 
 
Table 8 Table of sorted cell populations for each sample taken for RNA-Sequencing with correlating input cell 






Figure 35. Clustering visualisation of dorsal aorta haemato-endothelial population transcriptomes. V = ventral. 
D = Dorsal. VC = VC+CD45-, VC_CD45 = VC+CD45+, CD45 = VC-CD45+ a) Principle component analysis of 
sequenced cell populations, principle components (PC) 1 and 2 (left) and PC3 and 4 (right). b) Heatmap of top 























 Dorsal-ventral differences are evident in the endothelial VC+CD45- population, 
including ventrally enriched EDN1. 
There were 94 DE genes between the V_ VC+CD45- and D_VC+CD45- populations. This included EDN1 
which was also ventrally enriched in the Mid layer of the LCM-Seq spatial transcriptome analysis 
(Fig.36, red box and Fig. 32 from chapter 3). It was not significantly enriched in the ventral domain of 
the Inner layer however (log2FC = 2.4, p.adj = 0.4) which is where most endothelial cells are found. 
This indicates that more precise sorted populations were required to find these D-V differences in the 
endothelial population which may have been occluded by DE genes in the perivascular cells. Indeed, 
there is only 1 overlapping gene between the ventral vs dorsal VC+CD45- and Inner layer LCM-Seq 
datasets which is PAX1 – a dorsally enriched gene in both datasets (Fig.36, green box). This is a TF 
which, in the mouse, is expressed in the sclerotome between E9.5 and E11.5 in the mesenchyme 
dorsally adjacent to the dorsal aorta in response to Shh signalling from the notochord (Furumoto et 
al., 1999). It is reasonable then that it should also be expressed in the dorsal cells of the aorta. Other 
TFs were defined using the GO term ‘DNA-binding transcription factor activity’ GO:0003700 and are 
indicated with an asterisk (Fig.36) and include ventrally enriched GATA4 and TBX5.  
A proportion of the genes enriched in the D_VC+CD45- are haemoglobin genes (HB*) which might 
indicate that these populations were contaminated with erythrocytes which have highly abundant 
globin mRNA. However, bona fide expression of these genes in the D_VC+CD45- populations should 
not be ruled out. Notably the haemoglobins are embryonic (HBE1, HBZ) and foetal (HBG1, HBG2) sub-
types.  
 Dynamic expression of genes across the endothelial-to-haematopoietic transition 
By finding differentially expressed genes between the endothelial, HSPC and haematopoietic cell 
populations in the ventral domain, the gene expression changes during EHT could be elucidated 
including TFs, secreted factors, and cell receptors (Fig.37a-c). In total the ventral HSPC population has 
1050 and 910 genes upregulated compared to the endothelial and haematopoietic populations 
respectively (Fig.37d). Out of these genes, 251 are overlapping indicating that they are upregulated in 
the transition from VC+CD45- to VC+CD45+ then downregulated to VC-CD45+ providing an HSPC 
specific ‘signature’. Some of the genes within this signature can be clearly visualised in the heatmaps 
(Fig.37a-c). For example, the TFs MYB and SETBP1 are strongly upregulated only in the HSPC 
population whereas expression of others such as RUNX1, IKZF1, and SPI1 continue to be expressed in 
the more mature haematopoietic cells. There are also a number of genes which are downregulated 
on the HSPC population compared to both endothelial and haematopoietic populations such as the 
TFs ZFP36L1 and BHLHE40 and the secreted factors NRP1 and A2M suggesting inhibition of these 
factors is required for HSPC production from endothelial cells but not for their maturation. The HSPC 




Figure 36. Dorsal-ventral polarised gene expression in the dorsal aorta endothelial cells. V = ventral. D = 
Dorsal. VC = VC+CD45-. Heatmap of top 50 differentially expressed genes between V_VC and D_VC populations 
p.adj = <0.05. Green box highlight PAX1, an overlapping gene with LCM-Seq Inner analysis. Red box indicates 






























expresses haematopoietic markers such as CD84, CSF3R, and CSF1R indicating that some cells within 
this population are lineage primed.  
To statistically define gradated monotonic change in gene expression across EHT (VC+CD45-  
VC+CD45+  VC-CD45+) a likelihood ratio test (LRT) was used instead of the default Wald test of 
DESeq2. This determined 3615 significantly differentially expressed genes along the EHT axis 
(p.adj<0.01) some of which are shown in Fig.38. As to be expected CDH5 (VC) decreases in expression 
from VC+CD45- to VC-CD45+ and PTPRC (CD45) increases. For some genes such as ADGRF5 and G0S2 
the change in expression across the EHT axis is gradual whereas others decrease or increase sharply 
from one population to the next. For example, ADGRL4 and PRND drop steeply in expression level 
between the endothelial and HSPC populations and stay much the same between the VC+CD45+ and 
VC-CD45+ populations. These steeper changes in gene expression may indicate a switching on or off 
of genes required for HSPC specification from the endothelium whereas more gradual changes could 
indicate secondary changes.  
 
Figure 37. Differentially expressed genes across the EHT axis. VC+ = VC+CD45-. CD45+ = VC-CD45+ Heatmaps of 
top 25 enriched genes for V_VC+CD45- vs. V_VC+CD45+ and vice versa for a) Transcription Factors, b) Secreted 
Factors, c) Cell receptors. p.adj = <0.05. d) Venn diagram of genes enriched in the ventral HSPC VC+CD45+ 




Figure 38. Gradients of gene expression across the EHT axis. Graphs of normalised counts for the top 24 
differentially expressed genes determined using a likelihood ratio test to define gradated changes across the 3 
populations. VC+ = VC+CD45-, VC+CD45+ = VC+CD45+, CD45+ = VC-CD45+. P.adj<0.05 
 
 Gene set enrichment analysis reveals pathways differentially enriched along EHT axis 
GSEA of the differentially expressed genes between sub-populations in the ventral domain can reveal 
pathways involved in EHT and integration of these pathways with the GSEA from the LCM-Seq (Chapter 
3.3.5) may indicate how signalling pathways from the niche interact with these populations to 
promote HSC emergence.  
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Gene sets enriched in the endothelial population compared with HSPC include more structural and 
extracellular matrix related gene sets such as ‘Core Matrisome’ (NABA), ‘Extracellular Matrix 
Organisation’, ‘Collagen Formation’ (Reactome), ‘Collagens’ (NABA),  and ‘Basement Membranes’ 
(NABA) which is to be expected from the structural integrity of the endothelium and its interactions 
with the underlying cells of the vessel wall (Fig.39a). It follows that in the HSPC population gene sets 
related to haematopoietic cell function are enriched such as ‘Hematopoietic Cell Lineage’ (KEGG), 
‘Immune System’ (Reactome), ‘Immunoregulatory Interactions Between a Lymphoid and a Non 
Lymphoid Cell’ (REACTOME) to name just a few (Fig.39b).  
In the LCM-Seq analysis ‘TGF Beta Signalling’ (Hallmark) and ‘TNFA signalling via NFKB’ (Hallmark) were 
ventrally enriched in both the inner endothelial/perivascular layer and the mid sub-aortic 
mesenchyme (Fig.28,29). In this dataset ‘TGF Beta Signalling’ (Hallmark) is enriched on the endothelial 
population and ‘TNFA signalling via NFKB’ (Hallmark) is enriched on the HSPC population indicating 
that these niche pathways may influence distinct cell populations (Fig.39a, b). Multiple pathways 
enriched in cells of the vessel wall as determined by the LCM-Seq Inner vs Outer analysis are also 
differentially enriched on the endothelial and HSPC populations. ‘Notch Signalling’ (Hallmark) is 
enriched on the endothelial population whereas ‘IL6 JAK STAT Signalling’ is HSPC enriched. Of note, 
‘Hedgehog signalling’ is also enriched on the endothelial population. This is consistent with reports 
that hedgehog signalling is required for dorsal aorta development and arterial specification (Gering 
and Patient, 2005).        
There are much fewer pathways enriched in the HSPC population when compared with the VC-CD45+ 
haematopoietic population (Fig.40a). This may indicate that many of the enriched HSPC pathways vs. 
the endothelial population derive from the acquisition of mature haematopoietic cell traits rather than 
the underlying specification process. Several of the pathways that are enriched in the HSPC population 
compared to both endothelial and haematopoetic populations (Fig.40a, indicated with an asterisk) are 
involved in translation e.g. ‘Peptide Chain Elongation’ (Reactome), ‘Translation’ (Reactome) etc. This 
indicates a push for high protein synthesis. ‘Myc Targets V2’ is also enriched on the HSPC population 
indicating proliferation and, along with increased protein synthesis, higher metabolism of these cells.  
Interestingly, a high proportion of pathways enriched on the VC-CD45+ haematopoietic population 
are also dorsally enriched in Inner and Mid layers from the LCM-Seq datasets (Fig.40b, and Figs.28,29). 
This includes ‘Chemokine Receptors Bind Chemokines’ (Reactome), ‘IL12 STAT4 Pathway’ (PID) 
involved in regulation of differentiation and proliferation of T cells (Watford et al., 2004) and ‘CTLA4 
pathway’ (Biocarta) involved in modulation of T cell function (Buchbinder and Desai, 2016). This raises 
the question of whether signals from the dorsal domain may be supporting the maturation of certain 
haematopoietic cell types, perhaps through chemokine signalling. Of note, there are some pathways 
enriched in both the endothelial and haematopoietic populations compared with HSPC population 
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such as ‘NOTCH signalling’ (HALLMARK) and ‘Hedgehog Signalling’ (Hallmark and KEGG). This suggests 
that these pathways require downregulation during HSPC generation Notably, downregulation of 
Notch in mouse HSC maturation has been shown(Souilhol et al., 2016b; Lizama et al., 2015; Tang et 
al., 2013).   
 
Figure 39 Gene Set Enrichment Analysis for the V_VC+CD45- vs V_VC+CD45+. GSEA input was differentially 
expressed genes ranked by log2 fold change. a) V_VC+CD45- enriched pathways. b) V_VC+CD45+ enriched 







Figure 40 Gene Set Enrichment Analysis for the V_VC+CD45+ vs V_VC-CD45+. GSEA input was differentially 
expressed genes ranked by log2 fold change. a) V_VC+CD45+ enriched pathways. b) V_VC-CD45+ enriched 








 Renin and Endothelin pathway components are differentially expressed on the 
haematopoietic and endothelial populations of the dorsal aorta. 
The LCM-Seq analysis reported in Chapter 3 revealed that blood pressure regulators renin (REN) and 
endothelin-1 (EDN1) are ventrally enriched in the blood vessel wall of the dorsal aorta. As previously 
mentioned in 4.1.2 ventral enrichment of EDN1 is also seen in the VC+CD45- endothelial cells. This 
sorted dorsal aorta RNA-Seq dataset can be used to visualise expression of components of the renin 
and endothelin pathways in the dorsal aorta and build up the picture of how these cells may interact 
across sub-populations of the EHT and with the niche. The heatmap in Figure 41 shows normalised 
expression of some of the main components of these pathways.  
 
 
Figure 41. Components of the Renin and Endothelin pathways are differentially expressed on the dorsal-aorta 
haemato-endothelial populations. Heatmap of normalised expression values for each population. Scale bar 
shows deviation from the row mean. V = Ventral. D = Dorsal. VC = VC+CD45-, VC_CD45= VC+CD45+. CD45 = VC-
CD45+. Some genes are not differentially expressed and are present at low levels across the populations (above 
horizontal black line). Others show higher levels of expression on specific populations and are not expressed on 
others (below black line).   
 
REN is not differentially expressed across populations indicating that its strong ventral enrichment is 
not in the endothelial or haematopoietic populations of the dorsal aorta but may be in the underlying 
mesenchymal niche cells. ACE encoding Angiotensin-converting enzyme, which has been described as 
an HSC marker in the human AGM (Jokubaitis et al., 2008) is most strongly expressed on the 
V_VC+CD45+ cells which is the HSC containing population (Ivanovs et al., 2014).  AGT, which encodes 
Angiotensinogen the substrate for REN and subsequently ACE is not highly expressed consistently on 
any population. It was also not expressed in any layer of the LCM-Seq analysis suggesting that, if it is 
the substrate for REN and ACE in this instance, it derives from another cell source, perhaps through 
the blood stream. There is no strong expression of either of the angiotensin receptors AGTR1 or AGTR2 
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on any of the populations. The receptor for prorenin, the inactive precursor to renin, ATP6AP2, is 
expressed most strongly on the VC-CD45+ populations.  
EDN1, as described, is expressed across the whole aorta in the VC+CD45- cells but more strongly in the 
ventral domain. It then has a sharp decrease in expression in the VC+CD45+ population but some lower 
level expression in seen on the more mature VC-CD45+ population. The gene encoding endothelin-
converting enzyme -1, ECE1¸is also more strongly expressed on the endothelial VC+CD45- cells. Of the 
endothelin receptors, EDNRB rather than EDNRA has consistent differential expression between EHT 
populations with highest expression on the VC-CD45+ populations and lower expression on VC+CD45- 
cells, with a similar drop in expression to EDN1 on the VC+CD45+ cells. This suggests a potential 
autocrine signalling of ET-1 (endothelin-1, protein) via ET-B (endothelin receptor B, protein).  
 Modelling interactions of the niche with haematogenic populations of the aorta.  
The LCM-Seq spatial transcriptome and the sorted dorsal aorta populations analyses, can be brought 
together to model how niche signals may interact with the endothelial and HSPC cells to promote HSC 
emergence and support maturation. To this end, LCM-Seq ventrally enriched secreted factors and 
receptors from the VC+CD45- vs. VC+CD45+ populations were analysed for known interactions using 
the STRING database (Fig.42a (V_VC+CD45+), b (V_VC+CD45-)). The number of connections 
corresponds to the size of the node on the interaction networks potentially indicating top of the 
hierarchy signalling factors. Secreted factors are in red, receptors are in blue. An interaction could be 
one of the following; activation, inhibition, binding, catalysis, phenotype, posttranslational 
modification, reaction, transcriptional regulation (see Materials and Methods). SPP1 which encodes 
osteopontin, is a highly significant ventralised secreted factor in the Mid domain which directly binds 
the top 2 most significantly differentially expressed receptors on the V_VC+CD45+ HSPC population 
compared to the V_VC+CD45- endothelial population, CD44 and ITGA4 (Fig.42a) highlighting a 
potential niche-HSPC signalling interaction. However, SPP1 is also expressed on the HSPC population 
(but not VC+CD45- endothelial) itself so signalling with CD44 may be autocrine.  
The secreted factor with the highest amount of connections to HSPC receptors is PLAU, encoding the 
serine protease urokinase that converts plasminogen to plasmin (O'Leary et al., 2016) and interacts 
with numerous diverse receptors types such as the integrin receptors ITGAM and ITGB2, the TNFα 
receptor TNFRSF1B, the G protein-coupled receptor GPR84 and the immunoglobulin receptors LILRB2, 
FCER1G, CD300A and LAIR1. PLAU modulates cell adhesion through the integrins facilitating cell 
mobility during migration raising the idea that this niche-HSPC interaction aids the movement of HSPCs 
as they round up and bud into the lumen, detaching from the endothelial and ECM structures of the 
vessel wall. Furthermore, PLAU, along with EDN1 and the smooth muscle constrictor NMB all interact 
with PTAFR (Platelet activating receptor) which is also a potent smooth muscle constrictor indicating 




Figure 42 . Modelled interactions of the niche with the ventral endothelial and HSPC population. StringDB 
interactome of ventrally enriched secreted factors (Inner and Mid from LCM-Seq) in red with a) V_VC+CD45+ or 
b) V_VC+CD45- (next page) enriched receptors in blue. High confidence interactions only (>0.7/1). Asterisk 
highlights secreted factors discussed in results. Size of the node reflects number of interactions. b) Clusters are 
grouped together by coloured dotted lines; green = integrin receptors, red = ephrins and ephrin receptors, blue 









In the network of niche secreted proteins and VC+CD45- endothelial receptors (Fig.42b) EDN1 has the 
highest number of connections indicating a central signalling role to the endothelial cells, although as 
the VC+CD45- express EDN1 highly themselves (Fig.36), this is likely to be in part, if not fully, autocrine 
signalling. A direct action of EDN1 on this population is further evidenced by expression of endothelin 
receptor EDNRB as previously mentioned (Fig.41). In contrast, NMB which also has a high number of 
overlapping connections with EDN1, is highly expressed in the ventral sub-aortic mesenchyme (Mid) 
indicating a paracrine mode of action. The shared connections cluster into a group of G-protein 
coupled receptor (GPCR) signalling related genes.  This includes further blood pressure regulation 
receptors BDKRB2 (B2 bradykinin receptor) and APLNR (Apelin receptor). Taken together, components 
of systems involved in regulating vascular constriction and dilation are differentially expressed in the 
endothelial, HSPC and mesenchymal cells indicating a complex, compartmentalised regulation of 
vascular tone.  
PLAU and SPP1 cluster on the VC+CD45- network with integrin receptors as with VC+CD45+ indicating 
that they may influence focal adhesion and cell migration at both the VC+CD45- and VC+CD45+ level 
on different receptors. One striking difference between VC+CD45- and VC+CD45+ types of receptors 
are the respective presence and absence of ephrin receptors highlighting a downregulation of these 
receptors during HSPC generation. The ventral sub-aortic mesenchyme secreted ephrins EFNA1 and 
EFNA4 have many interactions with this group of receptors as expected. Several neuroactive ligand 
receptors are also upregulated in the VC+CD45- vs VC+CD45+ cell group, although they have minimal 
connections to the niche secretome captured with LCM-Seq. 
TGFβ signalling is a ventrally enriched pathway in both the endothelial, perivascular and sub-aortic 
mesenchyme compartments (VC+CD45-, Inner, Mid resepectively). Notably the VC+CD45- endothelial 
cells have several receptors to the TGFβ ligand superfamily including BMP receptors BMPR2, BMPR1A, 
BMPR1B and ACVRL1 and TGFβ receptors TGFBR2, TGFBR3 and ZFYVE9 (Fig.42b) demonstrating that 
the VC+CD45- are effector cells for this signalling pathway. TNFα signalling was also ventrally enriched 
in the perivascular and sub-aortic mesenchyme but enriched on the HSPC over the endothelial 
compartment. However, there are differing TNFα signalling receptors enriched on both the HSPC cells 
(TNFRSF13C, TNFRSF1B) (Fig.42a) and endothelial cells (TNFRSF19, TNFRSF10D, TNFRSF12)  (Fig.42b) 
demonstrating that the effects of this signalling pathway on the different cell types are modulated 
through different receptors.   
Although secreted factors in the niche are just one way in which it may influence the cells of the dorsal 
aorta, this analysis highlights potential interactions of the niche with the endothelium or HSPC 




 Single cell RNA-Seq analysis of the ventral dorsal aortic cell populations 
RNA-Seq of bulk sorted populations is useful for modelling interactions of the niche with the 
populations along the EHT axis as well as the dynamics in gene expression during this process. 
However, the sorting based on VC and CD45 expression does not allow for the exploration of 
transcriptional differences in sub-populations. For example, the VC+CD45- endothelium may contain 
both non-haematogenic and haematogenic endothelium or pre-HSCs that do not yet express CD45+. 
Although the V_VC+CD45- vs D_VC+CD45- analysis provides evidence of potential genes that may 
confer haematogenic vs non-haematogenic identity, the signals that mark the initiation of HSC 
emergence from the endothelium may derive from relatively small sub-populations and therefore get 
lost in the bulk population transcriptome. To address this, 10X single cell sequencing of the ventral 
domain of the dorsal aorta was carried out. The dorsal aorta of a CS16 specimen was sub-dissected 
into ventral (AoV) and dorsal (AoD) domains, dissociated into single cells and CD34+ cells were purified 
using MACS column separation (Fig.43). CD34+ cells mark both the endothelial cells and the IAHCs. 
Clustering of these cells into sub-populations would thus allow resolution of the heterogeneity of the 
ventral endothelium and haematopoietic progenitor cells. Furthermore, lineage inference tools would 
facilitate identification of the direct endothelial ancestors of HSPC cells. 
 
Figure 43 Experiment plan for single cell analysis of CD34+ cells in the ventral dorsal aorta. The dorsal aorta (Ao) 
was sub-dissected by hand into ventral (AoV) and dorsal (AoD) regions. The AoV was dissociated and CD34+ cells 
were selected using MACS bead column separation. 10X genomics was used to prepare the single cell RNA-Seq 
libraries for sequencing and subsequent analysis. 
 
 Quality control testing of the dataset and removal of confounding effects 
The AoV CD34+ cells were run on two lanes of the 10X chip resulting in a combined total of 2,421 cells 
with 71,270 mean reads per cell. The data were pre-processed based on widely accepted quality 
control metrics (Ilicic et al., 2016).The number of genes per cell, the number of unique feature counts 
per cell (n_counts) and the percentage of mitochondrial genes were visualised using violin plots 
116 
 
(Fig.44a). Cells were removed that had above a threshold of 3500 unique genes detected, determined 
by the graph  
 
Figure 44. Quality control testing of the CS16 AoV CD34+ cell 10X single cell dataset. a) Violin plots showing 
the number of genes (n_genes), number of UMI counts (n_counts) and percentage of mitochrondrial genes in 
total (percent_mito) per cell. b) Dot plots showing cut-off thresholds (red line) for n_genes and percent_mito. 
Cells above threshold were discarded from the analysis. c) Normalised and non-normalised dispersions of genes, 
indicating in black the highly variable genes used in the differential expression testing. d) Principal component 
plots for cells based on cell cycle gene expression before (upper) and after (lower) regression of cell cycle 









of n_counts vs. n_genes, as high numbers indicate cell doublets or multiplets (Fig.44b). As high 
mitochondrial reads are evidence of low-quality cells, cells with more than 0.05% mitochondrial genes 
were also removed. The numbers of UMI counts per cell had a large range of ~2,000-10,000 counts 
with a median of 2,768. The reads per cell were then normalised so that counts become comparable 
among cells.  
Highly variable genes were identified (Fig.44c) and the data were subsetted to include only these as 
this enhances the discovery of biological variation between cells in downstream analyses (Brennecke 
et al., 2013). Furthermore, PCA analysis of cell cycle genes in the dataset highlighted that some of the 
variance in the dataset is explained by cell cycle so the effect of these genes was regressed out 
(Fig.44d). As the cells were run on two lanes of the 10X chip, they were checked for batch effects. Basic 
t-SNE clustering was done on the Loupe Cell Browser software and the cells were colour coded for 
each lane (Fig.44e). There was an even distribution of cells from both lanes in each cluster indicating 
that there was no large batch effect. 
 Dimension reduction of the single cell dataset reveals haematopoietic, endothelial and 
niche sub-populations.  
Clustering the cells was done using a nonlinear dimensionality-reduction technique, uniform manifold 
approximation and projection (UMAP) using the louvain algorithm which generated 10 clusters 
(Fig.45a). By visualising patterns of expression of gene markers some basic cell-type identities could 
be conferred to the clusters. CD34 and CDH5 (VC) expression indicates that the endothelial cells and 
their immediate derivatives expressing these markers include clusters (Cl.) 0, 1, 2, 5, 7, 8, 10 indicating 
substantial heterogeneity across these populations in the dorsal aorta. The additional clusters most 
likely derive from contaminating CD34- cells from the niche. Cl.3 expresses PDGFRA and ACTA2 
identifying it as containing mesenchymal cells whereas clusters 4 and 9 express EPCAM and therefore 
represent an epithelial fraction. PTPRC (CD45) expression is highest on cl.6. There are only a few 
scattered CD34 and CDH5 expressing cells in this cluster indicating that this contains mainly more 
mature haematopoietic cells – however, the possibility that CD34 or CDH5 expression levels were just 
below the detection threshold cannot be ruled out. PTPRC is also expressed on a fraction of cl.5 
indicating that this population contains the double positive VC+CD45+ HSPC population and puts cl.5 
as the most likely candidate for endothelial cells committed to a haematopoietic fate. Cl.10 expresses 






Figure 45. UMAP clustering reveals sub-populations of the dorsal aorta. a) UMAP partitioning and Louvain 
cluster identification reveals 10 clusters. Expression of known markers of endothelial, haematopoietic and 
mesenchymal populations are shown in smaller plots. b) PAGA indicates relatedness of clusters. c) RNA Velocity 
mapping of differentiation trajectories. d)i. RNA Velocity pseudotime trajectory plot with separate plots 
indicating ii. root cells and iii. end points. 
a) 
b) c) 
d)i ii iii 
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 Cluster inter-connectivity and RNA Velocity mapping reveals potential lineage 
trajectories.  
The first step towards lineage trajectory inference is to define connectivity between the clusters. For 
this, Partition-based graph abstraction (PAGA) was used (Wolf et al., 2019). This first uses PCA 
dimensional reduction of the data to determine neighbourhood distances between cells. The data are 
then partitioned using the Louvain algorithm as used before for generating the UMAP. Nearest 
neighbour connections between clusters are weighted statistically based on the number of 
connections as a fraction of the connections expected if assigned randomly. 
The resulting PAGA graph shows high inter-connectivity between endothelial clusters 5,1,2 and 7 with 
several clusters branching off from them (Fig.45b). Cl.6 has a weighted connection with cl.5 lending 
further evidence that these haematopoietc cells derive from the cl.5 endothelial cells. Intriguingly, the 
large endothelial cl.0 is apart from the central network of endothelial cells connecting most strongly 
with cl.5. Cl.10 and cl.8 CDH5 expressing cells also branch off from the central network. The 
mesenchymal cl.3 connects with endothelial clusters 1 and 0, albeit with lower statistical weighting, 
which raises the question of whether there is a shared ancestor between the two cell types. The 
EPCAM expressing clusters have a weighted connection suggesting that they are related cell types.  
RNA velocity, which uses the relative proportions of spliced and unspliced transcripts to predict the 
direction  of cellular state progression (Manno et al., 2018), was used to infer a lineage trajectory from 
the data (Fig.45c) as well as predict cells at the root of the trajectory and at the end (Fig.45di-iii). 
Clusters 2 and 1 of the endothelial cells were determined as ‘end points’ thus indicating a stable 
population of non-differentiating cells. The velocity graphs indicate a movement from cl.5 towards the 
haematopoietic population (cl.6) as well as towards cl.0 suggesting a bifurcation in cell fate potential 
of cl.5 to transition to haematopoiesis or to an alternative endothelial cell type. Whereas the velocity 
of most clusters is moving away from the central endothelial clusters, cl.10 is determined as containing 
root cells with velocity towards the endothelial cells, which unusually suggests that they are 
differentiating towards an endothelial fate and may represent a population of endothelial progenitors. 
Indeed, this was the only clear pseudotime trajectory that the RNA Velocity tool could define (Fig.45d). 
Cl.3, has 2 groups of cells highlighted as being root cells indicating that there are alternately 
differentiating sub-groups within this cluster. The mesenchymal markers PDGFRA and ACTA2 mark 
different cells within that cluster suggesting it may be made up of multiple mesenchymal cell types. 
 A more in-depth analysis of cluster-specific cell identities 
Heterogeneity within the endothelial populations 
In order to better define the cell-types in each cluster a Wilcoxon rank-sum test was used to find 
differentially expressed genes in each cluster compared to the rest. A dot plot identifying the top 5 
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markers for each cluster are shown in (Fig.46a) with a separate heatmap of the top 50 genes (Fig.46b) 
for each cluster. Furthermore, the top 100 genes per cluster were computed for overlaps with 
Hallmark pathways (Fig.47). Clusters 1 and 2 make up the bulk of the central CD34+ endothelial group 
of clusters. The heatmap shows that these clusters are highly similar to each other as well as the other 
endothelial clusters, 5, 7, and 8 and with even some of the top markers for each cluster shared among 
them (Fig.46).  
 
Figure 46. Heatmap visualisation of AoV single cell dataset Louvain cluster relatedness. a) Dot plot of top 5 
markers for each cluster. b) Heatmap of expression for top 50 genes per cluster with hierarchical clustering. The 
close relatedness of endothelial clusters 8,2,5,1 and 7 can be visualised as well as the distinct signature of 





Figure 47. Computed overlaps of cluster marker genes with Hallmark gene sets resolves niche signalling to 







Figure 48 Expression maps of selected cluster marker genes onto the AoV single cell dataset for a) cluster 0 b) 
cluster 3, c)i ‘haematogenic’ cluster 5 and ii. close view of area enclosed by dotted red line in i. d) Expression of 
VC+CD45+ marker genes from bulk sorted EHT population dataset. e) marker genes for cluster 8, g) cluster 10 h) 
cluster 4, i) and k) cluster 9. f) Expression of TNF localised to cluster 6A m. j) Expression of TH localised to a region 
of Cluster 3. Cluster boundaries are defined in Fig.44a.  
 
Cluster 0: A distinct endothelial sub-type  
By contrast, the endothelial cl.0 has a very different signature to the rest of the endothelial clusters 
indicating that it represents a distinct sub-type of endothelial cells. Top marker genes for this are the 
Heparan Sulfate Proteoglycan HSPG2, the heparin sulfate endosulfatase SULF1 and Gap Junctiom 
Protein Alpha 5 (GJA5) (Fig.46a,48). It also has an enrichment for ‘TNFα signalling via NFκB’ (Fig.47) 
and expresses several pathway components such as EDN1, PTGS2 and the transcription factors JUNB 
and FOS. This pathway was ventrally enriched in the Inner and Mid layers of the LCM-Seq analysis and 
in the bulk-population analysis, was shown to increase along the EHT axis. TNF itself is expressed at 
highest levels on the VC-CD45+ bulk-seq population and the PTPRC (CD45) expressing population (cl.6) 
in the single cell dataset (Fig.48f). It is tempting to postulate that the TNFα signalling via NFκB pathway 
could be originating from the haematopoietic cells and signalling back towards the niche (see 
discussion). Cl.0 also has enrichment of Notch pathway components including the ligands DLL4, JAG1 
and the effector TF HEY2.  
Cluster 5: Proliferating endothelial cells 
Cl.5 which contains the HSPC population and is lineage linked to cl.6 haematopoietc population shares 
expression of many genes with the other endothelial clusters. However, cl.5 is additionally enriched 
for genes involved in mitosis such as the mitosis cyclin CDK1, and TOP2A, a DNA topoisomerase 
involved in chromatid separation (Fig.46a,48c). Furthermore, highly enriched gene sets include 
proliferation related pathways such as ‘E2F Targets’, ‘G2M Checkpoint’, and ‘MYC Targets V1’ (Fig.47). 
This suggests that the cl.5 endothelial cells are related to the bulk of the endothelial cells but with a 
higher proliferative status. The marker genes however are noticeably down regulated in the cl.5 
subpopulation of the cluster expressing PTPRC. Markers from the bulk-seq VC+CD45+ population were 
mapped on to the single cell dataset and although their expression was not restricted to cl.5, their 
expression within cl.5 was restricted to the PTPRC+ portion (Fig.48d) This indicates that the majority 
of cells within cl.5 are not HSPCs but are mostly proliferating endothelial cells. Cl.5 lacks any discerning 
markers or transcription factors that distinguish it from the other central endothelial clusters (cl.1 and 
cl.2) indicating that they are a sub-population of the endothelial cells with a higher proliferative status. 
This could perhaps indicate that they are endothelial progenitors. This proliferation signature is then 
absent in the cells which express PTPRC and other HSPC signature genes indicating that proliferation 
is slowed as a haematopoietic identity is acquired.  
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Cl.8: Hypoxia sensitive endothelial cells 
Cl.8 is another endothelial population branching away from the central endothelial group of clusters. 
Although, it has a more similar transcriptional signature to the central group than cl.0 it does express 
additional markers including neurotensin, NTS, fibroblast growth factor 23, FGF23, Oncoprotein 
Induced Transcript 3, OIT3 and the osteopontin regulator, acid phosphatase 5, ACP5 (Fig.46a, 48e).  
Cl.8 has enrichment for ‘MTORC1 Signalling’ and ‘Hypoxia Signalling’ which are both pathways found 
in the ventral niche using LCM (Fig.47).  
Cl.10: Embryonic/foetal erythromyeloid progenitors 
The final cluster branching off from the central endothelial group of clusters is cl.10 which expresses 
haemoglobin genes (Fig.46a,48g). Intriguingly, these include Epsilon, Zeta and Gamma haemoglobin 
subunits HBE1, HBZ and HBG2 which are embryonic and foetal haemoglobins respectively. As these 
earlier erythroid progenitors are generally considered to emerge in the yolk sac it is surprising to find 
them seemingly related to the bulk of the endothelial cells in the AoV. It is also unusual that their 
velocity is moving towards the main bulk of the endothelial cells as if they are differentiating from an 
erythroid towards an endothelial lineage rather than vice versa.  
Marker genes for cl.7 are mitochondrial genes indicating that these are low quality cells that were 
below the percentage mitochondrial genes per cell threshold and so evaded being filtered out.   
Cl.3: mesenchymal/perivascular cells 
A top marker for cl.3, which was identified as a mesenchymal/perivascular cluster based on ACTA2, 
PDGFRA and PDGFRB expression, is GPC3 which encodes glypican 3, a cell surface proteoglycan to 
which heparan sulfate chains attach (Fig.46a, 48b). It has a described role in inhibition of Hedgehog 
signalling and activation of Wnt signalling, both of which are pathways found in the niche (Hedgehog 
on ventral VC+CD45- and VC-CD45+ cells, Wnt signalling in the Inner and Mid layers vs Outer)(Capurro 
et al., 2008; Capurro et al., 2014). PTN, Pleiotrophin, is another top marker which is a secreted factor 
that binds heparin to regulate many processes including cell migration, growth, differentiation, 
proliferation and survival and, moreover, is important for haematopoietic regeneration in the bone 
marrow(Himburg et al., 2018; Deuel et al., 2002). Taken together, this indicates that this cluster 
contains important cells that regulate various biological processes in the AGM niche. The overlap in 
heparan proteoglycan related genes with cl.0 may also indicate some relatedness between the clusters 
or shared signalling and functionality. Furthermore, both clusters 3 and 0 have a strong enrichment 
for the ‘Epithelial Mesenchymal Transition’ gene set suggesting they influence cell mobility and 





Cl.4 and 9: Epithelial cells 
Clusters 4 and 9 express EPCAM which indicate that they are neither endothelial nor perivascular 
(Fig.45a). The top marker for cl.4 is CLDN4, a claudin that is part of epithelial cell tight junctions 
indicating that these cells derive from an epithelial structure (Fig.46a, 48h). Cl.9, has high expression 
of GATA3, which suggested that they might be sympathoadrenal cells (Fitch et al., 2012)(Fig.48i). 
However, the sympathoadrenal marker TH was not co-expressed on this cluster but on a sub-
population of cl.3 (Fig.48j). There is some overlap in gene expression between clusters 4 and 9. GATA3 
is also expressed on one branch of cl.4 and cl.9 expressed CLDN4 at a lower level (Fig.48h, i). Cl.9 does 
however exclusively express parathyroid hormone (PTH) indicating that they are endocrine cells (Fig. 
48k). Intriguingly, cl.4 enriched HALLMARK pathway are similar to cl.8, including mTORC1 signalling 
and hypoxia (Fig.47), potentially indicating that these clusters may co-operate. Glycolysis pathway and 
hypoxia in cl.4 and oxidative phosphorylation pathway enrichment in cl.9 indicates both anaerobic and 
aerobic respiration in the niche.  
Taken together this dataset demonstrates how the AoV endothelial cells are heterogenous with 
several resolved cell types which may have specialised roles. It also suggests that endothelial cells 
destined to become haematopoietic may increase their proliferative status before subsequent 
acquisition of haematopoietic identity. Finally, it also provides additional evidence of overlap in 
signalling pathways between the endothelial cells and other niche cells reinforcing the idea of 
signalling interplay between the niche and aorta. 
 Resolution of niche secreted factors to cell sub-populations 
As the single cell dataset includes both endothelial and non-endothelial cells from the AoV, expression 
of ventrally enriched secreted factors from the LCM-Seq Inner and Mid domains can be resolved to 
clusters and their cell origin revealed (Fig.49). Several of these are expressed on the endothelial 
clusters themselves, such as CCL2, EDN1, EFNA1 and CXCL2 although expression levels differ. EDN1 is 
most highly expressed on cl.0 and CCL2 and CXCL2 have highest expression on cl.8. PLAT has notably 
higher expression on the EPCAM+GATA3+PTH+ cl.9.  The Complement C1qA Chain gene C1QA 
unexpectedly is most highly expressed on the haematopoietic cl.6. However, cl.6 also has the highest 
expression of osteopontin, SPP1 suggesting that expression of SPP1 in the ventral mesenchyme may 
derive from macrophages in the sub-aortic mesenchyme. The Wnt signalling modulator FRZB is most 
highly expressed in the cl.3 mesenchymal cells. This corresponds with the Wnt signalling activator 





Figure 49. Resolution of niche secreted factors to cell sub-populations. Violin plots showing expression of 
secreted factors in the Inner and Mid ventral domains from the LCM-Seq analysis for each cluster (1-10). Violin 
plot colours correspond to Louvain cluster colours.  
 
 Resolution of Renin and Endothelin pathway components to sub-populations 
EDN1 and REN were highly ventrally enriched in the sub-aortic mesenchymal cells from the LCM-Seq 
analysis. The single cell analysis was used to map the main components of their signalling pathways to 
resolve their expression to cell populations (Fig.50). In the bulk analysis, EDN1 was found to be most 
highly expressed in the ventral VC+CD45- endothelial population. The single cell analysis enabled 
further resolution of EDN1 expression; it is found expressed across all the endothelial cells but at a 
higher and more consistent level in cl.0 (Fig.50a). Resolution of ECE1 to cl.0 was even more 
pronounced providing further evidence that this cluster has the most active endothelin signal. Cl.0 
also has enrichment of ‘TNFα signalling via NFκB’ pathway, to which EDN1 contributes (Fig.47). EDN1 
was also enriched in the LCM-Seq V_Mid (vs. D_Mid) region which may derive from additional 
expression in the EPCAM+ cl.4 and low expression on mesenchymal cl.3 (Fig.50a) As in the bulk-seq 
analysis, EDNRB is expressed on the CD45+ haematopoietic cells in cl.6 but also on the endothelial 
cells coincident with hotspots of EDN1 expression. EDNRA was however, expressed exclusively on the 
127 
 
perivascular/mesenchymal cl.3. This suggests a two-direction mode of action of EDN1 from the 
endothelium signalling towards the haematopoietic cells in the lumen via EDNRB and towards the 
perivascular cells via EDNRA. 
REN and ACE themselves were not detected in this dataset (see discussion) and AGT and its receptor 
AGTR1 were very lowly expressed in just a few cells (Fig.50b). AGTR2 expression was confined to cl.0 
suggesting that both renin and endothelin pathways act primarily through the same subset of 
endothelial cells. The renin receptor ATP6AP2 was expressed broadly across the whole dataset but 
strongly upregulated on cl.9.    
 
Figure 50. Resolution of Renin and Endothelin pathway components to sub-populations. Gene expression was 







 Immunohistochemical and RNA Scope visualisation of Renin and Endothelin gene 
and protein expression in the CS16 AGM 
 EDN1 expression 
The multiplex fluoresecent in situ hybridisation technique RNAScope was used to further spatially 
resolve expression of REN and EDN1 in the AGM. EDN1 was confirmed as being expressed in the aortic 
endothelium across the whole D-V axis (Fig.51a-c). However, there are endothelial cells and groups of 
cells which had a higher density of EDN1 probe signal to make a signal cluster, which will be referred 
to as EDN1 hotspots. ImageJ was used to define these hotspots as being larger than 300 pixels and the 
numbers of hotspots were counted in the ventral and dorsal domains of aortas from 14 tissue sections 
spanning the embryo from the hind gut to the lungs (Fig.51d). Significantly more hotspots were found 
in the ventral domain compared to the dorsal (paired t-test, p<0.01) which confirms the ventral 
enrichment of endothelial EDN1 found in the bulk-seq analysis (Fig.51dii). Furthermore, EDN1 
hotspots were found underlying IAHCs (Fig.51b, c). To formally quantify a correlation between position 
of EDN1 hotspots and IAHCs sister sections were stained with VC+, CD45+ and Runx1+ to mark the 
position of IAHCs and Runx1+ endothelial cells (e.g. Fig.51a, b). Their positions were then correlated 
with the positions and frequencies of EDN1 hotspots on the sister sections. There was a strong positive 
correlation between the number of Runx1+ endothelial cells/IAHCs in a dorsal aorta section and the 
presence of an EDN1 hotspot in a proximal position on an adjacent section (Fig.52a, R = 0.9, p=1.4e-
05) indicating that most Runx1+ IAHCs are found near higher local EDN1 concentrations. Vice versa, 
there was a positive correlation between the number of EDN1 hotspots in a dorsal aorta section and 
the number near Runx1+ IAHCs (Fig.52b, R = 0.68, p = 0.011).  
EDNRB cells were found in the endothelial cells, sometimes at the base of IAHCs and frequently near 
EDN1 hotspots (Fig51a, c and 53b). There were also EDNRB cells in the mesenchyme lateral and ventral 
to the aorta (Fig.53b). Images of the whole tissue section revealed a stream of these cells running from 
the spinal ganglia and down through the spinal nerves as well as in the mesenchymal cells below and 
lateral to the dorsal aorta and continuing up and around the inside of the abdominal wall mesenchyme 
(Fig.53a). The walls of the midgut loop were also positive for EDNRB expression. EDNRA expression 
was less resolved to individual cells but more spread across the mesenchymal cells surrounding the 
aorta and, in some sections, exhibited a stronger ventral signal (Fig.53b). There was evidence also of 
EDNRA signal from the mesenchyme surrounding the vitelline artery (Fig.53a). Both receptors are 




Figure 51. Visualisation of Renin and Endothelin pathway components in the AGM. All sections show the dorsal 
aorta (Ao) from a CS16 embryo. a-b) Protein immunostaining of Ve-Cad(VC), CD45 and Runx1 with a sister section 
RNAScope showing gene expression of a) EDN1, EDNRA, EDNRB and b) EDN1 and REN.  Arrows indicate Runx1+ 
clusters or endothelium cells and corresponding position on sister section with nearby EDN1 hotspot (>300 pixels) 
or EDNRB expression. c) RNAScope gene expression of EDN1, EDNRA, EDNRB. IAHC indicated by the square and 
zoomed in image of the area is shown to the right. Arrow indicates EDN1 hotspot below IAHC. di) Binary image of 
a section of the dorsal with the EDN1 hotspots indicated in red. d.ii) Quantification of EDN1 hotspots in the ventral 
and dorsal aorta of all sections spanning the rostral-caudal axis of the AGM (14 sections).  D=Dorsal V=Ventral. 




Figure 52. Correlation of position of EDN1 hotspots with position of Runx1+ hotspots. a) The number of 
Runx1+ IAHCs positively correlates with the number of Runx1+ IAHCs near EDN1 RNA hotspots. R = 0.9 p=1.4e-
05 b) Correspondingly, the number of EDN1 hotspots near Run1+ IAHCs positively correlates with the number of 
EDN1 RNA hotspots. R = 0.68, p=0.011. 
 
Immunohistochemical analysis was also carried out to see how the protein counterparts were 
expressed. Intriguingly, ET-1 (Endothelin-1 protein) was found expressed in rounded cells budding 
from the endothelium suggesting that it is expressed on haematopoietic progenitors (Fig.54a,d). 
Expression of EDN1 was found on the VC+CD45- endothelium and not the VC+CD45+ HSPC population 
however (Fig.41). This raises the notion that ET-1 protein expression may be secreted and sequestered 
onto progenitor cells from underlying endothelial cells or that gene/protein expression may be on an 
earlier CD45- haematopoietic progenitor population. ET-B (Endothelin receptor B, protein) was also 
seen expressed on single budding cells in the ventral domain as well as expressed at the top of IAHCS 
(Fig.54a, b). Corresponding with RNA expression, ET-A (Endothelin receptor A, protein) was found 
expressed in the mesenchymal cells around the dorsal aorta (Fig54c), although no clear D-V 





Figure 53. Visualisation of endothelin-1 and its receptors’ gene expression across the embryo and dorsal aorta. 
All sections are from a CS16 embryo. a-b) RNAScope multiplex visualisation of EDN1, EDNRA, EDNRB across the 
whole embryo transverse section in a) and across the dorsal aorta (Ao) in b). Arrows in b) indicate single EDNRB 
expressing cells in the sub-aortic mesenchyme. D=Dorsal V=Ventral. cv= cardinal vein. VA = vitelline artery. NT = 





Figure 54. Visualisation of endothelin-1 and its receptors’ protein expression across the embryo and dorsal 
aorta. All sections are transverse sections of the dorsal aorta (Ao) from CS16 embryos. a) ET-1 and ET-B 
expression with zoomed in images of ET-1 and ET-B budding cells (i, ii). b) ET-1 and ET-B expression with (i) and 
without (ii) DAPI. c) VE-Cadherin (VC) and ET-A expression with and without (ii) DAPI. The box highlights the 
IAHC shown in (ii). d) VC, ET-1 and ET-B expression with and without (ii) DAPI. Box highlights IAHC shown in (i). 




 REN expression 
REN expression was also characterised by RNAScope, and despite being found very highly expressed 
in the ventral domains of the CS17 and CS16 LCM-Seq datasets it was found expressed in just a few 
cells directly below the ventral endothelium (Fig.55b) These cells were also found close to EDN1 
hotspots. There was notably higher expression of REN along the vessels branching ventro-laterally 
from the dorsal aorta towards the mesonephros (Fig.55a, biii). These thin vessels had high EDN1 
expression within the VC+ endothelial cells and high REN expression on the cells along the outside of 
the VC+ cells which may be perivascular. There were also strong EDN1 and REN expressing cells in the 
mesonephros (Fig.55a). Similarly, immunostaining with a renin (REN) antibody showed strong 
expression along the outside of the ventral branching vessels (Fig.55c). It is probable that the high 
ventral expression of REN from the LCM-Seq analysis resulted from including cells from the ventro-
lateral branching vessels within the Mid sub-domain.  
Taken together, REN and EDN1 are both ventrally enriched with EDN1 having an expression pattern 
more closely linked to the IAHCs suggesting a more direct influence on the processes involved in EHT. 
However, that is not to say the low levels of REN expression seen underlying the aorta aren’t sufficient 
for an influence, and the expression from the ventro-lateral branching vessels may have an indirect 
effect on EHT.  
 Quantification of Runx1 clusters 
The systematic staining of sections along the AGM for VC+CD45+Runx1+ cells provided an opportunity 
to observe where the IAHCs most frequently develop along the D-V axis. It was noticed that where the 
major ventral vessels, the vitelline and coeliac artery, branch off from the dorsal aorta is frequently 
where larger clusters are found. In sections where a ventral vessel was branching from the dorsal aorta 
(as in Fig.51a) the positions of IAHCs were quantified and found to come almost exclusively from within 
the branching vessel or at the junction with it (Fig.56). This suggests that IAHCs emerge preferentially 






Figure 55. Visualisation of renin gene and protein expression across the AGM. All sections are transverse 
sections of the dorsal aorta (Ao) from CS16 embryos. a) VE-Cadherin (VC), EDN1 and REN expression in the AGM 
showing high EDN1/REN expression in the ventro-lateral branching vessel (LBV) to the mesonephros (Mes.). 
Image taken with fluorescent microscope. b) Same section as a) but with confocal microscope. i. and ii. show 
dorsal aorta with (i) and without (ii) DAPI. Arrow indicates IAHC with high expression EDN1 and spots of REN either 
side. iii. Zoomed  confocal image of branching vessel in a) . c) VE-Cadherin (VC) and renin (Ren) expression . 




Figure 56. Quantification of Runx1+ cells per IAHC for each position in the AoV, AoD and ventral branching 
vessels. The number of Runx1+ cells per IAHC were counted in CS16 transverse tissue sections stained with a 
Runx1 antibody where the dorsal aorta branched ventrally into either the vitelline or coeliac artery. The position 
of each IAHC was noted; AoV (Ventral, orange), AoD (Dorsal, Grey), Branching vessel (Blue). The numbers along 
the X-axis denote different tissue sections. If there were no Runx1+ cells at one position the number of Runx1+ 
cells in IAHC = 0. 
 Discussion 
The cells of the dorsal aorta and surrounding tissues represent a dynamic niche of multiple cell types 
and many signalling pathways which intersect to influence and promote the emergence of HSCs. Due 
to the ventrally polarised emergence of HSCs and IAHCs in the dorsal aorta as well as the demonstrated 
importance of polarised signalling in promoting HSC generation, it is important to define positional 
information when investigating signals in the niche. This was achieved with the spatial transcriptome 
dataset from Chapter 3 which elucidated polarised gene and pathways expression both proximal and 
distal to the dorsal aorta, highlighting factors with a potential role in influencing HSC emergence such 
as the ventrally enriched REN and EDN1 or the TGF-β and TNFα via NFκB pathways. However, the 
spatial transcriptome data represents just one dimension of the niche; relative position to the dorsal 
aorta and site of HSC emergence. The RNA-Seq analyses in this chapter retained some spatial identity 
by sub-dissecting the AoV and AoD, but also explored cell population specific transcriptomes. The 
combined spatial transcriptome and cell population analyses builds up a more complete picture of the 
niche and enables modelling population interactions for experimental analysis.   
 Clues to the processes behind endothelial-to-haematopoietic transition 
The bulk-seq analysis of haemato-endothelial populations in the dorsal aorta was used to define an 
HSPC signature including several TFs. These include MYB, which has been shown to generate short-
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term myeloid-erythroid progenitors (MEPs), and GFI1 which has been used to reprogram murine 
endothelial cells into HSCs (Yokomizo et al., 2019; Doulatov et al., 2013; Lis et al., 2017). This suggests 
that this VC+CD45+ population contains both HSCs and more committed progenitors. Further HSPC 
signature TFs could be tested for their ability to reprogram PSCs to HSCs such as the highly HSPC 
specific SETBP1 and PRDM16. Notably, the receptors upregulated on the HSPC population vs. the 
endothelial population were similarly expressed in the more mature VC-CD45+ population. This may 
explain in part why it has been a challenge to refine the markers that define the HSPC population. 
The HSPC signature provides a snapshot of the gene expression of HSCs and progenitors but does not 
necessarily reveal the signals and processes required to become those cells. In order to identify the 
signals that initiate HSC specification, it is useful to identify the endothelial fraction destined to 
become haematopoietic, and for this the single cell analysis was useful. It revealed that the AoV 
endothelium contains heterogenous endothelial cells with distinct expression signatures. A central 
network of 4 clusters (clusters 1,2,5 and 7) of endothelial cells which had similar expression signatures 
(Fig.46b) could be considered the default endothelial cell type with more specialised endothelial 
clusters branching off: 1) FGF23 expressing cells with enrichment of Hypoxia and mTORC1 signalling 
pathway (cl.8). 2)  GJA5 expressing cells with an enrichment of ECM associated proteins and TNFα via 
NFκB and Epithelial-Mesenchymal Transition pathways (cl.0).  
Within the central group of endothelial cell clusters (cl. 1,2,5 and 7) one cluster, cl.5, contained a 
fraction of double positive VC+CD45+ cells. The lineage inference analysis showed lineage links of cl.5 
with the haematopoietic cl.6 but also cl.0 GJA5+ endothelial cells. The cl.5 endothelial cells had no 
discerning markers from the other central network cells other than proliferation associated genes 
which were markedly reduced in the VC+CD45+ population. There is a possibility that HSC specification 
genes were not captured in this dataset or that the cells expressing these genes were too few to cluster 
separately. The data do suggest however that an increase in proliferation precedes differentiation 
towards GJA5 endothelial cells or haematopoietic cell fate. This parallels an increase in the 
proliferative status of pre-HSCs in the mouse which reduces as they acquire a adult-type HSC state 
(Batsivari et al., 2017). Further experiments to investigate the effects of proliferation status on 
haematopoietic output would be useful. Furthermore, the lack of defining gene markers on this sub-
population of ‘haematogenic’ endothelial cells could indicate that a different layer of regulation is 
involved in specifying endothelial cells to become haematopoietic. For example, gene expression may 
be modified post-transcriptionally by non-coding RNAs such as micro-RNAs which are not detected by 
the RNA-Seq methods in this project.   
Another insight from these data is the enrichment within the GJA5+ endothelial cells (cl.0) of the 
Epithelial-Mesenchymal Transition (EMT) gene set. Cells undergoing EMT dissociate from a structured 
epithelium with high cell-cell adhesion and apico-basal polarity (Campbell and Casanova, 2016). This 
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requires changes in morphology and therefore actin-myosin skeleton organisation, a break-down of 
cell adhesion and polarity, and loose, dynamic attachments with ECM facilitating motility and 
migration. The process has been likened to EHT during which a haematogenic endothelial cell must 
simultaneously round its morphology whilst dissociating from the structured endothelium, become 
more motile and bud into the lumen (Kissa and Herbomel, 2010). It is reasonable to assume that EHT 
and EMT share mechanisms to facilitate this cell movement. It is possible that this sub-population of 
endothelial cells (cl.0), even if they are not necessarily the cells undergoing EHT they may facilitate this 
process. It would be useful to see if markers from cl.0 correspond to the localisation of IAHCs. Indeed, 
high expression of EDN1, correlates highly with the presence of IAHCs, although a more specific marker 
like GJA5 may be more revealing. Taken together, the single cell data suggest a model whereby 
endothelial cells in cl.5 increase their proliferation status and differentiate towards either a 
haematopoietic fate or to specialised endothelial cells which in turn may enhance EHT through 
signalling or modulation of the ECM interactions. 
 Lessons from the datasets  
This chapter investigated the transcriptomes of individual cell types of the haemato-endothelial 
compartments of the dorsal aorta and niche cell sub-types both through bulk population and single 
cell RNA-Seq. With these additional data, signalling in the niche could be resolved to distinct cell 
populations.  
i. TNFα via NFκB 
The TNFα via NFκB pathway, which was ventrally enriched in the cells of the vessel wall and sub-aortic 
mesenchyme was also enriched in the haematopoietic and HSPC (VC+CD45+) population compared 
with the VC+CD45- endothelial populations. However, further resolution of the endothelial 
populations by single cell revealed that this signalling pathway is enriched on endothelial sub-types 
(clusters 0 and 2), including upregulation of pathway target genes. There were also TNF receptors on 
both the endothelial (VC+CD45-) and HSPC (VC+CD45+) populations. This, along with the fact that TNF 
itself is expressed in the haematopoietic cells, suggests that TNFα via NFκB signalling initiated in 
haematopoietic cells stimulates a response in the endothelial, HSPC and other niche cells through 
different receptors. Indeed, in the zebrafish it has been shown that TNFα provided by neutroph ils 
stimulates EHT via Notch signalling, specifically the Notch ligand Jag1 (Espin-Palazon et al., 2014) 
(Fig.57a). Intriguingly, in this single cell dataset, cl.0 which had enrichment of TNFα via NFκB pathway 
and highest endothelial expression of TNFRSF1B (TNF receptor 2) also had enrichment of Notch targets 
(HEY2) and ligands including JAG1. In the mouse, yolk-sac derived macrophages in the sub-aortic 
mesenchyme, express inflammatory genes including Tnf, migrate to the dorsal aorta, intravasate the 
vessel wall and interact with emerging IAHCs (Mariani et al., 2019) (Fig.57b). The authors reported 
that this process was critical for HSC emergence. Macrophages have been shown to accumulate below 
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the endothelium in the ventral part of the dorsal aorta in humans (Travnickova et al., 2015). It is 
tempting to postulate that a similar process occurs in the human embryo:  proinflammatory 
macrophages or neutrophils produce TNFα which acts on a specific endothelial sub-population (cl.0) 
via TNFR2, stimulating Notch signalling through production of Notch ligands and thus promoting EHT.  
 
 
Figure 57 TNFα signalling in the zebrafish and mouse models. a) Taken from R. Espin-Palazon et al., 2014 (Espin-
Palazon et al., 2014). Primitive neutrophils provide Tnfa signal which is received onto endothelial cells of the 
dorsal aorta via the receptor Tnfr2. This activates Notch signalling stimulating endothelial-to-haematopoietic 
transition. b) Taken from S. A. Mariani et al., 2019  (Mariani et al., 2019). Primitive macrophages which express 
an inflammatory signature including Tnf migrate to the endothelium of the dorsal aorta, intravasate and associate 
with the emerging IAHCs – a process that is critical for HSC emergence. 
  
ii. mTorC1 signalling 
The mTORC1 signalling pathway was enriched in the LCM-Seq ventral Mid vs dorsal Mid as well as in 
the Inner and Mid layers vs Outer. The single cell analysis from this chapter resolved this signalling 
pathway to an endothelial cluster (8). As discussed in the introduction, a previously published single 
cell analysis of E11 endothelial, pre-HSCs discovered that pre-HSC I has an enrichment of mTOR 
pathway and disruption of the mTORC2 pathway inhibited HSC emergence in the AGM (Zhou et al., 
2016). It is unlikely that cl.8 represents pre-HSCs as there is no strong lineage relationship with cl.5 
which contains HSPCs or haematopoietic cl.6. However, mTORC1 pathway is also enriched at lower 
levels on cl.5.  Notably, hypoxia pathway is also enriched in cl.8 which acts upstream and regulates 
mTORC1 signalling.  This suggests that this sub-population may sense hypoxia and mediate 





iii.  Osteopontin 
Osteopontin is a secreted phosphorylated glycoprotein that, in the bone marrow niche, mediates HSC 
migration and proliferation (Guidi et al., 2017; Nilsson et al., 2005). However, its role in the embryonic 
haematopoietic niche is not characterised. In these datasets it was upregulated in the ventral sub-
aortic mesenchyme (LCM-Seq Mid) but also on the VC+CD45+ HSPC and VC-CD45+ haematopoietic 
populations indicating that its expression in the ventral mesenchyme may derive from CD45+ 
haematopoietic cells such as macrophages. Indeed, osteopontin expression on activated macrophages 
has previously been described (Zohar et al., 2000). Further immunostaining studies would confirm this. 
Intriguingly, osteopontin directly binds the two top enriched receptors of the HSPC population 
(compared with endothelial), CD44 and ITGA4. However, a subset of endothelial cells, cl.8, express the 
gene for acid phosphatase 5 which regulate osteopontin activity (O'Leary et al., 2016). This expression 
on a small population of endothelial cells suggests localised regulation of this pathway. Furthermore, 
endothelin stimulates osteopontin expression (Berglund et al., 2016; Shioide and Noda, 1993). It 
would be interesting to explore the effects of osteopontin on HSC emergence.  
iv. Plasminogen activators 
The gene PLAU encoding the secreted factor Plasminogen Activator, Urokinase, was found to be 
ventrally enriched in the dorsal aorta vessel wall and has a large number of known interactions with 
receptors on the ventral HSPC population. Further experiments are required to define the cell origins 
of PLAU in the human AGM as it was not detected in the single cell dataset. However, PLAT, another 
ventrally enriched plasminogen activator was detected specifically on the EPCAM+ cl.9 which may be 
neuroendocrine cells due to their expression of GATA3 and parathyroid hormone (PTH). Notably, in 
the bone marrow plasminogen activation releases Kit ligand (SCF) from stromal cells resulting in 
increased haematopoietic progenitor proliferation and differentiation (Heissig et al., 2007). SCF has 
been shown to stimulate HSC production in the mouse embryo (Rybtsov et al., 2014). It would be 
interesting to see if PLAU acts in a similar way to make SCF more available in the human embryo dorsal 
aorta.  
v. Erythromyeloid progenitors 
The single cell dataset indicated a cluster (cl.10) of CD34+VC+ cells which express embryonic and foetal 
haemoglobins and had an RNA velocity towards the central endothelial network indicating that they 
contribute towards this pool of endothelial cells. Furthermore, the dorsal endothelial (VC+CD45-) cells 
had enrichment of embryonic and foetal hemoglobins (HBE1, HBZ, HBG1, HBG2) compared to the 
ventral domain adding further evidence of a link between aortic endothelium and primitive erythroid 
progenitors. Indeed, it has been reported that embryonic erythro-myeloid progenitors can contribute 
to the endothelium of blood vessels in the embryo proper (Plein et al., 2018). If a contribution of 
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embryonic haemoglobins to the aortic endothelium is true then a re-evaluation of the EHT paradigm 
is required.  However, it cannot be absolutely ruled out that this is not an artefact of RNA Velocity as 
it is unclear whether all embryonic cell types have equivalent splice kinetics which may affect the 
direction of velocity. This relationship needs to be demonstrated functionally and with further single 
cell analyses before any real conclusions can be drawn.  
It must be noted that the single cell data were just one replicate and that further single cell analyses 
would strengthen the conclusions drawn from this analysis. The ‘contamination’ by non-CD34 
expressing cells in the single-cell dataset provided the possibility of an exploration of the niche cells 
which was of great use. However, it is highly likely that not all niche cell sub-types were captured as 
expression of certain genes found highly expressed in the ventral mesenchyme, such as REN were not 
found in the dataset indicating that these cells were missing. It is unlikely that this is the result of drop-
outs, where the gene is below the threshold of expression detected by the datasets, as expression 
levels were high in the LCM-Seq dataset. This dataset also did not let us explore the HSPC population 
in much resolution as the cell numbers captured were small. An alternative single-cell technique such 
as Smart-Seq2 may be more appropriate for this as it allows for deeper sequencing of small sorted 
populations. 
The analyses described in this discussion demonstrates how application of what is known in model 
organisms can be consolidated with the datasets in this work to uncover probable analogous 
mechanisms of HSC specification such as for TNFα signalling. These can then be a starting point for 
experiments to functionally validate the proposed mechanisms. The combined datasets are also a 
source of previously unexplored potential players such as the plasminogen activators, osteopontin and 
novel HSPC specific TFs, to name a few. The next section describes how these datasets can be used to 
functionally explore novel players which is the focus of the rest of this thesis.  
 Using the dataset as a starting point for functional validation experiments  
The combined spatial transcriptome, bulk-seq and single cell analyses provide a detailed, multi-
dimensional description of the developmental haematopoietic niche. It has revealed many genes and 
pathways with a potential influence on HSC emergence and which may serve as the foundation of 
future functional assays. In this work, REN and EDN1 have been the focus due to their ventral 
enrichment and relevant downstream pathways (see Chapter 3 discussion 3.4.5). Resolution of their 
central pathway components found only ACE marks the HSPC population itself which is in line with 
previous reports that it is an HSC marker in the human embryo (Jokubaitis et al., 2008; Sinka et al., 
2012). By immunostainings and in situ hybridisation, REN itself was found most strongly expressed 
surrounding the endothelial cells of ventro-lateral branching vessels although weaker expression was 
seen localised in spots beneath the ventral aortic endothelium. It will be interesting to see if these 
spots correspond to endothelial expression of the angiotensin receptor AGTR1 which was expressed 
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exclusively on the GJA5 endothelial subset (cl.0) in the single cell analysis. This is the same cluster with 
the highest and most consistent expression of EDN1, and its activating enzyme ECE1. It would also be 
interesting to see whether the EDN1 hotspots seen on the RNAScope analysis correspond with GJA5 
expression.  
EDN1 was highly upregulated in the endothelial cells compared to the progenitors, and although 
expression of EDN1 may not contribute towards HSC identity itself, the high correlation of EDN1 
hotspots with sites of Runx1+ IAHCs suggests that it may be an important niche signal. Furthermore, 
cl.0 contains Notch ligands JAG1, DLL4, and downstream TF HEY2 adding further evidence that these 
cells are important niche cells. Notably, ET-1 (endothelin-1 protein) treatment of giant cell tumour 
stromal cells increases expression of Jagged1, Hey2 and Mmp2 (also cl.0 enriched), increasing cell 
growth and migration (Yuan et al., 2019). EDNRB expression was both on the endothelial cells 
themselves and on the mature haematopoietic cells as shown on the bulk-seq, single cell, RNAScope 
and IHC analyses. ET-B (endothelin receptor B, protein) was seen expressed on the top of the IAHCs, 
yet EDN1 is expressed in the endothelium. This leaves a gap of VC+CD45+ progenitors between them 
raising the question of whether ET-1 is secreted across them. The immunostainings indicate that 
although EDN1 is expressed on the endothelial cells, the protein can be seen expressed on rounded 
cells at the bottom of IAHCs suggesting that the progenitors express ET-1 at the protein level.  
EDNRB expression in the endothelium was seen on individual cells interspersed throughout the 
endothelium. Further co-staining experiments of the EDNRB probe with IAHC marking antibodies may 
help define whether selective EDNRB expression is related to HSPC emergence. The EDNRB also had a 
pattern of expression on cells streaming down from the spinal ganglia to the ventral mesenchyme 
below the dorsal aorta consistent with the ventral migration pattern of the neural crest,  Notably, in 
the mouse, neural crest cells fated to become melanocytes and enteric neuronal cells express Ednrb 
and at E9.5 are found in ventro-lateral positions adjacent to the bifurcated dorsal aorta (Lee, Levorse 
and Shin, 2003). In zebrafish neural crest cells migrate towards the dorsal aorta making contact with 
it at the onset of HSC emergence and perturbation of this contact leads to loss of HSCs (Damm and 
Clements, 2017). Previous studies suggest that sympathetic ganglia derived from the neural crest 
lodging beneath the dorsal aorta influence HSC emergence (Fitch et al., 2012). This study indicates 
that these effects may be mediated by endothelin signalling.  
 Concluding remarks 
Combining the spatial transcriptome dataset with single-cell and sorted bulk population sequencing 
as well as fluorescent microscopy has resolved polarised signalling pathways to discrete populations 
facilitating modelling of potential mechanisms behind HSC emergence. However, the data in this thesis 
have thus far been descriptive and the proposed mechanisms theoretical. As proof of the utility of this 
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dataset, the next chapter aims to define a functional role for endothelins and renin in promoting HSC 
emergence in the AGM. 
5. Functional analysis of the role of Renin and Endothelin in promoting HSC generation 
In the preceding chapters, renin and endothelin-1 were identified as candidates with a potential role 
in promoting HSC generation. In this chapter the mouse floating reaggregate culture system is used to 
assess whether these factors can increase HSC numbers derived from the AGM and how they influence 
haematopoietic output.  
 Renin and endothelin pathway genes are enriched in the ventral domain of the 
mouse AGM during HSC development 
A recent publication from this lab investigated D-V transcriptome differences in the mouse AGM at 
the time of development of HSCs (E10.5) and their precursors pre-HSCs (E9.5)(McGarvey et al., 2017). 
Genome-wide RNA sequencing was carried out on the sub-dissected dorsal and ventral domains of 
AGMs pooled from 15-34 embryos in 3 experiments, providing robust spatial transcriptome data. 
Using this dataset, the polarisation of central renin and endothelin pathways’ genes could be 
elucidated (Fig.58). This included genes encoding renin and endothelin isoforms and the angiotensin 
and endothelin converting enzymes. Every gene was ventrally enriched at either E9.5, E10.5 or both 
except for Ece2 which was slightly dorsally enriched. Ren1 has some of the lowest expression levels of 
all the genes but exhibited consistently high differential expression in the ventral vs dorsal domain. 
Ace2 had high log2 fold change (FC) enrichment in the ventral domain at E9.5 and E10.5 whereas Ace 
had a more modest log2 FC enrichment at E9.5 only, suggesting that in mouse Ace2 and not Ace may 
be the RAS effector influencing haematopoiesis. Both Edn1 and Edn3 showed ventral enrichment at 
E9.5 only whereas Edn2, although expressed at much lower levels, had a much higher ventral 
enrichment at both E9.5 and E10.5. Ece1 was the most highly expressed gene taken for this dataset 
and had a roughly two-fold ventral enrichment at E9.5 and E10.5. 
Transverse sections of E10.5 embryos were immunostained using antibodies for CD31 and cKit, to 
visualise IAHCs, and ET-1 (Endothelin-1). Intriguingly, within the dorsal aorta ET-1 was found to be 
expressed most highly on the cKit+ IAHCs on the cell membrane (Fig.59). Expression was often 
localised to the membrane exposed to the lumen of the dorsal aorta. There was also lower expression 
throughout the sub-aortic mesenchyme.  
Taken together this shows that both renin and endothelin pathway gene expression is polarised in the 
mouse AGM indicating analogous roles in the AGM during HSC development. Furthermore, ET-1 
expression on the IAHCs indicates a signalling role on the HSPCs. This opens up the mouse model as a 
system for exploring the functional roles of these pathways in HSC development providing a 
mechanism paralleling that in the human embryo. As Ren1 and Edn1 are homologues of the genes 
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from the human dataset these were used in further functional validation assays along with the 
addition of Edn2 due to its high ventral enrichment.  
 
Figure 58 : Expression of renin and endothelin pathway members in spatial transcriptome data from A. 
McGarvey et al., 2017. a) Log2 fold change of the AoV vs AoD at E9.5 and E10.5. b) Fragments Per Kilobase of 






Figure 59 : ET-1 expression in the mouse dorsal aorta. (Immunostaining done by H. Felchle). E10.5 transverse 
section showing the dorsal aorta (Ao) immunostained with CD31, cKit and ET-1. Arrowheads indicate cKit+ET-1+ 
IAHCs or single rounded cells attached to endothelium. The box indicates a lateral IAHC which is shown at higher 





 Investigation into the functional role of renin, ET-1 and ET-2 in promoting HSC 
emergence 
In order to assess whether any of the three secreted proteins are able to enhance HSC emergence E9.5 
caudal tissues and E10.5 AGMs were cultured for 7 days as cell reaggregates or explants respectively, 
on membranes floating on media with addition of one of the 3 factors at either 10ng/µl or 100ng/µl 
(Fig.60).  At the end of the culture period the effect of the factors on haematopoietic output was 
assessed through haematopoietic colony (CFU-C) assays and immunophenotypic analysis of the 
haematopoietic stem/progenitor and mature cell compartments. E9.5 reaggregates were also 
transplanted into irradiated mice in a repopulation assay to assess the effect on HSC production.  
 
Figure 60. Experiment layout for E9.5 floating reaggregate cultures and assays to assess the effects of Renin, 
ET-1 and ET-2 on developmental haematopoiesis. E9.5 caudal parts were dissociated into single cells and 
reaggreged (1 embryo equivalent / aggregate). The reaggregates were cultured on floating membrane cultures 
supplemented with IL3, Flt3, SCF and addition of one of the test factors. After 7 days cells were dissociated and 
analysed by repopulation assay, CFU-C assay and immunophenotypic analysis.  
 
 In vitro haematopoietic colony forming-cell assay indicates a trend towards more 
immature colony types after culture with renin and endothelins. 
E9.5 caudal tissue were dissociated into single cells and cultured for 7 days as reaggregates on a 
floating membrane system with addition of haematopoietic cytokines SCF, IL3 and Flt3 (SIF) as well as 
one of the factors of interest, renin, ET-1 and ET-2 at 2 concentrations each; 10ng/µl and 100ng/µl 
(Fig.60). Notably, CFU-C total numbers decreased with addition of any of the factors (Fig.61ai). A look 
at the numbers of different colony types showed that CFU-Mac which derive from a more mature 
progenitor committed to macrophage production, are the main cause for the reduction in total CFU-
C numbers after culture with renin, ET-1 or ET-2 which is significant for ET-1 100 (Mann-Whitney U 
test, p < 0.05) (Fig.61aii). However, there is a trend towards production of higher numbers of more 
immature CFU-Cs with greater differentiation potential: colony-forming unit-granulocyte, erythroid, 
macrophage, megakaryocytes (CFU-GEMM), for each of the added proteins, significantly for the ET-2 
100 (Fig.61aiv, Mann-Whitney U test, p < 0.05). Colony-forming unit-granulocyte, macrophage (CFU-




Figure 61 CFU-C numbers for a) E9.5 caudal parts (n=4) and b) E10.5 AGM cultures (n=3). i: Total CFU-Cs. ii: CFU-
Mac. iii: CFU-GM iv: CFU-GEMM. Error bars indicate standard deviation around the mean. CFU-C numbers that 




E10.5 AGM explants were also cultured for 7 days with addition of one of Ren, ET-1 or ET-2 at 10ng/µl 
and 100ng/µl but this time without FCS and SIF cytokines to remove potential confounding effects of 
these factors. At this stage there was again a trend towards higher numbers of CFU-GEMMs but also 
a higher numbers of CFU-GMs for each test condition with the exception of Ren 10ng/µl CFU-GM 
numbers (Fig.61bi,iii,iv). The increase in both these types of early progenitor colony resulted in a net 
increase of overall colony numbers for all test conditions except Ren 10ng/µl and this was statistically 
significant for Ren 100ng/µl (paired t-test, p<0.001). Taken together, the data highlight a potential 
drive of production of multipotent progenitors over more mature progenitor types when renin, ET-1 
or ET-2 are added to the haematopoietic cultures of both E9.5 and E10.5 AGM cells. 
 Phenotypic characterisation of AGM cell populations cultured with Ren, ET-1 and ET-2  
After 7 days of E9.5 reaggregate culture with Ren, ET-1 or ET-2 the cell phenotypes of the reaggregates 
were analysed with two panels of antibodies to investigate A) HSC/HSPC and vessel wall cell 
compartments (Fig.62) and B) the haematopoietic lineage compartments (Fig.64). In Panel A, the 
HSC_HSPC compartment was defined as VC+Sca1+Kit1+CD44+CD41lo CD45+ (Fig.62a-c). From the 
VC+CD45-CD41-CD146- endothelial compartment, CD44 was used to define arterial vs. venous 
endothelium (Fig.62g). Perivascular and epithelial populations were also analysed using CD146 and 
EpCAM from the VC- population respectively (Fig62d-e). 
For each of the test culture conditions there is an increase in the proportion of cells in the SK+ and VC-
CD45+ haematopoietic cell populations compared to the control suggesting that, although not 
statistically significant, all 3 factors may have a positive influence on haematopoiesis in the cultures 
(Fig.63). However, there is no increase in the phenotypically defined HSC_HSPC population.  Although 
modest, addition of both endothelins to culture increases the proportion of the aortic and venous 
endothelium compared to control. Conversely the epithelial compartment appears reduced in these 
conditions suggesting a drive for endothelial over epithelial production. No difference was seen in the 
perivascular compartment.  
After 7 days of E10.5 explant culture there are not many appreciable differences in the cell populations 
analysed (Fig.64). However, it is of note that ET-1 10 has the highest average SK+, HSC_HSPC and VC-
CD45+ haematopoietic populations and the highest number of CFU-GEMMs in the haematopoietic 
colony assay (Fig.61). This suggests that ET-1 has a positive influence on haematopoietic progenitor 
production. However, the higher concentration shows reduced levels of VC+, SK+, HSC_HSPCs and VC-
CD45+ populations indicating that the effect of ET-1 is dose dependant at E10.5. 
Panel B defines mature haematopoietic lineages through a series of markers to determine whether 
addition of any of the factors to culture skews haematopoietic differentiation towards one lineage or 
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another (Fig.65a). The populations analysed are defined as Monocytes and early macrophage 
progenitors(Mo, Gr1-CD11b+), Gr1+CD11b- granulocytes, macrophages (Mac, Gr1+CD11b+), B220-
CD3+ lymphoid cells, B cells (B220+CD3-), pro-B cells (B220+CD3-CD45+CD5+), NK Cells (CD335+CD5-
), unknown population B220-CD5+, erythrocytes (All-Ter119+) and dendritic cells (DC, All- 
CD11c+)(Fig65a(a-d)). 
For E9.5 cultures an increase in the proportion of B cells within the total live cell population is seen in 
Ren and ET-2 higher concentrations and both concentrations of ET-1 (Fig.65b). This is accompanied by 
the appearance of a population positive for both the B cell and T cell markers (B220+CD3+). Such 
double positive cells have been found in the foetal liver defining a lymphoid progenitor cell with both 
T cell and B cell potential (Sagara et al., 1997). This population is thus denoted as a lymphoid 
progenitor (Fig.66). The percentage increase in B cell and lymphoid progenitors in the Ren 100, ET-1 
10 and ET-1 100 cultures (1.37, 0.9 and 1.66% respectively) are accompanied by a similar reduction in 
proportions of the monocyte and macrophage populations (-2.06, -1.68 and -1.48%) respectively 
(Fig.65b). This suggests that these factors may skew differentiation towards lymphoid rather than 
myeloid lineages in haematopoietic culture conditions.  
For both concentrations of Ren there is a dilution dependant increase of the Gr1+CD11b- population 
which may be a granulocyte subset (Fig.65b). Finally, in the ET-2 culture there is a reduction in B220-
CD3+ cells which may include T cells and a marginal increase in the proportion of dendritic cells within 
the total live population.  
The phenotype of haematopoietic cells was also analysed after 7 day culture of E10.5 AGMs for one 
experiment (Fig 65c). Haematopoietic output was much higher for this later stage culture as would be 
expected, with haematopoietic cells making up a higher proportion of the live cells than at E9.5. The 
increase in B cell production seen for E9.5 was not replicated at E10.5 except for ET-1 10. Production 
of Gr1+CD11b- cells were no longer seen in the Ren cultures but a significant population in ET-1 100. 
There was no evidence of the population termed lymphoid progenitor in the E10.5 cultures, suggesting 
that production of this population derives from earlier cells produced at E9.5.  
Taken together, although addition of the each of the factors to culture does not have a statistically 
significant effect on any of the cell types analysed the data suggests that each factor drives a push 
towards an increase in haematopoietic output and that each factor may favour differentiation of 





Figure 62. HSC_HSPC and vessel wall cell phenotype analysis of cultures after 7 days floating membrane culture. 
Gating strategy for Panel A. The top 3 plots shows gating for cells of interest, single cells and live cells respectively. 






Figure 63. E9.5 phenotypic analysis of HSC_HSPC and vessel wall populations after 7 days floating membrane 
culture with Ren, ET-1 or ET-2 (10ng/µl and 100ng/µl each). N=4. Error bars are standard deviation around the 





Figure 64. E10.5 phenotypic analysis of HSC_HSPC and vessel wall populations after 7 days floating membrane 





Figure 65: Haematopoietic lineage analysis of AGM cells after 7 day culture. a) Panel B gating strategy 
for analysis of E9.5 (n=3) (b) and E10.5 (n=1) (c) cells after 7 days culture as reaggregates and explants 
respectively. Proportions of haematopoietic cell types are shown as a percentage of live cells. 





 In vivo transplantation assays demonstrate that Ren, ET-1 and ET-2 positively influence 
HSC production in E9.5 haematopoietic cultures. 
Following 7 days E9.5 caudal tissue culture with either Ren, ET-1 or ET-2 cells were dissociated and 
transplanted into irradiated Ly5.1 mice. Donor repopulation (CD45_2) was assessed at 8 weeks and 18 
weeks to confirm that repopulation was long-term. In each of 3 experiments the control gave no 
repopulation, which is likely due to the lack of support from OP9 cells in culture (Fig.67b,c)(Rybtsov et 
al., 2011). In contrast each of the 3 test conditions gave repopulation (>5%) at both high and low 
concentrations which was significant (p<0.05, paired t-test) for both Ren 100 and ET-2 100. ET-2 100 
had the highest number of long-term repopulated mice with 6/12 although Ren 100 had a similar 
number 5/12 but with higher reconstitution levels overall. ET-1 10 had more mice repopulated than 
ET-1 100 (3/12 compared to 1/12) which corresponds with ET-1 10 having a higher average SK+ 
population compared with ET-1 100 for both E9.5 and E10.5 cultures. 
  
Figure 66. Example plots demonstrating appearance of a B220+CD3+ population for Ren 100, ET-1 10 and ET-100 
conditions – indicated with an asterisk. The cell populations shown are from the Gr1-CD11b- population of live 





Figure 67 Addition of renin and endothelins increases the number of HSCs derived from E9.5 caudal part 
reaggregate cultures a) Example gating strategy for donor population CD45_2 cells from the peripheral blood of 
transplanted mice. Erythroid cells are first excluded (left panel). Single cells and live cells were gated as before. 
Short term (8 weeks) and Long-term (18 weeks) repopulation levels for each condition is shown in b) and c) 
respectively. An asterisk indicates statistically significant differences in the test condition compared with control 
(paired t-test, p<0.05).  
 
At 20 weeks, mice were culled and multilineage analysis was carried out on haematopoietic organs to 
assess whether the repopulating HSCs gave multilineage reconstitution according to the gating 
strategy in Fig.68. Ren cultured HSCs reconstituted all lineages with a balance as previously described 
for E9.5 AGM cultures (Rybtsov et al., 2014) with a dominant myeloid population in the bone marrow 
(BM), more balanced myeloid-lymphoid contribution in the blood and a lymphoid bias in the spleen 
(Fig.69a). ET-1 10 shows a similar distribution of lineages in the BM and spleen. In the blood however, 
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there is a greater proportion of T cells and minimal myeloid output. Conversely, ET-1 100 produces a 
drive for myeloid cell production in the BM, blood and spleen with almost no T cell or B cell production 
at all in the BM and very little in the blood. ET-2 has the opposite effect with a high lymphoid output 
in the BM and marginal myeloid cell production in blood. CD4 and CD8 T cell populations in the thymus 
were also analysed including CD4+CD8+ thymocytes and mature CD4+ helper and CD8+ cytotoxic T 
cells. Levels were equivalent for each condition (Fig.69b), indicating unimpaired homing of thymocytes 
to the thymus from the bone marrow and maturation.  
 
  
Figure 68. Gating strategy for analysis of multilineage reconstitution of mice transplanted with 
E9.5 reaggregate cultured CD45.1 cells. Bone marrow, blood spleen were analysed with panel (a) 
and thymus with panel (b). Plot  in (b) is from donor cells gated in the same way as (a) and 





Figure 69. Multilineage analysis of transplanted mice at 20 weeks for two experiments: a) Relative proportion 
of haematopoietic cell subtypes in bone marrow (BM), blood and spleen. (b) Relative proportions of CD4/CD8 T 






All 3 of the secreted factors investigated, renin, ET-1 and ET-2 have a positive effect on HSC generation 
from cells of the E9.5 embryonic caudal tissue as demonstrated by the repopulation assay. At E9.5 
there are no pre-HSCs or adult-type HSCs yet present in the AGM, only pro-HSCs (Rybtsov et al., 2014) 
which are matured to HSCs during the 7 day culture with cytokines. Culturing the reaggregates with 
OP9s provides the cells with a stabilising stroma and maturation is robust. However, OP9s were not 
used here in case they provided signals which confound the effects of the factors being tested. Indeed, 
datasets from (McGarvey et al., 2017) show that Ren and ET-2 are expressed in OP9s at low levels and 
ET-1 at high levels. Without supporting OP9s the conditions were not supportive enough to derive 
HSCs from the control AGMs across 3 experiments. The reconstitution of mice from cultures with each 
renin, ET-1 and ET-2 indicate that these factors produced more favourable conditions for the 
production of HSCs with the strongest effects seen for renin and ET-2. It is unknown whether this is an 
enhanced maturation of pro-HSCs to adult-type HSCs,  an increase in production of pro-HSCs from the 
haematogenic endothelial cells, or an expansion of pre-existing HSCs. More experiments will be 
required to investigate this. It may also be of use to co-culture the reaggregates with OP9s in order to 
get repopulation from the control cells and check that enhanced reconstitution in the test conditions 
holds true.  
Intriguingly, ET-1 had contrasting effects at the lower and higher concentrations. At E9.5 ET-1 10 
showed a slightly higher average SK+ population than ET-1 100 in the cultured cells which was even 
more exaggerated at E10.5 as well as in the HSC_HSPC and VC-CD45+ haematopoietic compartments. 
ET-1 100 in fact, had reduced SK+, HSC_HSPC and VC-CD45+ compartments compared with all other 
conditions. This suggests that the lower concentration may have a stimulatory effect on 
haematopoiesis which becomes inhibitory at the higher concentration. This is further evidenced by 
the higher levels of reconstitution in the repopulation assay by ET-1 10 over ET-1 100. Furthermore, 
the two concentrations appear to give different balance of multilineage reconstitution with ET-1 100 
having a high myeloid bias, particularly in the bone marrow and blood compared to a more balanced 
reconstitution for ET-1 10.  
The mouse model was used for these experiments due to the lack of availability of sufficient human 
samples for functional assays. Analysis of the previously published mouse AGM spatial transcriptome 
(McGarvey et al., 2017) demonstrated conserved ventral enrichment of renin and endothelin pathway 
components indicating that a functional role for these factors may be conserved across mouse and 
human also. Furthermore, the close association of ET-1 protein expression with the IAHCs in the E10.5 
mouse as was demonstrated in the human dorsal aorta in chapter 2 is further evidence of a conserved 
role between species. It is therefore likely that the stimulatory effect on the generation of HSCs 
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established in these experiments would be demonstrable with human cells. To this end human PSCs 




6. Concluding Remarks 
The goal of this project was to generate an in-depth analysis of signalling within the human HSC 
developmental niche. Due to the relative lack of availability of early human embryos and the sensitivity 
of the material, signalling in the human AGM has thus far not been well characterised. Experiments in 
the mouse and other animal models have been highly informative towards our understanding of the 
processes and pathways underlying adult-type HSC emergence in the embryo. Although many 
mechanisms are conserved between model species and human, each organism has unique differences. 
This makes understanding the human AGM of great clinical importance as human-specific niche signals 
may be what are required to derive fully functional HSCs in culture.  
Signalling across the AGM is polarised across the dorsal-ventral axis with both ventral and dorsal 
signals contributing towards promoting HSC emergence (Peeters et al., 2009; Souilhol et al., 2016a; 
McGarvey et al., 2017). HSC emergence itself is polarised to the ventral domain of the dorsal aorta 
(Taoudi and Medvinsky, 2007b; Ivanovs et al., 2011). This project set out to define the signals that 
cause HSCs to emerge in this spatio-temporally controlled manner. In order to interrogate the 
transcriptome of the dorsal aorta and surrounding cells without losing important spatial information, 
laser capture microdissection was used. The resulting spatial transcriptome provided a detailed map 
of signalling across the dorsal aorta region. Of particular use are the data revealing polarised genes 
and pathways across the dorsal-ventral axis. These polarised factors are the most likely candidates to 
have a role in regulating emergence of HSCs. In this study the genes REN and EDN1 were chosen as 
the focus of functional assessment but this dataset can serve as the starting point for investigation of 
many other factors.  
Renin, endothelin-1 and endothelin-2 were shown to positively influence HSC emergence through 
functional validation experiments which emphasises the utility of the datasets generated in this 
project. These experiments were in mouse and it is now important to begin functionally assessing 
these factors in a human model, namely human PSC cultures. Using the most current protocols to 
derive HSC-like cells from PSCs, these factors can be added to the culture at several time points i.e. 
mesoderm induction or haematogenic endothelium specification, to assess whether these factors can 
functionally improve the HSCs generated. Lessons from developmental biology have greatly facilitated 
attempts to derive HSCs artificially. These datasets are an additional contribution to the field to aid 
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8. Appendix Figures 
 
Appendix 1. CS16 LCM-Seq sample N3_Cut 1 (C1). Immunostaining of VE-Cadherin (VC) and Runx1. This region 




























Appendix 2 Control slides: ai-iii)) CS16 human transverse section with RNAScope positive controls for each 
channel (C1-Opal520, C2-Opal570, C3-Opal690). NT = neural tube. Nc = Notochord. b) Negative control for 
RNAScope. C) Negative control for human CS16 immunostain with secondary antibodies only. 
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